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Background: Identification of permanent hearing impairment at the earliest possible age is crucial to
maximise the development of speech and language. Universal newborn hearing screening identifies the
majority of the 1 in 1000 children born with a hearing impairment, but later onset can occur at any
time and there is no optimum time for further screening. A universal but non-standardised school entry
screening (SES) programme is in place in many parts of the UK but its value is questioned.
Objectives: To evaluate the diagnostic accuracy of hearing screening tests and the cost-effectiveness of
the SES programme in the UK.
Design: Systematic review, case–control diagnostic accuracy study, comparison of routinely collected
data for services with and without a SES programme, parental questionnaires, observation of practical
implementation and cost-effectiveness modelling.
Setting: Second- and third-tier audiology services; community.
Participants: Children aged 4–6 years and their parents.
Main outcome measures: Diagnostic accuracy of two hearing screening devices, referral rate and source,
yield, age at referral and cost per quality-adjusted life-year.
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Results: The review of diagnostic accuracy studies concluded that research to date demonstrates
marked variability in the design, methodological quality and results. The pure-tone screen (PTS)
(Amplivox, Eynsham, UK) and HearCheck (HC) screener (Siemens, Frimley, UK) devices had high sensitivity
(PTS ≥ 89%, HC ≥ 83%) and specificity (PTS ≥ 78%, HC ≥ 83%) for identifying hearing impairment. The
rate of referral for hearing problems was 36% lower with SES (Nottingham) relative to no SES (Cambridge)
[rate ratio 0.64, 95% confidence interval (CI) 0.59 to 0.69; p< 0.001]. The yield of confirmed cases did not
differ between areas with and without SES (rate ratio 0.82, 95% CI 0.63 to 1.06; p= 0.12). The mean age
of referral did not differ between areas with and without SES for all referrals but children with confirmed
hearing impairment were older at referral in the site with SES (mean age difference 0.47 years, 95% CI
0.24 to 0.70 years; p< 0.001). Parental responses revealed that the consequences to the family of the
referral process are minor. A SES programme is unlikely to be cost-effective and, using base-case
assumptions, is dominated by a no screening strategy. A SES programme could be cost-effective if there are
fewer referrals associated with SES programmes or if referrals occur more quickly with SES programmes.
Conclusions: A SES programme using the PTS or HC screener is unlikely to be effective in increasing the
identified number of cases with hearing impairment and lowering the average age at identification and is
therefore unlikely to represent good value for money. This finding is, however, critically dependent on the
results of the observational study comparing Nottingham and Cambridge, which has limitations. The
following are suggested: systematic reviews of the accuracy of devices used to measure hearing at school
entry; characterisation and measurement of the cost-effectiveness of different approaches to the ad-hoc
referral system; examination of programme specificity as opposed to test specificity; further observational
comparative studies of different programmes; and opportunistic trials of withdrawal of SES programmes.
Trial registration: Current Controlled Trials ISRCTN61668996.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment; Vol. 20, No. 36. See the NIHR Journals Library website
for further project information.
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NHBRU Nottingham Hearing Biomedical
Research Unit
NHI not hearing impaired
NHSP Newborn Hearing Screening
Programme
NICE National Institute for Health and
Care Excellence
NIHR National Institute for Health
Research
OAE otoacoustic emission
OME otitis media with effusion
PenCTU Peninsula Clinical Trials Unit
PSA probabilistic sensitivity analysis
PTA pure-tone audiometry
PTS pure-tone screen
QALY quality-adjusted life-year
QUADAS quality assessment of diagnostic
accuracy studies
ROC receiver operating characteristic
SD standard deviation
SES school entry screen(ing)
SNPC sensorineural or permanent
conductive
TEOAE transient-evoked otoacoustic
emission
UNHS Universal Newborn Hearing
Screening
WTE whole-time equivalent
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Plain English summary
D iscovering if a child has problems with their hearing is important for development and education.Screening babies when they are born identifies most problems but hearing problems can start at any
age. Many parts of the UK screen children for hearing problems when they start school but others have
stopped doing this. We wanted to see whether having the screen was better or worse than not having it.
We also wanted to see what was the best test to use.
We compared the screening test that is most commonly used, the pure-tone screen (PTS) (Amplivox,
Eynsham, UK), with a hand-held device, the HearCheck screener (Siemens, Frimley, UK), which might be
quicker to use but has not been used in schools before.
We found the two tests were equally good at finding children with hearing problems but that school
nurses preferred to use the PTS.
We compared an area that has a school hearing screening programme (Nottingham) with an area that
does not (Cambridge). We found that more children were referred for further testing in the area that did
not have the screen but there was little evidence of a difference between the areas in terms of finding the
children with problems.
We found that not having the screen when children start school is as good as having it in terms of finding
children with problems and is probably better value but there has to be another system in place to find
children. This usually depends on parents, schools and health professionals noticing promptly when a child
might have hearing problems and referring them.
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Scientific summary
Background
Identification of permanent hearing impairment at the earliest possible age is crucial to maximise the
development of speech and language, and contribute to the best opportunities for educational achievement
and quality of life. Approximately 1 in every 1000 children in the UK is born with a permanent bilateral
hearing impairment > 40 dB (average across four frequencies: 0.5, 1, 2 and 4 kHz) and a further 0.6 per
1000 has a unilateral impairment. This equates to 800 children per year born with a permanent bilateral
hearing impairment (moderate or greater) and 500 with a unilateral impairment. The introduction of the
highly sensitive and specific Universal Newborn Hearing Screening (UNHS) programme has led to the
identification of the vast majority of children born with a hearing impairment who undergo the screen.
However, not all children who will ultimately have a hearing impairment are identifiable at birth.
The adjusted prevalence of permanent hearing impairment > 40 dB (average of 0.5, 1, 2 and 4 kHz) at age
3 years is reported as 1.07 per 1000 and the prevalence for children aged 9–15 years as 2.05 per 1000.
Thus, because of acquisition, progression or late onset of hearing impairment and/or geographical
movement of families, there remains a significant number of children to be identified with a permanent
hearing impairment after the newborn period. The onset of hearing impairment in children can occur at any
time, which means there is no optimum time for a further universal hearing screen. The universal distraction
hearing test, established in the UK in the 1950s and undertaken by health visitors at around 8 months of
age, was abandoned following the introduction of UNHS, based on a lack of robust implementation and
a low yield of cases. Without formal screening between the newborn period and school entry, identification
of hearing impairment in children is achieved through parental and professional awareness and a close
follow-up of children who pass the neonatal screen but are considered to be at risk. A universal hearing
screen when children start school, the school entry screening (SES) programme, was established in 1955
and remains in place in many parts of the UK. It is considered as a ‘back-stop’ screen to identify children as
part of a ‘captive population’ at school entry.
Objectives
The overarching aims of this project were to evaluate the diagnostic accuracy of hearing screening tests
and the cost-effectiveness of screening for hearing impairment at school entry in the UK.
The specific research objectives of this project were:
l to update the latest systematic review of diagnostic accuracy of tests used for SES, summarising the
literature that has been published since the previous review and drawing together the evidence from
the previous review and the updated review
l to estimate and compare the diagnostic accuracy of the pure-tone screen (PTS) (Amplivox, Eynsham, UK),
and HearCheck (HC) screener (Siemens, Frimley, UK) tests for discriminating between children with a
hearing impairment (of any type) and children with no hearing impairment, using pure-tone audiometry
(PTA) results as the reference standard
l to investigate the impact of a potential false-negative result by reviewing the literature on the impact
of false-negative results from screening tests and describing children with false-negative screening
results in the diagnostic accuracy study
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l to compare children referred for investigation of suspected hearing impairment in a geographical area
that applies a routine SES programme (Nottingham) with those referred in an area with no routine SES
programme (Cambridge) with respect to the number of referrals, the age at referral, the source of
referral, the route through assessment to intervention, the number of children ultimately identified to
have a hearing impairment (yield) and the nature of hearing impairment identified
l to determine the impact, both psychological and economic, for the child and the family of the child
being referred for further assessment following SES (both true and false positives)
l to determine the time resource in implementing either of the two alternative screening methods
(PTS and HC) in primary schools and to elicit the views of the school nurses implementing the
screening tests
l to refine an existing SES economic model {from the 2007 Health Technology Assessment (HTA) report
[Bamford J, Fortnum H, Bristow K, Smith J, Vamvakas G, Davies L, et al. Current practice, accuracy,
effectiveness and cost-effectiveness of the school entry hearing screen. Health Technol Assess 2007;11(32)]}
and assess the cost-effectiveness of the SES programme
l to estimate the health-related quality of life, costs and utilities of the SES programme compared
with no screening, and of the PTS compared with HC screener, with comparisons based on cost per
quality-adjusted life-year (QALY) gained.
Methods
In order to explore and summarise the existing literature we updated the review of diagnostic test accuracy
reported in a previous HTA report and reviewed the literature on false-negative rates in hearing screening.
For children with a known hearing impairment and for children assumed to have no hearing impairment
we compared the diagnostic accuracy of two screening methods administered at or around the time
children start school. These were the established and widely used PTS (which is applied using headphones)
and HC screener (a hand-held PTS). We used PTA as a reference standard.
The yield, referral age and route through assessment to intervention for childhood hearing impairment
were assessed for a paediatric audiology service that implements a routine universal SES programme
(Nottingham) and one that does not (Cambridge) by collecting data prospectively for all children aged
between 3 years and 6 years 364 days.
We surveyed parents of children referred from the SES programme in Nottingham via a postal
questionnaire to assess the impact for the child and the family of a positive result from a screen (both true
and false positives).
We determined the time spent in implementing either of the two screening tests in primary schools and
explored the practical issues involved and the views of nurses conducting the screening tests.
The component data from each study were used to refine an existing SES economic model, providing
robust estimates of key parameters beyond accuracy of SES to be assessed; in particular, the yield and
nature of hearing impairment detected in a system with no SES progamme; the yield, consequences and
costs of screen-positive individuals in an SES programme; and the costs of setting up a SES programme.
SCIENTIFIC SUMMARY
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Results
The updated review of diagnostic accuracy studies confirms the conclusion from the 2007 HTA report that
research to date demonstrates marked variability in the design, methodological quality and results. Robust
conclusions about the performance of individual test types for use in SES cannot be drawn. It was
found that:
l Parental questionnaires had the poorest diagnostic accuracy compared with all other tests.
l The findings from the new audiometry-based studies evaluating computer-based devices and the HC
screener reported higher and more consistent specificity but lower and widely varying sensitivity
estimates compared with the sweep PTA studies included in the original report.
l Studies evaluating transient-evoked otoacoustic emissions reported variable sensitivity with wide
confidence intervals (CIs), whereas specificity estimates were relatively high and more consistent.
l The study evaluating the automated auditory brainstem response reported high sensitivity
and specificity.
The review included studies from countries with and without an established UNHS system and with very
different systems of health-care delivery. The generalisability of the findings to other situations, including
the UK NHS system, is likely to be limited.
The findings of our diagnostic accuracy study indicate that the PTS and HC devices have a high level of
sensitivity (PTS ≥ 89%, HC ≥ 83%) and specificity (PTS ≥ 78%, HC ≥ 83%) for identifying hearing
impairment at the level of the ear. These conclusions appear robust, the child-level analyses indicating
similar levels of sensitivity and specificity.
From our review of the existing literature and data from the diagnostic accuracy study, we are unable to
quantify the effect of false-negative results for the PTS or HC screener, but were able to confirm that the
rate was extremely low. Of the 16 ears in our diagnostic study (total n= 630) that passed one or both of
the screening tests but were referred by the PTA measure, only four were confirmed to have a hearing
impairment at diagnostic evaluation and all were mild.
There was strong evidence that the rate of referral for hearing problems is lower when a SES programme
is present. The referral rate was 36% lower in Nottingham (SES) relative to Cambridge (no SES) (rate ratio
0.64, 95% CI 0.59 to 0.69; p< 0.001).
There was little evidence that the yield of confirmed cases differs between areas with and without a SES
programme (rate ratio 0.82, 95% CI 0.63 to 1.06; p= 0.12); a higher proportion of referred children were
subsequently confirmed to be hearing impaired in the area with a SES programme (17.0% in Nottingham
vs. 10.6% in Cambridge).
The mean age of referral was nearly identical between areas with and without a SES programme when
looking at all referrals, but for children who were subsequently confirmed as having a hearing impairment
there was strong evidence that the children in the site with a screening programme are older at referral
(mean age difference 0.47 years, 95% CI 0.24 to 0.70 years; p< 0.001).
We found from our survey of parents of children referred by the SES programme in Nottingham that the
consequences of the referral process for parents and children, including false positives, are minor.
The difference for parents whose child is referred by the SES programme is that they may have had no
concerns prior to the screening test.
We demonstrated minimal differences between the PTS and HC screener in terms of time taken to
conduct each examination and practical issues. Testing covered a range of schools throughout the school
year and thus we suggest the findings might be generalisable beyond the Nottingham schools.
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Our economic modelling showed that SES is unlikely to be cost-effective and, using base-case assumptions,
is dominated by a no screening strategy. This is consistent with the observed results of the clinical studies,
which suggest that cases of hearing impairment are identified in similar numbers but at a younger average
age in the absence of SES.
Two situations where SES might be cost-effective were identified. In the first situation, a reduction in the
number of referrals associated with SES or, conversely, an increase in referrals without SES, can give a
cost-effectiveness ratio for the no screening option above the National Institute for Health and Care
Excellence (NICE) £30,000 per QALY benchmark. This is supported by the observation from our clinical
study that the referral rate (and by assumption, potential false positive rate) was lower in the site where
SES had been in place for many years. However, in order for this to be the case, the reduction in referrals
would need to be attributable to SES and there is considerable uncertainty about this. The second situation
is subject to still greater uncertainty and requires referrals to happen more quickly with screening than is
observed from our study comparing SES and non-SES sites.
Conclusions
In the context of the UK NHS, and similar health-care systems, SES using screening tests, such as the PTS
and HC screener, is unlikely to be effective in increasing the number of cases of hearing impairment
identified and lowering the average age at which these cases were identified. SES is also unlikely to be
cost-effective when judged against the benchmarks normally used by NICE, relative to a system entirely
reliant on ad-hoc referral when a suspicion of hearing impairment is raised.
Implications for practice
Although our finding of the lack of cost-effectiveness of SES may be considered as a reason to withdraw
SES where it is currently being practised, we would highlight aspects of the results that suggest caution.
First, we have shown that there are at least two scenarios in which it may be cost-effective. Second, our
findings are very dependent on findings in the two specific areas (Nottingham and Cambridge) that
were used here, and our conclusions from comparing areas with a SES programme and without a SES
programme may not be generalisable to other areas. Third, the cost-effectiveness of SES depends on how
effective (or ineffective) the ‘no SES system’ is. This in turn is highly dependent on the effectiveness of
ad-hoc identification and referral for a diagnostic evaluation with an audiologist (DEA), which is not only
largely unknown, but likely to be variable. It seems plausible that SES may have greater potential to be
cost-effective where ad-hoc identification and referral is less well developed than in a system where it is
well established. If withdrawal of the SES programme is to be considered it needs to be carefully managed
to ensure that the ad-hoc referral system is working effectively. Health professionals, school and nursery
staff, and parents who would then be responsible for referral of children about whom there were concerns
in the school entry year may need to be reminded to be more vigilant for signs of hearing impairment.
Implications for research
Systematic reviews of the accuracy of devices, which might be used to measure hearing in children at
around school entry age, should continue to be pursued.
Characterising and measuring the cost-effectiveness of different approaches to the ad-hoc referral system
with a view to optimising it should be undertaken.
Examination of the process by which concern, or referral from SES, is converted into DEAs would be useful
to inform further research on what determines programme specificity (as opposed to test specificity).
SCIENTIFIC SUMMARY
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We should improve understanding of why the referral rate varies across different sites and determine if this
is related to the presence of SES. Further observational studies similar to our comparison between
Nottingham and Cambridge could be undertaken, albeit recognising the difficulty of matching the
geographical areas.
Further research to better quantify the impact of referral, particularly with respect to anxiety, and whether
or not all referrals are affected to the same degree as respondents in our study may be required,
particularly if it appears that overall effectiveness and cost-effectiveness could be critically dependent on
the costs and disutility experienced by false positives.
If withdrawal of SES is contemplated in particular settings, this could be used as an opportunity for further
data collection; in particular where the pattern of referrals and cases was known over many years in the
run up to withdrawal, any change in pattern of referrals/cases could be very useful evidence confirming
the lack of effectiveness and cost-effectiveness of SES, or challenging it. More formally, if SES cessation is
being contemplated in many areas, a randomised trial of withdrawal of SES services could be designed
using referrals and hearing impairment cases identified as outcomes.
Trial registration
This trial is registered as ISRCTN61668996.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Background and main questions
Childhood hearing impairment and screening
Identification of permanent hearing impairment at the earliest possible age is crucial to maximise the
development of speech and language and contribute to the best opportunities for educational achievement
and quality of life.1 Approximately 1 in every 1000 children born in the UK has a permanent bilateral hearing
impairment of > 40 dB (average across four frequencies: 0.5, 1, 2 and 4 kHz) and a further 0.6 per 1000 has a
unilateral impairment.2 This equates to 800 children per year born with a permanent bilateral hearing
impairment (moderate or greater) and 500 with a unilateral impairment. The introduction of the highly
sensitive and specific Universal Newborn Hearing Screening (UNHS) programme has led to the identification of
the vast majority of children born with a hearing impairment who undergo the screen.3,4 However, not all
children who will ultimately have a hearing impairment are identifiable at birth. Data published in 20015
reported an adjusted prevalence of permanent hearing impairment of > 40 dB (average of 0.5, 1, 2 and
4 kHz) at age 3 years of 1.07 per 1000 and a prevalence for children aged 9–15 years of 2.05 per 1000. Thus,
because of acquisition, progression or late onset of hearing impairment and/or geographical movement of
families, there remain a significant number of children to be identified with a permanent hearing impairment
after the newborn period. The onset of hearing impairment in children after the newborn period can occur at
any time, which means there is no optimum time for a further universal hearing screen. The universal
distraction hearing test, established in the UK in the 1950s and undertaken by health visitors at around
8 months of age, was abandoned following the introduction of UNHS, based on a lack of robust
implementation and a low yield of cases.6,7 Identification of hearing impairment in children in the time
between the newborn period and school entry is achieved through parental and professional awareness and a
close follow-up of children who pass the neonatal screen but are considered to be at risk.8 A universal hearing
screen when children start school, the school entry screening (SES) programme, was established in 1955 and
remains in place in many parts of the UK. It is considered as a ‘back-stop’ screen to identify children as part of
a ‘captive population’ at school entry. Note: SES always refers to the hearing screening in this report.
A number of studies and reviews2,9–12 have explored evidence for the value of the SES programme but
without clear conclusions. Research has shown that the number of children identified by this screen
around age 5 years (the yield) has decreased following the introduction of UNHS, and widespread
development of a system that is responsive to professional and parental concerns at any age.8,12 The SES
programme is no longer universally applied. Bamford et al.12 reported in 2007 that one in eight services
had stopped offering the screen by 2005 and it is more likely that others have stopped since 2005 than
that services have reinstated the screen. There are no guidelines on standard methodology nationally and
procedures are variable. However, despite a lack of evidence of its value, many support its continuation
as a ‘back-stop’ to identify an acknowledged small number of children who would otherwise not be
identified with the consequent effect on their development of speech and language.
Childhood hearing impairment can be permanent (usually sensorineural although permanent conductive
impairment also occurs) and will not improve, or transient (also referred to as conductive) and will usually
fluctuate and can get better.
A sensorineural impairment occurs when the inner ear (cochlea) or auditory nerve does not function
properly; this can be caused by many factors. As mentioned, the majority of children with sensorineural
impairments will have been identified by the newborn screening programme. However, there is the
possibility that a child has a progressive impairment that, at birth, was minimal and therefore enabled
them to pass the newborn screen. It is also possible for a child to develop a sensorineural impairment.
Sensorineural impairments are permanent and require management to ensure that the child has access to
language; management is usually to fit children with hearing aids or cochlear implants.
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Many more children will have a transient hearing impairment at some point in their childhood than will
have a permanent impairment. A conductive loss occurs when there is a problem with the outer or middle
ear, such as impacted wax in the ear canal or a build up of fluid in the middle ear [otitis media with effusion
(OME), which usually is associated with colds and respiratory tract infections]. Conductive impairments are
usually temporary, unless there is a malformation of the outer or middle ear, which can lead to a permanent
impairment. Prevalence is greatest in the first year of life and again at around age 4–5 years. For children
< 6 years, 80% will experience OME.13,14 Most episodes of OME get better in a couple of months but a
small proportion (3–4%) can be persistent and severe and lead to problems with behaviour, communication
and progress at school. It is therefore important to identify those children with an ongoing problem,
as their hearing impairment needs management to ensure that they can access spoken language clearly.
The recommended management options are initially to watch and wait. Owing to the fact that the majority
of these transient impairments will resolve spontaneously, most children will be observed for 3 months
before any active management takes place, then the usual options are surgical insertion of grommets if the
child’s hearing impairment meets national recognised criteria,15 or for them to be fitted with a hearing aid.
Some children with permanent sensorineural impairments may also have an additional transient conductive
impairment that would require management.
Screening tests for hearing impairment identify any child who has a hearing impairment. The tests do not
discriminate between a permanent impairment and a transient impairment. They are also able to identify
a hearing impairment in one ear or in both ears. Thus, all children with a hearing impairment, whether
permanent or transient, bilateral or unilateral, should be identified by the screening test if it is
100% sensitive.
Testing children between the ages of 4 and 6 years can be difficult. Most tests require the engagement of
the child in a simple task, such as raising their hand or putting a ball on a stick. Some children may find it
difficult to maintain their attention throughout the test and this can give rise to spurious results. It is
important that the screener/tester has experience in working with children to enable them to identify when
their attention could be affecting the results of the test and be able to change their own behaviour
accordingly to engage with the child. At any age it is possible that some children may not be able to
co-operate with the testing because of specific learning or behavioural needs.
The pure-tone screen (PTS) (Amplivox, Eynsham, UK) test involves placing headphones over the child’s ears
and then presenting pure tones across the key frequencies for speech understanding (0.5, 1, 2 and 4 kHz).
The child needs to indicate by a simple action that they have heard a sound. The screen works on the basis
that a child needs to hear two out of three presentations of each frequency at 20 dB hearing level (HL) in
each ear to pass the screen.
The HearCheck (HC) screener (Siemens, Frimley, UK) is placed over the child’s ear and an automatic
sequence of pure tones is played once at each of three levels at each of the frequencies 1 kHz (55 dB,
35 dB and 20 dB) and 3 kHz (75 dB, 55 dB, 35 dB), which is six tones in total. The child needs to indicate,
usually by raising their hand that they have heard each tone.
Any child identified by a screening test as having a possible hearing impairment should be referred to
audiology services, but many children at school entry have a transient conductive impairment and hence it
is the case that many children referred will ultimately be found to have no permanent impairment.
The commonly used screening method of the PTS can identify all types of impairment. Specifically
including tympanometry would indicate a problem with the middle ear, but only by including both air
and bone conduction thresholds from pure-tone audiometry (PTA), masked where necessary, could a
conductive impairment be indicated.
BACKGROUND AND MAIN QUESTIONS
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This is important because there are conflicting opinions on the target group of children to be identified by
SES. Should it be designed to only identify children with a permanent impairment for whom intervention
is a priority, or should it be designed to identify any impairment to ensure every child is assessed
appropriately and intervention provided for all who would benefit, regardless of the permanence of the
condition? For this report, in both the analyses of diagnostic accuracy in Chapter 3 and in the analyses of
yield in Chapter 5, we have considered identification of any type of impairment as the outcome for
assessing the screening tests or the screening programme as a whole.
Previous Health Technology Assessment study
A previous National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme-
commissioned study to evaluate SES by Bamford et al.12 reported a survey of current practice, longitudinal
data on yield, a systematic review of effectiveness of SES (which included a systematic review of the
diagnostic accuracy of screening tests) and an economic model estimating cost-effectiveness. The 2007 HTA
report12 concluded that there was insufficient good-quality data on which to base a decision about the value
of SES following the introduction of UNHS. The executive summary of the report is included as Appendix 1.
However, the 2007 study did report longitudinal data from a single district in London which indicated a
small but significant number of children with a permanent hearing impairment first identified via SES in
that particular population,8 and national survey data which reported examples of children not identified by
other methods.
One of the recommendations of the 2007 HTA report12 was the need for trials to compare the
effectiveness and cost-effectiveness of alternative approaches to the identification of a post-newborn
screen for permanent hearing impairment. Studies concerned with the relative accuracy (in terms of
sensitivity and specificity) of alternative screening tests are difficult to compare and are often flawed by
differing referral criteria and differing case definitions. The 2007 HTA report12 identified 25 publications
reporting studies of alternative screens or tests for screening at school entry. These data indicate that,
using full PTA as the reference standard, the PTS test appears to have high sensitivity and high specificity
for minimal, mild and greater hearing impairments – better than alternative tests for which evidence was
identified. Spoken word tests were reported with acceptable levels of sensitivity and specificity but are
variable in their implementation. Otoacoustic emissions (OAEs), tympanometry, acoustic reflectometry,
parental questionnaires and otoscopy were reported with either variable or poor sensitivity and specificity.
Only one study, published in 1980,16 has compared screening with no screening and the results
were inconclusive.
Assessment of cost-effectiveness
In order to best provide a service for the identification of permanent childhood hearing impairment while
making best use of scarce NHS resources, it is important to gather robust evidence to support particular
cost-effective implementations of service delivery at times relevant to the aetiology of hearing impairment
and the child’s development. There is no question that screening for hearing impairment at birth is
efficient and cost-effective,3 but the value of any further universal screen remains uncertain. Aside from the
minimal and very weak evidence for the effectiveness and cost-effectiveness of different implementations
of SES reported by the 2007 HTA report12 we are not aware of literature on the resource implications of
different implementations or different technologies. A version of the HC screener has been evaluated as a
screening tool in children in only one published paper,17 but it did not report any resource use.
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Study aims and objectives
The two overarching aims of this project were to evaluate the diagnostic accuracy of hearing screening
tests and to assess the cost-effectiveness of screening for hearing impairment at school entry.
The specific research objectives of this project were:
l To determine and compare the diagnostic accuracy of two screening methods used to identify hearing
impairment at or around school entry. These are the widely established PTS (which is applied using
headphones) and the HC screener, a hand-held PTS.
l To investigate the impact of a potential false-negative result.
l To update the 2007 HTA report12 systematic review of diagnostic accuracy of tests used for SES.
l To assess the yield, referral age and route through assessment to intervention for childhood hearing
impairment and measure the costs of referrals for a service that employs a routine SES programme
and for a service that does not.
l To determine the impact, both psychological and economic, on the child and the family of the child
being referred for further assessment following the school entry hearing screen (both true and
false positives).
l To determine the resource costs in implementing either of the two alternative screening methods in
primary schools and to elicit the views of the school nurses implementing the screening tests.
l To refine an existing SES economic model (from the 2007 HTA report12) and to assess the
cost-effectiveness of SES.
l To provide estimates of the yield and nature of hearing impairment detected in a system with no SES
system; the yield, consequences and costs of screen-positive individuals in a SES system; and the costs
of setting up a SES system.
This study thus addressed the question of whether or not there should be a screening programme to
identify permanent hearing impairment in children when they start primary school. It assessed if the cost
of such a screen is appropriate for the outcomes achieved, that is, the number of children identified by this
method compared with a system with no screen, which is responsive to parental or professional concern,
along with comparisons of diagnostic accuracy of two different ways of doing the screen. Based on the
findings, we make recommendations to contribute to decisions regarding the continued implementation
of SES and the form that implementation should take.
Structure of the project and the report
The project comprised four primary studies, a questionnaire survey and two systematic reviews.
The planned participant flow for the four studies is illustrated in Figure 1.
Chapter 2 reports results from a systematic review undertaken to update the 2007 HTA report12 review of
diagnostic accuracy of tests used for SES.
Chapter 3 reports results from the study that assessed the diagnostic accuracy of two methods of screening
for the identification of hearing impairment for children aged 4–6 years. The PTS (four frequencies and
one level) was compared with the HC screener (two frequencies and three levels) with respect to sensitivity
and specificity.
Chapter 4 reports results from a systematic review of the issues around false negatives in screening
for hearing impairment, and from the diagnostic accuracy study described above.
Chapter 5 reports and compares outcomes, including yield and age at referral, for an area where SES
is in place (Nottingham) and an area where there has been no SES since 1997 (Cambridge).
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Chapter 6 reports results from a questionnaire survey of parents of children referred to audiology services
in Nottingham from SES. Data on parent experience are reported.
Chapter 7 reports results of a study of the practical implementation of the two screening tests in a primary
school environment.
Chapter 8 reports results from the cost-effectiveness model of SES. Data from Chapters 3, 5, 6 and 7
informed the parameters in the model.
Finally, Chapter 9 summarises the discussion points from each part of the project and makes conclusions
and recommendations.
Patient and public involvement
We acknowledge the importance of the involvement of members of the public in all health research.
This project evaluated a screening system for children and input from parents to the development and
interpretation of the research question was very important. Recruiting such a person proved challenging,
as parents have childcare responsibilities and/or employment considerations, which mean they have
little time to spare and commit to a 2.5-year project. Having advertised and discussed the project with
several parents, most of whom were unable to commit the time, we recruited the parent of a child who
had experienced conductive hearing impairment during his early school years. This parent became a full
member of the research team (JW).
He provided comments on research literature for parents, including the questionnaire used for the survey
of parents of children referred to audiology services from SES. He also contributed to the development of
methodology, offering advice on how to deal with lower-than-expected recruitment. He attended all the
meetings of the research team, either in person or via the telephone, and contributed to discussions of
the findings, presentation of results and development of recommendations. The project addressed various
issues concerned with the identification of hearing impairment in children, and we recognise that
individual parents may have experience of only one part of the service. Nonetheless, they bring the lay
perspective to research design and, as an individual, represent other parents. To access input from a wider
range of parents we recruited a representative from the National Deaf Children’s Society to the project
steering group. Based on the guidelines issued by INVOLVE (the organisation funded by NIHR to support
public involvement in NHS, public health and social care research) we provided reimbursement to the
parent joining the research team for their input of an average of 1 day per month to advise the design
and attend research meetings. In addition all travel costs were reimbursed.
BACKGROUND AND MAIN QUESTIONS
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Chapter 2 Update of the diagnostic accuracy
systematic review
Introduction
This chapter presents an update of the systematic review of the diagnostic test accuracy undertaken in the
2007 HTA report.12 That report identified 25 publications reporting studies of alternative screens or tests for
screening at school entry, showing that, using full PTA as the reference standard, the PTS test appears to
have high sensitivity and high specificity for minimal, mild and greater hearing impairments – better than
alternative tests for which evidence was identified. Other tests (spoken word tests, OAEs, tympanometry,
acoustic reflectometry, parental questionnaires and otoscopy) had either variable or poor sensitivity and
specificity. Using additional evidence published since the 2007 HTA report, the aim of this update was to
produce an updated summary of diagnostic test accuracy.
Objectives
To update the 2007 HTA report systematic review of diagnostic accuracy of tests used for SES. This work
summarises the literature that has been published since the previous review and draws together the
evidence from the previous review and the updated review.
Methods
Search strategy
The search strategy used and published in the 2007 HTA report on SES12 was reviewed and updated
by an information specialist in the Peninsula Technology Assessment Group and re-run to identify studies
published in the period January 2005 (search cut-off date of 2007 report, May 2005) to July 2014
(see Appendix 2). The following electronic databases were searched: The Cochrane Library (via Wiley)
(Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Database
of Abstracts of Reviews of Effects), MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations
(via Ovid), EMBASE (via Ovid), Cumulative Index to Nursing and Allied Health Literature (via Ovid), PsycINFO
(via Ovid), Science Citation Index (via Web of Science), Education Resources Information Center and
ongoing trial databases (National Research Register, ClinicalTrials.gov and Research Findings Register).
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Inclusion/exclusion criteria
The inclusion and exclusion criteria were identical to those of the 2007 HTA report12 unless
stated otherwise:
l Study design: we included all primary diagnostic accuracy studies regardless of their specific design.
l Population: we included children 4–6 years old. We excluded studies with a discrete age range that
was completely outside our criteria (e.g. 1–3 years or 7–10 years). If a study included 4- to 6-year-old
children but the age range was too wide (e.g. 6–19 years) and the results for different age categories
were not reported separately, the study was also excluded from the review. We included, however,
studies that at least partially covered but slightly exceeded the 4–6 years age range (e.g. 5–10 years)
provided they met all other inclusion criteria. Whenever relevant and possible, the age of the included
children is noted in the list of excluded full-text studies (see Appendix 2).
l Screening tests or programmes: studies that evaluated one or more of the following hearing screening
tests were included: sweep PTA, single-frequency PTA, transient-evoked otoacoustic emissions (TEOAE),
distortion product otoacoustic emissions, questionnaires, otoadmittance tests, tympanometry,
reflectometry and speech audiometry. (Note: sweep PTA and PTS are alternative terms for the same
procedure. Where publications have used the term sweep PTA this description has been maintained.)
Tests had to have been undertaken in either a primary school or the community [e.g. community clinic,
family home or general practitioner (GP) surgery]. This could include hearing screening as a component
of a multifaceted screen, such as a school entry medical examination.
l Comparator: no hearing screening or hearing screening based on different tests or test protocols.
We did not exclude studies without a comparator (studies that evaluated a single screening test) as
long as they measured the performance of the evaluated test against an acceptable reference standard.
l Reference standard: we included all studies that assessed the accuracy of the evaluated test(s) against
a reference standard that included PTA.
l Outcomes: the 2007 HTA review12 had a wider scope and also included studies that reported (1) the
screen performance, that is, uptake (the number of children who actually received the screen) and yield
(the number of cases identified); and (2) screen effectiveness, that is, language skills, health-related quality
of life, communication skills, social interaction and educational performance. The current update focused
on diagnostic accuracy only and included studies that reported the diagnostic accuracy of the evaluated
test(s), regardless of whether or not the reported data were sufficient to reconstruct two-by-two table(s).
l Language: no language restrictions were applied to the search and selection of studies.
Selection of studies and data extraction
After removing the duplicates, all records identified by the electronic searches were screened
independently by two reviewers (HF and ZZ) at title and abstract level. Full-text copies were obtained for all
publications identified as potentially relevant by at least one of the reviewers. Their suitability for inclusion
in the review was assessed by one reviewer (ZZ) and checked by a second reviewer (CH) against the criteria
specified above. Data were extracted from included studies by one reviewer (ZZ), entered into an Excel 2010
(Microsoft Corporation, Redmond, WA, USA) spreadsheet and checked by a second reviewer (CH).
Disagreements in the selection of studies and data extraction were resolved through discussion. Data were
extracted from studies published in a language other than English with the help of a translator.
UPDATE OF THE DIAGNOSTIC ACCURACY SYSTEMATIC REVIEW
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Assessment of the methodological quality
Although a new version of the quality assessment of diagnostic accuracy studies (QUADAS) tool used in
the 2007 HTA review12 is now available, the difference between the two versions is mainly in the structure
and process of customising the tool and does not concern the contents of the actual checklist.18,19
Therefore, we assessed the methodological quality of the included studies using the original QUADAS
checklist from the 2007 HTA review. This allowed for a direct comparison between the quality of the
studies included in the 2007 report and in the current update. However, we provided more specific
definitions of some QUADAS items that were not explicitly defined in the original checklist (see
Appendix 2).
Statistical analysis and data synthesis
Whenever possible, two-by-two tables were used to report the numbers of true-positive, false-positive,
false-negative and true-negative results. The sensitivity and specificity of the index test (the test under
evaluation) were calculated using The Cochrane Collaboration’s Review Manager (RevMan) software
version 5.3 (The Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark). The same
software was used to create forest plots of the paired sensitivity and specificity estimates and to plot the
true-positive rate (sensitivity) versus the false-positive rate (1 - specificity) in receiver operating characteristic
(ROC) space. Heterogeneity was investigated visually by examining the forest plots and the ROC plot, and a
decision was made whether or not to pool the results across studies. As standard funnel plots and tests for
publication bias are not recommended in systematic reviews of diagnostic accuracy studies, we did not
investigate publication bias.20
Results
Search results and selection of studies
The electronic searches returned 892 papers after removal of duplicates. Screening at title or/and abstract
level led to 39 citations being identified as potentially relevant. A further seven citations were found
through hand-searching.
We obtained full-text copies of 45 of these studies and failed to obtain one.21 After full-text evaluation
10 studies were selected for inclusion in the review.17,22–30 Figure 2 details the selection process while the
reasons for exclusion of full-text papers are given in Appendix 2.
Citations retrieved after
removal of duplicates
(n = 892)
Papers selected for
full-text screening
(n = 46)
Citations excluded on the
bases of title and/or abstract
(n = 853)
Studies excluded
(see Appendix 2)
(n = 35)
1 unobtainable
Additional titles found 
by hand-searching
(n = 7)
Primary studies included
(n = 10)
FIGURE 2 Flow diagram of the selection process.
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Characteristics of included studies
The characteristics of the included studies are summarised in Tables 1 and 2. Briefly, 10 primary studies
were included in this update.17,22–30 One was published before 200524 but was included here as it had
been missed by the original 2007 HTA report.12 The other nine studies were published in the period
2005–2014.17,22,23,25–30 Four of them were conducted in China22,23,27,30 and one in each of the following
countries: Brazil,25 Greece,29 Japan,26 Kenya,24 the Philippines17 and the USA.28
TABLE 1 Study characteristics: sampling and participants
Source and
country
Sampling and inclusion
criteria Exclusion criteria
Number of
children
(% male)
Mean age in
years, (SD)
or range
Bu et al.,22 2005,
China
Convenience sample of children
grade 1–6 studying at one
primary school
No exclusion criteria
(except for a lack of consent)
317 (49.5) 9.43 (1.79)
Georgalas et al.,29
2008, Greece
Convenience sample of primary
school children (6–12 years old)
in one geographical area
No exclusion criteria
(except for a lack of consent)
86 (52.0) 8.7 (2.0)
Gloria-Cruz et al.,17
2013, Philippines
Convenience sample of grade
one elementary school children
from three metropolitan schools
No exclusion criteria
(except for a lack of consent)
418 (56.9) 8.6 (n/a)
Li et al.,23 2009,
China
Convenience sample of children
grade 1–6 studying at one rural
school
No exclusion criteria
(except for a lack of consent)
154 (n/a) 9.3 (1.7)
McPherson et al.,30
2010, China
Convenience sample of children
6–8 years old from a mainstream
urban primary school
No exclusion criteria (except
for a lack of consent) but no
children with known cognitive or
hearing impairments took part
80 (62.5) 7.04 (0.74)
Newton et al.,24
2001, Kenya
Convenience sample of children
attending nursery schools and
child health clinics in districts
with audiologically trained ENT
officers
No exclusion criteria 735 (49.1) 5.2 (n/a);
range
2.21–7.5
Samelli et al.,25
2011, Brazil
Convenience sample of children
2–10 years old living in an
underserved metropolitan area
with no UNHS
None specified 214 (59.3) Range 2–10
Soares et al.,26
2014, Japan
Convenience sample of children
3–5 years old from a mainstream
kindergarten (unclear if children
from the nearby special school
for hearing impaired children
were also included in this age
group)
Children unable to lie down
still for several minutes
(unable to complete
procedure); lack of consent
115 (n/a) Range 3–5
Wu et al., 2014,27
China
Random sample
(5%, randomisation procedure
not described) of 6288 eligible
children enrolled from 41
kindergartens from a district area
with a total of 106 kindergartens
Children who refused to
participate or had learning
disabilities
312 (52.2) 5.06 (0.72)
Yin et al., 2009,28
USA
Convenience sample of children
2–6 years old who are
socioeconomically at risk
(14% special education
students) attending preschools in
a large, urban, metropolitan
school district
No exclusion criteria specified
(except for the lack of consent)
but no children previously
identified with hearing
impairment took part
135 (n/a) Range 2–6
ENT, ear nose and throat; n/a, not available; SD, standard deviation.
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Although the majority of the included children were at or around school entry age, there was marked
variability in terms of age range. Children’s age ranged from 225,28 to 13 years23 with the mean age ranging
from 5.1 years [standard deviation (SD) 0.7 years]27 to 9.4 years (SD 1.8 years)22 (three studies25–27 did not
report mean age and only gave age range as an inclusion criterion). The studies were relatively balanced in
terms of participants’ gender, the proportion of males ranging from 48.4%26 to 62.5%30 (two papers23,28
did not report details). Apart from lack of consent, most studies did not specify any other exclusion criteria.
One study26 excluded children who were unable to lie down still for several minutes, which was a necessary
requirement for completing the screen procedure; one study27 excluded children with learning disabilities
and two studies26,30 commented that no children with known cognitive or hearing impairments were
included but it was unclear if this had been a prespecified exclusion criterion. Seven studies17,22–25,27,30
were conducted in countries without established UNHS.
Studies evaluated the performance of questionnaires (n= 4), audiometry (n= 3), TEOAE (n= 3) and
automated auditory brainstem response (AABR) (n= 1). AABR is usually used to screen infants and was not
listed in the initial inclusion criteria. However, we decided to include the study, as it evaluated, probably
for the first time, the use of AABR in SES. Two studies22,23 evaluated different versions of the Chinese
Hearing Questionnaire for School Children (CHQS). Only one study22 compared directly the performance
of two different tests, a questionnaire and TEOAE, and one study29 evaluated a combination of TEOAE and
tympanometry but did not report the results as adding tympanometry had not improved performance.
Questionnaires were completed by parents or carers in two studies,22,23 either by parents/carers or by
teachers or community nurses interviewing parents (three different testing conditions) in one study24
and by unspecified evaluators in one study.25 All other index tests were performed either by audiologists,
otolaryngologists or other professional staff who had some preliminary training. With the exception of
questionnaires, all other tests were performed at school or a community health centre in a quiet but not
sound-treated room and the ambient noise level was monitored.
All studies except those evaluating questionnaires used a prespecified positivity threshold to define ‘pass’
and ‘refer’ outcomes. Data-driven selection of a threshold to achieve optimal performance (best sensitivity
and/or best specificity) could lead to overly optimistic diagnostic accuracy estimates and the test is likely to
perform worse when the same threshold is used in an independent sample of patients.31
The reference standard was a combination of otoscopy, tympanometry and audiometry in four
studies,22,23,25,29 otoscopy, tympanometry, audiometry and OAEs in one study,27 ear, nose and throat (ENT)
examination including audiometry in two studies,24,26 and audiometry only in three studies.17,28,30 The tests
were performed by audiologists and otolaryngologists, usually in quiet but not sound-treated rooms with
monitored ambient noise.
The mean prevalence of the target condition across all studies that reported outcomes at the level of
the individual was 10.8% (SD 12.6%) and ranged from 0.7%28 to 46.7%.25 The prevalence in the only
study that reported ear-level outcomes was 4.8%.17 These numbers should, however, be treated with
caution, as the studies varied in their pass/refer criteria and included convenience samples drawn from
populations likely to be different in terms of prevalence and spectrum of hearing impairments.
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Methodological quality of included studies
The definitions of the assessment criteria are given in Appendix 2 and the results from the methodological
quality assessment are summarised in Table 3. All studies had a prospective cross-sectional single-gate
design. ‘Single-gate’ is a term introduced by Rutjes et al.32 to describe diagnostic accuracy studies in which
a single sample drawn from the target population receives the index test and the reference standard to
allow calculation of the test’s sensitivity and specificity. In contrast, in ‘two-gate’ designs sensitivity and
specificity are calculated separately based on two different samples of participants, that is, one with and
one without the target condition. The two-gate design is prone to spectrum bias as the mix of participants
in the two samples combined is unlikely to be representative of the target population.32 Therefore, studies
using a single-gate design are considered to be of better methodological quality.
Although all included studies had a single-gate design, none of them included a representative sample of
a relevant target population defined for the purpose of this review as 4- to 6-year-old children (± 1 year) at
or around school entry stage who have no high-risk features (such as Down syndrome, cytomegalovirus
infection or meningitis) and have been tested and found to have no hearing impairment at birth.
Therefore, the studies are likely to suffer from a selection bias and to have limited applicability to the UK
context because of the following methodological issues. First, some studies included children younger or
older than the defined 4–6 years age range, which reflects, to some extent, the fact that school entry age
varies across countries. Second, seven of the studies17,22–25,27,30 were conducted in countries without
established UNHS, which is likely to impact on the prevalence and spectrum of hearing impairments in the
included children. Third, most of the studies included small self-selected samples recruited from a single
locality and, therefore, may not be representative, even when drawn from a relevant target population.
The execution of the index test(s) and the reference standard were reported in sufficient detail in the
majority of the studies. In five studies,17,24,26,28,30 however, the reference standard was suboptimal and did
not meet the quality criterion ‘PTA+ tympanometry’. The time between the performance of the index test
and the reference standard was < 1 month in four studies,17,22,23,30 was > 1 month in one study28 and was
not reported in five studies.24–27,29 Blinding of the index test evaluators to the results of the reference
standard was not reported in three studies22,26,29 and blinding of the reference standard evaluators to the
results of the index test was not reported in five studies.22,23,26,27,29 Those criteria that were consistently met
across the studies were questions 5–9 (see Appendix 2) concerning the application of the same reference
standard to the whole or random sample, regardless of the index test result (verification bias); the
independence of the reference standard from the index test (incorporation bias) and the description of
index test and reference standard in sufficient detail to allow replication. According to the criteria for
calculating a total quality score published in the 2007 HTA report,12 three studies25,26,29 were of ‘moderate’
quality (total score 7–9) and the remaining seven studies17,22–24,27,28,30 were of ‘good’ quality (total score
of > 9).
Test accuracy
Given the significant heterogeneity in the study characteristics and the reported test accuracy estimates
(see Table 2 and Figure 3) we considered quantitative synthesis inappropriate and, instead, summarised the
performance of different test types in tables and figures (Figures 3 and 4, and Table 4).
Parental questionnaires
Four studies22–25 reported the diagnostic accuracy of questionnaires, two of which evaluated different
versions of the same tool (CHQS).22,23 All questionnaires had been independently validated and the authors
reported satisfactory reliability. None of the studies used a prespecified positivity threshold, which means
that the reported diagnostic accuracy might be exaggerated. The two studies evaluating CHQS reported
results from a range of different scores23 or a range of sensitivity and specificity values obtained for
different individual questions and combinations.22 The results included in the forest plot and the ROC curve
plot (see Figures 3 and 4) for these two studies correspond to positivity thresholds that resulted in the best
overall performance: a total score of > 1 for the study by Li et al.,23 and sensitivity of 56% and specificity
of 60% read-off the ROC plot in the paper for the study by Bu et al.22
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TABLE 3 Results from the methodological quality assessment
Study
Representative
spectrum?
Selection
criteria
described?
Acceptable
reference
standard?
Acceptable
time
between
tests?
Whole/random
sample received
the reference
standard?
Same
reference
standard?
Reference
standard and
index test
independent?
Study 1 Bu et al.,22 2005 No Yes Yes Yes Yes Yes Yes
Study 2 Georgalas
et al.,29 2008
No No Yes Not clear Yes Yes Yes
Study 3 Gloria-Cruz
et al.,17 2013
No Yes No Yes Yes Yes Yes
Study 4 Li et al.,23 2009 No Yes Yes Yes Yes Yes Yes
Study 5 McPherson
et al.,30 2010
No Yes No Yes Yes Yes Yes
Study 6 Newton et al.,24
2001
No Yes No Not clear Yes Yes Yes
Study 7 Samelli et al.,25
2011
No No Yes Not clear Yes Yes Yes
Study 8 Soares et al.,26
2014
No No No Not clear Yes Yes Yes
Study 9 Wu et al.,27 2014 No Yes Yes Not clear Yes Yes Yes
Study 10 Yin et al.,28 2009 No Yes No No Yes Yes Yes
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Index test
described?
Reference
standard
described?
Blinded
interpretation
of index test?
Blinded
interpretation
of reference
standard?
Same
clinical data
available as
in practice?
Uninterpretable/
intermediate
results reported?
Withdrawals
explained
Total score
(number
of ‘yes’)
Yes Yes Not clear Not clear Not clear Yes Yes 10 Study 1
Yes Yes Not clear Not clear Not clear Yes Yes 8 Study 2
Yes Yes Yes Yes Not clear Yes Yes 11 Study 3
Yes Yes Yes Not clear Yes Yes Yes 12 Study 4
Yes Yes Yes Yes Yes Not clear Not clear 10 Study 5
Yes Yes Yes Yes Yes Yes Yes 11 Study 6
Yes Yes Yes Yes Yes Not clear Not clear 9 Study 7
Yes Yes Not clear Not clear Not clear Yes Yes 7 Study 8
Yes Yes Yes Not clear Yes Yes Yes 11 Study 9
Yes Yes Yes Yes Yes Yes Yes 11 Study 10
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Across all studies, sensitivity ranged from 44% to 100% and specificity from 55% to 87% (see Figure 3).
The ROC plot in Figure 4 clearly shows that the performance of the questionnaires was poor, with three
of the studies,22,23,25 close to the line of no effect (the dotted diagonal line), which indicates accuracy no
better than expected due to chance. Only the study conducted by Newton et al.24 showed relatively good
overall accuracy with excellent sensitivity (100%) and moderate specificity (75%). However, the definition
of hearing impairment in this study was bilateral hearing impairment of > 40 dB and three of the
four children with unilateral hearing impairment of > 40 dB were missed by the questionnaire. Including
these children in the analysis brings the sensitivity down to 82% while specificity remains the same (75%).
Audiometry
The diagnostic accuracy of audiometry was evaluated in three studies: two evaluated computer-based
audiometers27,30 and one a hand-held device.17 Sensitivity ranged from 23% to 78% and specificity from
92% to 97% (see Figure 3). McPherson et al.30 reported two sets of results – before and after excluding
the data for 0.5 kHz – which they considered problematic owing to possible interference from ambient
noise. With the 0.5 kHz data included, sensitivity was 100% and specificity was 50%; excluding 0.5 kHz
data led to a marked decrease in sensitivity (78%) and increase in specificity (92%). The forest plot and the
ROC plot (see Figures 3 and 4) show that, based on the studies included here, portable audiometry tools
have much better and more consistent specificity, but variable sensitivity, noting, however, that there is a
considerable difference between the technologies evaluated, particularly between the computer-based
audiometers and the hand-held HC screening device.
Transient-evoked otoacoustic emissions
Three studies22,28,29 evaluated the accuracy of TEOAE, one of which compared its performance with that
of a questionnaire (see Figures 3 and 4).22 Sensitivity ranged from 75% to 100% and specificity from
64% to 98%. However, the sensitivity estimate reported by Yin et al.28 had a very wide confidence interval
(CI) (3% to 100%), indicating considerable statistical uncertainty. The comparative study found that the
diagnostic accuracy of TEOAE was superior to that of the questionnaire with sensitivity of 75% versus 56%
and specificity of 98% versus 60%. The sensitivity estimates of the two tests, however, had overlapping CIs,
suggesting that the result might be due to chance rather than real superiority.
Automated auditory brainstem response
Only one study26 evaluated the diagnostic accuracy of AABR as a screening test for school entry children.
This study was conducted in Japan, included children 3–5 years old and the evaluated device, MB11
BERA-phone® (MAICO Diagnostic GmbH, Berlin, Germany), was operated by an audiologist. The study
had the lowest quality score of all included studies (see Table 3) because of a failure to provide a clear
description of the selection process and to report important aspects of the study design, such as time
between index test and reference standard, blinding and availability of clinical data to test administrators.
The test showed very high performance with 100% sensitivity and 94% specificity but the sensitivity
estimate had a relatively wide 95% CI (72% to 100%) owing to a small sample size and a low event rate.
Discussion
Summary of the findings from the 2007 Health Technology
Assessment report
The 2007 HTA report12 included 25 primary studies reporting the performance of a wide range of hearing
screening tests, including parental questionnaires, impedance audiometry/tympanometry, spoken word
tests, otoscopy, audiometry, TEOAE and other tests and combinations of tests. The overall conclusion was
that evidence was of unacceptable variability in terms of methodological quality and study characteristics
and, as a result, drawing strong conclusions about the performance of different tests was not possible.
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With those caveats taken into account and including only the subset of studies that used PTA as a
reference standard, the findings from the 2007 HTA report suggested that: sweep PTA had high sensitivity
and specificity; spoken word tests had acceptable levels of sensitivity and specificity; TEOAE had high
specificity but somewhat lower sensitivity; tympanometry and acoustic reflectometry had variable sensitivity
and specificity; parental questionnaires and otoscopy had poor sensitivity and specificity; and there was
insufficient evidence to comment on the accuracy of combinations of tests (p. 48).
Combining the results from the 2007 Health Technology Assessment report
and the current update
The studies identified in the current update provide additional test accuracy data for the following three
categories of tests evaluated in the original HTA review: parental questionnaires, sweep PTA tests and
TEOAE. Below we discuss the combined evidence from the two sets of studies for each category of tests.
Parental questionnaires
In the 2007 HTA report12 three studies33–35 examined the accuracy of parental questionnaires and reported
sensitivities ranging from 34% to 71% and specificities ranging from 52% to 95%. In the update we
included four studies22–25 evaluating questionnaires that reported sensitivities and specificities in the
range of 44–100% and 55–87%, respectively (Table 5). As none of them used a prespecified positivity
threshold, the reported test accuracy estimates are likely to be overoptimistic and the performance of the
evaluated questionnaires worse when applied in practice. The study by Newton et al.24 reported very high
sensitivity but the definition of hearing impairment was very restrictive and may not be appropriate for
most circumstances. Taking into account the methodological limitations of the studies and the marked
heterogeneity in their results, the combined evidence from the original 2007 HTA report and the current
update suggest that, on the whole, parental questionnaires have poor diagnostic accuracy and may not be
suitable for mass screening, especially in the context of established UNHS and sensitised educational and
health-care systems.
Audiometry-based tests
Five evaluations reported in four studies36–39 included in the original 2007 HTA report and three17,27,30
in the current update evaluated the accuracy of audiometry-based tests. The original five studies,
all assessing pure-tone sweep devices, reported sensitivities ranging from 86% to 100% and specificities
from 65% to 99%. The three studies in the update reported sensitivities in the range of 23% to 78% and
specificities 92% to 97% (Table 6). McPherson et al.,30 achieved high specificity (92%) only after the
results from the 0.5 kHz frequency were excluded from the analysis. This was a post-hoc decision made to
reduce the interference from background noise. With this caveat noted, the new studies reported higher
and more consistent specificity but lower and widely varying sensitivity estimates compared with the
TABLE 5 Sensitivities and specificities of all studies evaluating questionnaires and included in the 2007 HTA report12
and the current update
Report Study Sensitivity, % (95% CI) Specificity, % (95% CI)
Current update Bu et al., 200522 56 (30 to 80) 60 (54 to 66)
Li et al., 200923 67 (38 to 88) 55 (46 to 63)
Newton et al., 200124 100 (75 to 100) 75 (71 to 78)
Samelli et al., 201125 44 (34 to 54) 87 (79 to 92)
2007 HTA report12 Gomes and Lichtig, 200533 71 (n/a) 64 (n/a)
Olusanya, 200134 34 (n/a) 95 (n/a)
Hammond et al., 199735 56 (n/a) 52 (n/a)
n/a, not available.
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original studies. When combined, the results from the two sets of studies are more difficult to interpret, as
there is a marked heterogeneity in both sensitivity and specificity. However, given the gap of > 10 years
between the two sets of studies and the technical differences between the evaluated devices, it might be
more reasonable to interpret the results from the new studies separately instead of combining them with
those from the 2007 HTA review.12
Transient-evoked otoacoustic emissions
Only two of the studies included in the original 2007 HTA report12 evaluated the accuracy of TEOAE.36,40
The first reported sensitivity of 63% and specificity of 91%, and the second one reported sensitivities
ranging from 67% to 100% and specificities from 80% to 98% depending on the ‘refer’ criterion used.
In comparison, three studies22,28,29 were included in the current update, reporting sensitivities from 75% to
100% and specificities from 64% to 98%. Table 7 illustrates the heterogeneity in the results. Although the
new studies reported higher sensitivities, the CIs were very wide, indicating considerable statistical
uncertainty. With the exception of Georgalas et al.29 the specificity estimates across all studies were higher
and more consistent, suggesting a relatively low false-positive rate. We could not identify obvious reasons
for the low specificity reported by Georgalas et al.29 However, this was a small, poorly reported study with
considerable methodological limitations (total quality score= 8) and its results should be interpreted
with caution.
TABLE 6 Sensitivities and specificities of all studies evaluating audiometry-based tests and included in the 2007
HTA report12 and the current update
Report Study Sensitivity, % (95% CI) Specificity, % (95% CI)
Current update Gloria-Cruz et al., 201317 23 (11 to 39) 97 (96 to 98)
McPherson et al., 201030 78 (40 to 97)a 92 (83 to 97)
Wu et al., 201427 38 (15 to 65) 93 (89 to 95)
2007 HTA report12 Sabo et al., 200036 87 (n/a) 80 (n/a)
Orlando and Frank, 198737 Range 82–100b Range 65–90b
Orlando and Frank, 198737 Range 91–100b Range 97–98b
FitzZaland and Zink, 198438 93 (n/a) 99 (n/a)
Holtby et al., 199739 86 (n/a) 70 (n/a)
n/a, not available.
a After excluding the results from 0.5 kHz.
b Same study and for different age groups ranging from 4 to 6 years old.
TABLE 7 Sensitivities and specificities of all studies evaluating TEOAE and included in the 2007 HTA report12 and
the current update
Report Study Sensitivity, % (95% CI) Specificity, % (95% CI)
Current update Bu et al., 200522 75 (48 to 93) 98 (96 to 99)
Georgalas et al., 200829 90 (55 to 100) 64 (53 to 75)
Yin et al., 200928 100 (3 to 100) 94 (89 to 97)
2007 HTA report12 Sabo et al., 200036 63 (n/a) 91 (n/a)
Nozza et al., 199740 67–100 (n/a) 80–98 (n/a)
n/a, not available.
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Other tests
None of the studies included in the original HTA report assessed the accuracy of AABR and none of the
studies included in the update assessed the accuracy of spoken word tests, otoscopy, the audiometric Rinne
test and reflectometry. Although one study29 evaluated the accuracy of tympanometry in combination with
TEOAE it reported results only for TEOAE as adding tympanometry had failed to improve performance.
Conclusion
This updated review confirms the conclusion from the 2007 HTA report12 that, because of a marked
variability in the design, methodological quality and the results of the existing studies, it is not possible
to draw strong conclusions about the performance of individual test types for use in SES.
Moreover, there were significant differences in the technical characteristics of some of the evaluated
devices even when they belonged to the same screening modality (e.g. in the audiometry-based category
there were two computer-based devices, one of which involves joysticks, etc., to help children respond,
whereas the third one was a hand-held device). This is not surprising given that the studies included in
the 2007 HTA and the current update span a period of 30 years. Interpreting their results together,
even in the context of a narrative synthesis, requires careful consideration of the differences between the
evaluated tests, which, in some cases, might be too great to justify such an approach. Combining the
results from more modern devices with those from older ones and making general conclusions based on
all the studies included in a particular category may be inappropriate. The performance of currently
available tests is of interest to policy-makers.
With these caveats in mind, the findings from the current update, interpreted in the context of the 2007
HTA report,12 could be summarised as follows:
l We were able to identify a limited number of studies that provided additional diagnostic accuracy data
for only the following categories of hearing screening tests: parental questionnaires, audiometry-based
tests, TEOAE and AABR. No studies evaluating AABR were included in the 2007 HTA report.12
l Questionnaires had the poorest diagnostic accuracy compared with all other tests. The only study that
directly compared a questionnaire with another test (TEOAE) supported this finding.22
l Audiometry-based tests had high specificity but variable sensitivity.
l Studies evaluating TEOAE reported variable sensitivity with wide CIs, whereas specificity estimates were
relatively high and more consistent (with the exception of one study).29
l The study evaluating AABR reported high sensitivity and specificity.
The majority of the studies were conducted in countries without an established UNHS system and with
variable health-care arrangements and, therefore, the reported results may have limited applicability to
the UK context characterised with a well-established UNHS system, sensitised educational system and
highly accessible and responsive health care.
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Chapter 3 Diagnostic accuracy of the pure-tone
screen and HearCheck screener for identifying hearing
impairment in school children
Introduction
In the survey of practice reported in the 2007 HTA report12 the test used for the hearing screen was
in all cases the PTS but there was a wide variety of implementations of this, with different frequencies,
pass criteria and retest protocols. Studies concerned with the relative accuracy (in terms of sensitivity
and specificity) of alternative screening tests are difficult to compare and often flawed by their use of
different referral criteria and case definitions. As reviewed in Chapter 2, the 2007 HTA report12 identified
25 publications reporting comparative trials of alternative screens or tests for screening at school entry.
Most studies were undertaken in populations where the prevalence of undetected hearing impairment
was considerably greater than that likely to be encountered in a system where a UNHS programme
has been introduced. These published data indicate that, using full PTA as the reference standard,
the PTS test appears to have high sensitivity and high specificity for minimal, mild and greater hearing
impairments; better than alternative tests for which evidence was identified. Spoken word tests were
reported with acceptable levels of sensitivity and specificity but are variable in their implementation.
OAEs, tympanometry, acoustic reflectometry, parental questionnaires and otoscopy were reported,
with either variable or poor accuracy.
A new device, the HC screener, came onto the market in 2005 as a tool for screening for hearing
impairment in adults in a general practice setting. It is hand held and has an automatic presentation of a
series of tones at two frequencies and three levels: 1 kHz at 55, 35 and 20 dB HL, and 3 kHz at 75, 55 and
35 dB HL. It has potential to be a quicker test in the school setting but it has not previously been assessed
as a tool for screening in children.
Objectives
In this chapter we use a two-gate case–control design32 to:
l estimate the diagnostic accuracy of the PTS and HC tests for discriminating between children with a
hearing impairment (of any type) and children with no hearing impairment, using PTA results as the
reference standard
l compare the diagnostic accuracy between the PTS and HC methods.
Measures of diagnostic accuracy are reported at the level of the ear and at the level of the child. From the
outset we considered the ear-level analysis to be primary to the objectives addressed in this chapter
because it directly addresses the question of the accuracy of the tests for discriminating between hearing
and impaired ears. The child-level accuracy estimates are more relevant, however, for informing the
refinement of the existing economic model of the benefits of a SES programme, reported in Chapter 8.
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Methods
Design
This study used a directly comparative two-gate (‘case–control’) design,32 with separate sources (gates)
used to recruit those with the target condition (hearing impairment – cases) and those without (no hearing
impairment – controls). Case children were recruited through audiology services in England whereas the
control children were recruited largely from Nottinghamshire primary schools. The implications of this are
discussed later in this chapter (see Discussion).
Recruitment
Cases were children aged 4–6 years recruited between February 2013 and August 2014 who were identified
by collaborating audiology services [in Nottingham, Sheffield, Leicester (City and County), Chesterfield,
Derby, Mansfield, Lincoln, Birmingham, Huntingdon, Bradford, Rotherham and Doncaster] and who had
permanent sensorineural or conductive hearing impairment averaged across the four frequencies 0.5, 1, 2
and 4 kHz, either bilaterally (average of 20–60 dB HL) or unilaterally (any level ≥ 20 dB HL). The senior
paediatric audiologist in each centre drew up a list of all children meeting the definition criteria. Audiologists
were given stamped envelopes to address and post to potential participants and agreed together with the
researchers when to send the letters. Each identified family was sent a letter on behalf of the research team
inviting them to take part in the study, together with information about the study. Children were not invited
to take part if they were unwell such that their illness would affect the results of the tests or if the
responsible audiologist felt it would be inappropriate or cause added unnecessary burden (e.g. seriously or
terminally ill family member). Parents willing to take part replied directly to the research team. Eligible
children for whom agreement was provided to take part were invited to undergo the two screening tests,
either in their own homes, or at Nottingham Hearing Biomedical Research Unit (NHBRU), depending on
their preference. Researchers sent holding letters if necessary for children < 4 years old, explaining that an
appointment would be made for them after their fourth birthday. The reference standard definition of
hearing impairment was based on PTA results, thus case children were also excluded if there was no record
of a PTA in the previous 12 months or planned for the following 3 months, and if the family was unwilling
to travel to their local service or to Nottingham to undergo the assessment.
Control children, defined as having no previously identified hearing impairment, were recruited from the
Foundation Year and Year 1 of schools in the Nottingham area, between February 2013 and June 2014.
The study researchers provided a letter of invitation and information pack for the school to distribute to
all parents of children in the aforementioned year groups; invitation methods were agreed with the school.
Children for whom agreement to take part was provided were invited to undergo the two screening tests
and a PTA at NHBRU. Children needed to have the PTA measured in a soundproofed room, and hence the
option to have the screening test at home was not possible.
To help ensure that the cases and controls were representative of the sources from which they were
drawn, the audiologists and researchers were advised to not just pick those whom they thought might
be easy to test. For all children the invitation pack contained an invitation letter, a one-page summary
information sheet, a pictorial information sheet for the children and a pre-paid return envelope.
Full participant information sheets were sent to the parent (either via e-mail or post) once an appointment
was made (see Appendix 3) (the full sheet was originally included in the invitation pack, but a revision
was made in December 2013, to be less overwhelming for the parent and to save paper).
Parents of all children involved were offered the opportunity to receive a short summary of the findings
at the end of the study. A £20 book token (revised from £10 after 7 months of recruitment in an attempt to
improve recruitment) was given to each child as a thank you for his/her time and inconvenience. Travel
expenses to NHBRU were reimbursed in line with University of Nottingham standard policy. Schools that
participated in the recruitment of control children were entered into a prize draw with a chance to win £100.
THE PURE-TONE SCREEN AND HEARCHECK SCREENER FOR IDENTIFYING HEARING IMPAIRMENT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
28
Assessment
Once a reply slip was received, the researcher contacted the parent (via telephone, e-mail or letter) to
make an appointment either at NHBRU (case and control children) or at their home (case children only).
They were also asked about access issues or translator needs. Parents were usually reminded about the
appointment by telephone or e-mail on the day prior to the appointment. After case children had their
appointment, the researcher phoned the audiologist, asking them to post their most recent PTA results to
NHBRU. This could be a PTA measured in the previous 12 months or one that is scheduled to be measured
in the following 3 months.
For all appointments the researcher checked that the parent had all the study information, explained what
would happen at the appointment and how that fitted into the project, and answered any questions they
might have. The consent form was explained and written consent obtained. The researcher emphasised
that participation was voluntary and consent regarding the child’s participation in the project could be
withdrawn at any time without penalty or affecting the quality or quantity of the child’s future medical
care, or loss of benefits to which the child and his/her family was otherwise entitled. It was explained that
in the event of withdrawal, their data collected so far could not be erased and that consent would be
sought to use the data in the final analyses where appropriate. The informed consent form was signed and
dated by the parent or legal guardian and researcher before the child entered the study – usually at the
start of the screening appointment. Copies of the consent form were kept by the parent or legal guardian,
the researchers, and, for case children only, in the child’s hospital records (see Appendix 3).
Data collection was planned prospectively in advance of administering the tests and reference standard to
the children. Background details [visit date, school for control children, hospital for case children, date of
birth, postcode, background sound level, gender, ethnicity, medical conditions on the day (including
respiratory infections)] were recorded on the case report form (CRF) and testing was then administered.
The audiometer (used for the PTS testing for all children and for the PTA for control children) and HC
device were checked each day, by listening to the tones at the testing frequencies, to ensure they were
audible. Valid calibration was undertaken in the previous 12 months for the audiometer and sound level
meter and in the previous 3 years for the HC screener according to manufacturers’ recommendations.
Headphones were cleaned with a disinfectant wipe before each child was tested and new disposable cups
were used for the HC screener. Items likely to cause noise (e.g. mobile phones, washing machines,
televisions) were turned off where possible, and the level of background noise was measured with a sound
level meter. Although, for control children, the door of the room in which the two screening tests were
conducted was left open, and sometimes siblings were present, the ambient noise conditions were much
quieter than rooms that are usually available in schools for conducting the hearing screen. For case
children, where the screens were conducted at home, attempts were made to minimise the noise levels.
The researchers were trained in administering the PTA and PTS tests by the audiologists in the Children’s
Hearing Assessment Centre (CHAC) in Nottingham, using a mixture of observation, practice with children
and feedback. Further familiarisation with the equipment and procedures was gained by testing staff from
the research department.
The order of administering the two screening tests and which researcher undertook them were each
determined by separate lists based on computer-generated simple (unrestricted) random numbers. Each
test was administered to both ears. For case children, one researcher performed the PTS and another
researcher performed the HC screen. For control children, one researcher carried out both the screening
tests and then another researcher performed the PTA measurement. An effort was made to blind the
second researcher to the results of the first test(s) by asking them to leave the room. The PTA result for
case children obtained from their audiologist (measured within 12 months before or 3 months after the
study visit) was examined only after the result of the screening tests were known.
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Screening tests
Pure-tone screen
A traditional PTS tests across four frequencies (0.5, 1, 2 and 4 kHz), which cover the majority of the
frequencies contained in speech, was undertaken. The researcher was positioned to ensure that they had
a clear view of the child without giving any visual cues throughout the test. The child was instructed to
place a ball onto a frame every time they heard a sound, even if the sound was quiet. Hearing aids,
glasses, hairbands and earrings were removed where relevant. The headphones were placed over the
child’s ears, adjusting the fit if necessary. A familiarisation tone (1 kHz at 60 dB HL) was presented as a
practice to ensure that the child had understood the instructions. Up to three tones were presented at a
single level (20 dB HL) for each of the frequencies in the order 1 kHz, 2 kHz, 4 kHz and 0.5 kHz. Each tone
was held for 2–3 seconds, with staggered pauses between tones to reduce expectation. For each
frequency and ear, at least two out of three responses to a tone was considered to be a pass at that
frequency. One response from three presentations or zero responses from two presentations of the tone
was considered to be a refer result. If the first two presentations were both passed at a given frequency or
both referred at a given frequency the tone was not presented a third time. On the CRF a tick was used to
indicate response (i.e. child placed a ball on the frame) and a cross for no response. Failure to hear at any
frequency for a given ear was considered an overall refer result for that ear. All four frequencies were
tested in one ear before changing to the other ear. For children who did not appear to hear any of the
tones, the 20 dB HL tones were interspersed with sounds of greater intensity to check attention.
HearCheck screener
The HC41 screener (Figure 5) automatically generates six tones in total – one tone for each combination of
frequency and level: 1 kHz at 55, 35 and 20 dB HL and 3 kHz at 75, 55 and 35 dB HL. The tasks and test
were explained, in particular that there was one tone much louder than the others. Children were asked to
raise a hand when they heard a tone. The response method for the HC screen had to be quick to perform
as there was only a very short automated gap between the tones, and was also chosen to be different from
that for the PTS to keep the child’s interest. For some children a different response method (e.g. tap the
table) was used if they did not seem able to raise their hand for whatever reason. The child was asked to
remove hearing aids, and also glasses and earrings if necessary for a good fit. A disposable cardboard ear
cover was put onto the HC screener for each ear. The HC screener was held against the ear to be tested,
often holding the child’s head still with the free hand. The button was pressed and the first three tones
were allowed to play for the first frequency. The button was then pressed again for the remaining three
tones for the second frequency. The procedure was repeated on the other ear. A tick was recorded on the
CRF for a response, and a cross for no response. The refer criterion for each ear is anything less than all six
tones being responded to.
FIGURE 5 The HC screener.
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Pure-tone audiometry reference standard
The PTA used to define the reference standard was administered in the study to all children recruited as
controls. For control children, PTA was carried out in NHBRU at the same session as the screening tests
were administered, using the audiometer in a soundproofed booth with the child sat facing away from the
equipment. The parent was able to watch through an observation window. Instructions were given and
then the headphones were put on. For familiarisation, 1 kHz tones at 60 dB HL were presented in one ear
with further explanation provided if needed. Testing followed standard British Society of Audiology
recommended procedure42 without otoscopic examination or masking, for air conduction only. The testing
tones were administered in the order 1, 2, 4, 8, 0.5 and 0.25 kHz for each ear. Sounds were presented for
approximately 2 seconds with variable pauses between them. Each frequency was first presented at 40 dB HL.
If not heard then the intensity was increased to 60 or 80 dB if needed. If still not heard then the equipment
and the child’s concentration were checked. If the participant heard the tone, then intensity was decreased
by 10 dB HL, then if not heard it was increased by 5 dB HL. This stepwise approach was repeated until a
threshold was found (defined as the quietest sound heard twice as the intensity was increased) for each
frequency. The procedure was repeated in the second ear. The child indicated hearing the tone using the
response button connected to the audiometer. If the child did not understand the use of the response
button, then stacking bricks were occasionally used. The results were then printed out (only possible if the
response button was used) and the audiometer results were transcribed into the CRF. The child identifier (ID)
was written on the print out and attached to the CRF.
If a child decided that they did not want to continue with the testing during an assessment session, for
whatever reason, he/she could be withdrawn from the study.
As the children recruited as controls had no previously identified hearing impairment, it was expected that
they would pass the PTA. However, if the child was found to have a threshold of ≥ 30 dB HL at any
frequency then, regardless of screening results, their parents were asked if they would like a referral to
CHAC for further audiological testing. If such a referral was made this was indicated on the CRF and
patient details were obtained. A letter and leaflet about the referral were given to the parents with an
explanation that they would be contacted in the next 2–3 weeks with an appointment time. A copy of the
CRF was passed to CHAC who made the appointment.
For children recruited as cases, a suitable PTA (administered between 12 months before and 3 months
after the appointment) was obtained from the audiologist after the appointment and the data were added
to the CRF. The original PTA result (with name, hospital number and other IDs removed and study ID
added) was attached to the CRF.
Data collection
Each page of the CRF for each child was identified with the participant identity code, date of birth and
partial postcode. The researchers entered the data from the CRFs into the study database. Copies of the
CRFs were then sent to Peninsula Clinical Trials Unit (PenCTU) for second data entry and consistency
checks. Emerging queries were noted to the Nottingham researchers and corrected where appropriate.
Recruitment logs (for children nominally recruited as cases and controls, audiologist and school), the
password-protected appointment spreadsheet and progress documents were completed as appropriate.
Consent forms, reply slips and CRFs were filed in a secure place at NHBRU and then archived in a
secure facility.
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Sample size calculation
The target sample size was 80 hearing impaired (HI) case children and 160 not hearing impaired (NHI)
control children. Eighty HI children is a large enough sample to estimate a sensitivity of 80% with a margin
of error of 10.4% based on the lower bound of the 95% CI; 160 NHI children is large enough to estimate
a specificity of 80% with a margin of error of 7.0%. The margin of error for these estimates provides
plausible ranges of values within which to test the sensitivity of the results from the economic model to
our assumptions about screening accuracy (see Chapter 8).
Statistical analysis
The characteristics of the children were summarised separately for those nominally recruited as case
children (i.e. with impairment) and those nominally recruited as control children (without impairment),
using mean and SD for age, and numbers and percentages for gender and ethnicity. For case children,
the time interval in weeks between measurement of the PTA reference standard and administration of the
screening tests was summarised using the mean with SD and median with interquartile range (IQR).
The criteria used to define recruitment of case children were based on information available from the PTA.
The children who were recruited as controls had no known hearing impairment. However, it was possible
for children nominally recruited as cases to pass some elements of the reference standard and for children
nominally recruited as controls to receive a refer result from the reference standard. Evaluation of the
diagnostic accuracy of the screening tests was based on using the PTA reference standard, and not the
nominal recruitment status of the children (i.e. it was not based on the ‘gate’ through which they were
recruited). We classified those who were referred by PTA as HI and those who passed PTA as hearing
(or NHI), regardless of whether they were nominally recruited as cases or controls. The discordance
between nominal case–control status and the PTA reference standard classification is summarised later.
The accuracy of each of the screening test results was assessed in relation to the PTA reference standard
classification based on analyses at the level of individual ear and at the level of individual child. From the
outset we considered the ear-level analysis to be primary to the objectives addressed in this chapter
because it directly addresses the question of the accuracy of the tests for discriminating between hearing
and impaired ears. We also present child-level analyses, however, because the resulting accuracy estimates
from these are most relevant for the economic model reported in Chapter 8. For the child-level analyses
hearing was considered impaired (HI) if they had at least one impaired ear on the PTA reference standard
and considered to have been referred by a given screening test if at least one of their ears was referred by
the test.
When examining the relationship between the screening test results and the reference standard, separate
sets of analyses were carried out for two different definitions of hearing impairment status. Under the
primary definition, impairment was considered present when the PTA reference standard threshold was
≥ 30 dB on at least one of the four frequencies examined (0.5 kHz, 1 kHz, 2 kHz and 4 kHz) and considered
absent when the reference threshold was < 30 dB on all four frequencies. Secondary analyses were carried
out under the alternative definition where impairment was considered present when the mean PTA
threshold across the four frequencies was ≥ 30 dB and considered absent when the mean threshold was
< 30 dB. The primary definition is the stricter of the two.
THE PURE-TONE SCREEN AND HEARCHECK SCREENER FOR IDENTIFYING HEARING IMPAIRMENT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
32
Separate sets of analyses relating the screening test result and the reference standard classification were
also conducted based on the inclusion of different subsets of impaired ears (or children). In the primary
analysis all HI ears (or children) were included regardless of whether nominally recruited as a case child or
as a control child. In two further sets of secondary analyses we included only impaired ears (or children) for
those nominally recruited as cases and then included only impaired ears (or children) for those nominally
recruited as controls.
Cross-tabulation was used to report the test results (refer vs. pass) for the PTS and HC screen in relation
to each other, separately for the groups of ears (or children) that were classified on the PTA reference
standard as impaired (to compare sensitivity between tests), hearing (to compare specificity between tests)
and missing. Sensitivity, specificity, positive likelihood ratio and negative likelihood ratio were reported for
the PTS and HC screening tests for ear-level and child-level analyses and all scenarios defined by the above
definitions of impairment. Sensitivity is the percentage of impaired ears (or children) that are referred by
the test; specificity is the percentage of hearing ears (or children) that pass the test; positive likelihood ratio
is the ratio of the percentages that are referred by the screening test between the impaired and hearing
groups; and negative likelihood ratio is the ratio of the percentages that pass the screening test between
the impaired and hearing groups. For the ear-level analyses, correlation between the results for ears of a
given child was accounted for when reporting CIs for sensitivity and specificity by fitting null logistic
regression models (i.e. with no covariates) to the binary test result outcome with information sandwich
(‘robust’) estimates of standard error, with the resulting log odds and 95% CI converted to the proportions
(percentage) scale. When estimating sensitivity the model was fitted using only impaired ears and when
estimating specificity using only hearing ears. The test result outcome was coded 1 for refer and 0 for pass
when estimating sensitivity and vice versa when estimating specificity.
We report the absolute difference in percentages between the PTS and HC screen for both sensitivity
and specificity with 95% CIs and McNemar’s test p-value [using the mcc command in Stata software
(version 13.1, StataCorp LP, College Station, TX, USA)]. The calculation of the CI and p-value recognise the
pairing of the PTS and HC test results within ear (or within child). This was done for ear-level and child-level
analyses and all scenarios defined by the above definitions of impairment. Unlike when estimating the
accuracy of each test, when comparing accuracy between tests for the ear-level analysis there was no need
to allow for the correlation between results related to ears from the same children because the estimated
difference in sensitivity (and specificity) between the PTS and HC tests is based on information within ears.
An alternative analysis in which the data structure was reshaped so that there were four rows per child
(PTS result for the left ear, HC result for the left ear, PTS result for the right ear and HC result for the right
ear) and logistic regression models fitted to the test result outcome (coded 1 for pass and 0 for refer) on the
predictor test type (coded 1 for PTS and 0 for HC) to estimate the difference between test types in accuracy,
taking account of the correlation of test results for ears that belong to the same child, provided identical CIs
and p-values to those reported here.
Missing data
To be included in the main ear-level analysis the ear needed to have provided data on both the screening
tests and provided hearing-level data on all four frequencies presented under the PTA reference standard.
It was possible for a given child, therefore, to provide only one ear that was used in the ear-level analyses.
To be included in the child-level analysis the child had to provide full data on the PTS and HC tests and the
PTA reference standard for both ears. Analyses were carried out using Stata statistical software.
Results
Participants
Nominal case children were recruited from 14 centres. The original eight centres in the East Midlands
were: Nottingham, Leicester City, Leicester County, Sheffield, Derby, Lincoln, Mansfield and Chesterfield.
Owing to recruitment difficulties a further six centres were added: Bradford, Rotherham, Huntingdon,
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Birmingham Children’s Hospital, Birmingham Heartlands Hospital and Doncaster. From 379 invitations sent
by the audiologists, a total of 86 replies were received, a response rate of 23%. Eight children were not
eligible, being outside the required age range. We were unable to contact one of the initial respondents,
and we were unable to see a further two children due to researcher illness just before the close of
recruitment. We recruited and tested the remaining 75 children. See the flow diagram (Figure 6) below.
Details of recruitment by centre are given in Table 8.
Nominal control children were recruited from 51 of the 164 schools in the Nottingham area that were
invited by post to take part (response rate of 31% at school level). Twenty-three of the participating
schools agreed to take part only after a follow-up telephone call to discuss the information received.
The 51 schools, between them, gave information packs to the parents of 2787 children, of whom 291
(10.4%; median reply rate per school of 9.1%, IQR 4.6–14.9%, range 0–28.6%) replied, confirming they
would like to participate. Seven of the schools that agreed to take part did not recruit any children. An
additional 11 siblings of children who attended the appointment but who did not receive the invitation
were in the correct age range and parents agreed for them to take part, bringing the number of children
initially indicating that they wanted to participate to 302. Eight of these children were subsequently found
to be ineligible for the study (one was too old, six already had hearing problems identified and one replied
after recruitment closed), 11 changed their minds about taking part and we were unable to see 43 either
because we could not make an appointment (mostly not contactable) or because they did not attend the
arranged appointment.
The remaining 240 children were recruited as nominal controls and seen for study appointments (Figure 7).
Audiology centres agreed
to participate
(n = 14)
Invitations sent
(n = 379)
Replies received
(n = 86)
To contact
(n = 78)
Appointments made
(n = 77)
Appointments attended
(n = 75)
Not eligible
(out of age range)
(n = 8)
Unable to contact
(n = 1)
Appointments cancelled
owing to illness; not 
possible to reschedule
(n = 2)
FIGURE 6 Numbers of case children in the diagnostic accuracy study.
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Demographic characteristics
Table 9 summarises the demographic characteristics of children who attended appointments (315) by
whether they were nominally recruited as cases (75 children) or controls (240 children). The groups were
similar with respect to gender and age. Four-fifths of each group was categorised as white on ethnicity.
The nominal case group had a higher percentage of Asians (15% vs. 4%) and a lower percentage of
mixed ethnicity children (1% vs. 9%) than the nominal control group.
Schools invited to participate
(n = 164)
Schools took part
(n = 51)
Children invited
(n = 2787)
Replies received
(n = 291)
To contact
(n = 283)
Siblings
(n = 11)
Appointments attended
(n = 240)
Changed their mind 
about taking part
(n = 11)
Unable to make 
contact with them
(n = 43)
Not eligible
(n = 8)
• Too old, n = 1
• Had identified hearing problems, n = 6
• Replied after study close, n = 1
FIGURE 7 Numbers of control children in the diagnostic accuracy study.
TABLE 9 Demographic characteristics of recruited children
Characteristic Recruited as case child (n= 75) Recruited as control child (n= 240)
Male, n (%) 38 (51) 117 (49)
Age (years), mean (SD, range) 5.4 (0.9, 3.9–7.0) 5.4 (0.6; 4.0–6.9)
Ethnicity
White, n (%) 61 (81) 189 (79)
Black, n (%) 2 (3) 14 (6)
Asian, n (%) 11 (15) 10 (4)
Mixed, n (%) 1 (1) 22 (9)
Other, n (%) 0 (0) 5 (2)
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Time interval between screening test and reference standard for children
nominally recruited as cases
Table 10 summarises the time interval between when the screening tests were administered and when the
PTA reference standard was measured for the nominal cases, reporting the difference in weeks. Separate
rows summarise the time interval for the 65 nominal cases for which reference standard data were available
before the tests were administered, and for the 10 nominal cases who completed the screening tests before
the reference standard. The absolute time interval is summarised for all 75 nominal cases. The median
absolute time interval was 16 weeks. The reference standard was completed within the criterion period of
12 months (52 weeks) before to 3 months (13 weeks) after the screening tests for 73 children. For each of
the remaining two children a reference standard measure was available prior to the 52-week cut-off (65 and
63 weeks before the screening test) and another was available for each at 24 weeks after the screening test.
The two measures for each child showed very similar results and indicated a stable hearing impairment by
both definitions and the children were therefore included in the analyses. As described in the methods section
the children nominally recruited as controls completed the tests and the reference standard on the same day.
Missing data and indeterminate results
Of the 630 recruited ears, 600 (95.2%) provided full data on the PTS and HC tests and scores for all
four frequencies of the PTA reference standard and were included in the main analyses. Sixty-two
(82.7%) of the 75 children recruited as cases and 233 (97.1%) of the 240 children recruited as controls
(total= 295/315, 93.7%), provided full data on the tests and reference standard. There were no
indeterminate screening test or PTA results. For children recruited as cases it was usually the PTA that was
part missing; however, one child refused to do the HC test, another child refused to do the PTS test and
one child had no physical ear on one side. For those recruited as controls, PTA and PTS results were
missing for two participants due to equipment failure. There were a further two children with autism who
were unable to complete the tests and the remainder were children who refused to do or complete other
tests mainly because of lack of concentration or finding the headphones too tight.
Concordance between nominal case–control status and pure-tone
audiometry reference standard classification
A unique feature of the two-gate (‘case–control’) design used for this accuracy study is that the criteria
used to recruit children as cases and controls were not the same as the reference standard classification
(using the PTA) that was used to define presence of the target condition when evaluating the screening
tests. In other words the nominal target condition status is not necessarily consistent with the status based
on application of the reference standard. For children nominally recruited as cases, hearing status was
based on audiology notes. The criterion for inclusion was a bilateral impairment up to an average of
60 dB HL or a unilateral impairment of any level. Consequently, although nominally recruited as case or
control children, some of the case children had no hearing impairment when assessed on the PTA
reference standard and some of the control children were categorised as having impairment in the
child-level analyses. Furthermore, and of particular relevance to the fact that the primary analyses are
conducted at the level of the ear, there were case children for whom the PTA reference standard defined
them as having the target condition in one ear but not the other (i.e. had unilateral impairment). There
were, therefore, ears that were categorised and analysed based on the reference standard as HI that
belonged to children nominally recruited as controls and ears that were categorised and analysed as NHI
that belonged to children nominally recruited as cases.
TABLE 10 Time interval in weeks between administering the screening tests (PTS and HC) and the reference
standard (PTA) for children nominally recruited as cases only (n= 75)
Time interval in weeks n Mean (SD) Median (IQR) Range
Reference standard performed first 65 19.3 (14.2) 17.3 (7.4–24.4) 0.7–63.3
Screening test performed first 10 8.9 (7.0) 9.5 (1.6–11.9) 1.1–24.1
Absolute interval for all children 75 17.9 (13.9) 16.3 (6.9–24.1) 0.7–63.3
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Figure 8 indicates the number of ears belonging to participants nominally recruited as cases and controls
that under the reference standard PTA were classified as HI, classified as NHI or for which there were
insufficient data to classify the ear (i.e. PTA data were missing for that ear). The figure is based on the
PTA reference standard definition of impairment as having a HL of ≥ 30 dB on at least one of the four
frequencies (the primary definition). Twenty-six of the 150 ears of children nominally recruited as cases
were classified on the reference standard as hearing and 48 of the 480 ears of children nominally recruited
as controls were classified as impaired. Similar data are summarised at the level of child in Figure 9.
Two of the 75 children who were nominally recruited as cases were classified on the reference standard as
hearing. The pure-tone audiograms provided by the child’s local audiology service did not match the
inclusion criteria but the children were tested within the study because, as per the protocol, the research
team did not access the PTA until after the screening tests were undertaken. Of the 240 children who
were nominally recruited as controls 37 were classified as impaired. We suggest that parents who had
concerns about their child’s hearing were more likely to take up the invitation to take part.
Accuracy of the pure-tone screen and HearCheck screener for identifying
hearing impairment at the level of the ear
Figures 10 and 11 present flow charts that describe the number of impaired ears (based on a PTA score of
≥ 30 dB on at least one of the four frequencies) and hearing ears that passed and referred on the PTS and
HC tests, respectively. Table 11 summarises the relationship between the PTS test results and the HC test
results separately for impaired ears, hearing ears and ears for which information on the reference standard
was missing. The figures highlighted in green indicate the numbers that were used in the calculation of
sensitivity and specificity. The relationship between the PTS and HC results is summarised for the other five
scenarios (see Tables 47–51, Appendix 4).
Table 12 reports the sensitivity and specificity of the screening tests for the ear level. The sensitivity was
94.2% for the PTS and 89.0% for the HC screen. The 95% CIs for sensitivity indicate that we can be fairly
certain that the true sensitivity is no lower than 89% for the PTS but could be as low as 83% for the HC
screen. The McNemar’s test result (p= 0.02) indicates evidence that the true sensitivity is greater for the
PTS than for the HC screener. The difference of 5% in sensitivity implies that for every 20 impaired ears
tested the PTS would correctly identify an extra ear as having a hearing problem compared with using the
HC screener. The corresponding values for specificity were 82.2% for the PTS and 86.5% for the HC
screener, with evidence provided by McNemar’s test that the true specificity is higher for the HC screener
than the PTS (p= 0.02).
Table 13 reports the sensitivity and specificity for each combination of definition of impairment (PTA score
of ≥ 30 dB on at least one frequency vs. a mean PTA score of ≥ 30 dB across all four frequencies) and
subset of impaired ears used to calculate sensitivity (all ears, ears of children nominally recruited as cases
and ears of children nominally recruited as controls). The results for the primary analysis for which the
reference standard is a PTA score of ≥ 30 dB on at least one frequency and all ears are used to calculate
sensitivity is shown on the top row. The sensitivity is generally higher (especially for the HC screener) when
impairment is defined based on average HL across the four frequencies. This might be expected, as the
primary definition of impairment is more stringent and thus more likely to result in less severe impaired
ears being included in the impaired group. For the same reason the specificity is lower for both tests when
impairment status is based on average HL across the frequencies presented under the PTA. Restricting
impaired ears in the analysis to only those belonging to children recruited as cases results in increased
sensitivity relative to inclusion of all ears. Again, this would be expected as ears of such children would
be expected to have more severe hearing loss. Restricting impaired ears in the analysis to only those
belonging to children recruited as controls results in lower sensitivity. Although only a sensitivity analysis,
this latter result is notable because the impaired ears of children nominally recruited as controls may
be more representative of the spectrum of impairment in the type of child that the screen would
predominantly want to identify in a school-based setting (i.e. children with less severe hearing impairment).
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TABLE 11 Cross-tabulation of the PTS vs. HC test results: impaired ears defined as those with a PTA score of ≥ 30dB
on at least one of the four frequencies – analyses include all impaired ears regardless of whether belonging to
children nominally recruited as cases or controls
PTS test results
Refer Pass Missing Total
Impaired ears (by reference standard)
HC test results Refer 136 2 1 139
Pass 10 7 0 17
Missing 0 0 0 0
Total 146 9 1 156
Hearing ears (by reference standard)
HC test results Refer 34 26 0 60
Pass 45 340 0 385
Missing 0 1 0 1
Total 79 367 0 446
Missing ears (no reference standard)
HC test results Refer 13 2 1 16
Pass 3 2 1 6
Missing 2 0 4 6
Total 18 4 6 28
Shading indicates the numbers that were used in the calculation of sensitivity and specificity.
TABLE 12 Accuracy of the PTS and HC screener in ear-level analyses: impaired ears defined as those with a PTA
score of ≥ 30dB on at least one of the four frequencies – analyses include all impaired ears regardless of whether
belonging to children nominally recruited as cases or controls
Measure
PTS HC Difference in accuracy (PTS –HC)
Estimate (95% CI) Estimate (95% CI) Estimate (95% CI) p-value
Sensitivity 94.2% (89.0% to 97.0%) 89.0% (82.9% to 93.1%) 5.2% (0.2% to 10.1%) 0.02
Specificity 82.2% (77.7% to 86.0%) 86.5% (82.5% to 90.0%) –4.3% (–8.2% to –0.4%) 0.02
Positive likelihood ratio 5.31 6.60
Negative likelihood ratio 0.07 0.13
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Accuracy of the pure-tone screen and HearCheck screener for identifying
hearing impairment at the level of the child
Figures 12 and 13 contain flow charts that describe the number of hearing-impaired children (defined based
on a PTA score of ≥ 30 dB on at least one of the four frequencies in either ear) and hearing children who
passed and referred on the PTS and HC tests, respectively. Table 14 summarises the relationship between
the PTS test results and the HC test results for hearing-impaired children, hearing children and children
who did not provide full data on the reference standard. The numbers highlighted in green were used to
calculate sensitivity and specificity. The relationship between the PTS and HC results is summarised for the
other five scenarios (see Tables 52–56, Appendix 4). Table 15 reports the sensitivity and specificity of the
screening tests at child level. The sensitivity estimates (95.9% for the PTS and 88.7% for the HC screener)
were similar to those reported for the ear-level analyses. The McNemar’s test (p= 0.02) indicates that the
true sensitivity is greater for the PTS than for the HC screener. The difference of 7% in sensitivity implies
that for every 14 impaired children tested the PTS would correctly identify an extra child as having a hearing
problem compared with using the HC screener. Specificity at the child level was higher for the HC screener
than for the PTS (83.8% vs. 79.8%) but there was little evidence of a true difference (p= 0.18).
Table 16 reports the sensitivity and specificity for each combination of definition of impairment (PTA score
of ≥ 30 dB on at least one frequency vs. an average PTA score of ≥ 30 dB across all four frequencies) and
subset of hearing-impaired children used to calculate sensitivity (all children, children nominally recruited
as cases and children nominally recruited as controls). The results for the primary analysis in which the
reference standard is a PTA score of ≥ 30 dB on at least one frequency for at least one ear and all impaired
children are used to calculate sensitivity are shown on the top row. The pattern of results is similar to the
ear-level analyses. The use of less stringent passing criteria for the reference standard (average PTA score
of ≥ 30 dB across the four frequencies presented) generally results in higher sensitivity and markedly lower
specificity. Restricting the sample to impaired children who were nominally recruited as cases resulted in
higher sensitivity and restricting the sample to impaired children who were nominally recruited as controls
resulted in lower sensitivity.
TABLE 13 Accuracy of the PTS and HC screener at ear level across different definitions of impairment status and
using different subsets of impaired ears based on whether they belong to children nominally recruited as cases
or controls
Reference standard Subset of impaired ears
PTS HC
Sensitivity Specificity Sensitivity Specificity
PTA score of ≥ 30 dB on at
least one frequency
All (primary analysis) 94.2% 82.2% 89.0% 86.5%
Nominal cases 99.1% 82.2% 97.2% 86.5%
Nominal controls 83.3% 82.2% 70.8% 86.5%
Average PTA score of
≥ 30 dB across frequencies
All 95.7% 76.4% 94.8% 81.8%
Nominal cases 98.9% 76.4% 97.8% 81.8%
Nominal controls 84.0% 76.4% 84.0% 81.8%
DOI: 10.3310/hta20360 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 36
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Fortnum et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
43
Im
p
ai
rm
en
t 
st
at
u
s
b
as
ed
 o
n
 P
TA
 r
es
u
lt
s
C
h
ild
re
n
M
is
si
n
g
0
Pa
ss
ed
4 
ch
ild
re
n
R
ef
er
re
d
16
 c
h
ild
re
n
M
is
si
n
g
4 
ch
ild
re
n
N
o
 P
TA
 d
at
a
20
 c
h
ild
re
n
Pa
ss
ed
0
H
I
97
 c
h
ild
re
n
R
ef
er
re
d
93
 c
h
ild
re
n
31
5 
ch
ild
re
n
R
ef
er
re
d
40
 c
h
ild
re
n
M
is
si
n
g
0
N
H
I
19
8 
ch
ild
re
n
Pa
ss
ed
15
8 
ch
ild
re
n
PT
S 
te
st
 r
es
u
lt
s
FI
G
U
R
E
12
Pu
re
-t
o
n
e
sc
re
en
te
st
re
su
lt
s
at
th
e
ch
ild
le
ve
l
b
y
h
ea
ri
n
g
im
p
ai
rm
en
t
st
at
u
s
b
as
ed
o
n
a
PT
A
sc
o
re
o
f
≥
30
d
B
o
n
at
le
as
t
o
n
e
o
f
th
e
fo
u
r
fr
eq
u
en
ci
es
in
at
le
as
t
o
n
e
ea
r. I
m
p
ai
rm
en
t 
st
at
u
s
b
as
ed
 o
n
 P
TA
 r
es
u
lt
s
C
h
ild
re
n
M
is
si
n
g
0
Pa
ss
ed
11
 c
h
ild
re
n
Fa
ile
d
15
 c
h
ild
re
n
M
is
si
n
g
4 
ch
ild
re
n
N
o
 P
TA
 d
at
a
20
 c
h
ild
re
n
Pa
ss
ed
1 
ch
ild
H
I
97
 c
h
ild
re
n
Fa
ile
d
86
 c
h
ild
re
n
31
5 
ch
ild
re
n
Fa
ile
d
32
 c
h
ild
re
n
M
is
si
n
g
0
N
H
I
19
8 
ch
ild
re
n
Pa
ss
ed
16
6 
ch
ild
re
n
H
C
 s
cr
ee
n
te
st
 r
es
u
lt
s
FI
G
U
R
E
13
H
ea
rC
h
ec
k
te
st
re
su
lt
s
at
th
e
ch
ild
le
ve
l
b
y
h
ea
ri
n
g
im
p
ai
rm
en
t
st
at
u
s
b
as
ed
o
n
a
PT
A
sc
o
re
o
f
≥
30
d
B
o
n
at
le
as
t
o
n
e
o
f
th
e
fo
u
r
fr
eq
u
en
ci
es
in
at
le
as
t
o
n
e
ea
r.
THE PURE-TONE SCREEN AND HEARCHECK SCREENER FOR IDENTIFYING HEARING IMPAIRMENT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
44
TABLE 14 Cross-tabulation of the PTS vs. HC test results: impaired children defined as those with a PTA score of
≥ 30dB on at least one of the four frequencies in at least one ear – analyses include all children regardless of
whether nominally recruited as case or control
PTS test results
TotalRefer Pass Missing
Impaired (by reference standard)
HC test results Refer 85 1 0 86
Pass 8 3 0 11
Missing 0 0 0 0
Total 93 4 0 97
Hearing (by reference standard)
HC test results Refer 18 14 0 32
Pass 22 144 0 166
Missing 0 0 0 0
Total 40 158 0 198
Missing (no ears reference standard)
HC test results Refer 14 0 1 15
Pass 1 0 0 1
Missing 1 0 3 4
Total 16 0 4 20
Shading indicates the numbers that were used in the calculation of sensitivity and specificity.
TABLE 15 Accuracy of the PTS and HC screener in child-level analyses: impaired children defined as those with a
PTA score of ≥ 30 dB on at least one of the four frequencies in at least one ear – analyses include all impaired
children regardless of whether nominally recruited as case or control
Measure
PTS HC Difference in accuracy (PTS – HC)
Estimate (95% CI) Estimate (95% CI) Estimate (95% CI) p-value
Sensitivity 95.9% (89.8% to 98.9%) 88.7% (80.6% to 94.2%) 7.2% (0.3% to 14.1%) 0.02
Specificity 79.8% (73.5% to 85.2%) 83.8% (78.0% to 88.7%) –4.0% (–10.5% to 2.3%) 0.18
Positive likelihood ratio 4.75 5.49
Negative likelihood ratio 0.05 0.14
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Discussion
In this chapter we have estimated and compared the diagnostic accuracy of the PTS and HC tests for
discriminating between children with and without hearing impairment (sensorineural, permanent conductive
or transient) basing our reference standard on the results of PTA. Our primary definition of hearing
impairment was a threshold of ≥ 30 dB on at least one of the four frequencies presented for the PTA
assessment. Diagnostic accuracy was primarily assessed at the level of ear, as this chapter is principally
concerned with differentiating impaired ears from hearing ears, but child-level analyses were also reported,
as those estimates are most relevant for the economic analyses reported in Chapter 8. Our primary analysis
included ears and children regardless of whether they had nominally been recruited as cases or controls.
The inclusion of all ears/children is appropriate for assessing the extent to which the screening tests can
differentiate the presence of hearing impairment from no hearing impairment across all children. However,
the secondary analyses that include only impaired ears/children who were nominally recruited as controls
may provide estimates of accuracy that are more pertinent for assessing the value of such tests in the context
of a SES programme, where we are looking to identify children with previously unsuspected impairment.
Confidence intervals for the accuracy measures at ear level indicate that the sensitivity is likely to be no
lower than 89% for the PTS and 83% for the HC screener, and that the specificity is no lower than 78%
for the PTS and 83% for the HC screener. There was evidence at the 5% level that the sensitivity is greater
for the PTS than the HC screener and that the specificity is greater for the HC screener than for the PTS.
Considering only the results presented in this chapter and not taking into account other issues considered
in the cost-effectiveness analyses presented later in this report (see Chapter 8), the value of the SES tests
rests on the minimum accuracy level that makes them worthwhile in practice. The choice between the
screening methods hinges on the importance of the test being sensitive relative to the importance of it
being specific – in other words whether false negatives (children with a hearing impairment who pass the
screening tests) are a more important problem than false positives (children with no hearing impairment
referred by the screening tests). Reducing the false-negative fraction (i.e. increasing sensitivity) is more
salient because, ultimately, the priority is identifying impaired children rather than confirming the status of
children without impairment. On this basis one might lean towards the PTS as the ‘better’ test. It should be
noted that the additional impaired children who are identified as a result of the increased sensitivity are
likely to be at the less severe end of impairment and that there are therefore diminishing returns in
improved identification.
TABLE 16 Accuracy of the PTS and HC tests at child level across different definitions of impairment status and
using different subsets of impaired children based on whether they were nominally recruited as cases or controls
Reference standard Subset of impaired children
PTS HC
Sensitivity Specificity Sensitivity Specificity
PTA score of ≥ 30 dB on at
least one frequency
All (primary analysis) 95.9% 79.8% 88.7% 83.8%
Nominal cases 98.3% 79.8% 98.3% 83.8%
Nominal controls 91.9% 79.8% 73.0% 83.8%
Average PTA score of
≥ 30 dB across frequencies
All 97.3% 72.7% 93.3% 78.2%
Nominal cases 98.1% 72.7% 98.1% 78.2%
Nominal controls 95.2% 72.7% 81.0% 78.2%
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Another consideration in the interpretation of the accuracy estimates is to take account of the effect of the
prevalence of hearing impairment. This is particularly important in diagnostic case–control studies where
the study prevalence of hearing loss is artificially determined (Table 17). For this we have assumed a
prevalence of hearing loss typical of the pre and early school period as identified for the purposes of the
health economic model in Chapter 8 – 47 in every 10,000 children, which we have rounded up to 50 in
every 10,000 children to simplify the 2 x 2 table. We applied this prevalence to the primary analysis accuracy
estimates at child level for a PTA score of ≥ 30 dB on at least one frequency, PTS 95.9% sensitivity and
79.8% specificity, and HC screener 88.7% sensitivity and 83.8% specificity.
This allows quantification of the benefit of the PTS relative to the HC screener arising from improved
sensitivity in context, with four additional true positives identified for every 10,000 children screened – the
number needed to screen to achieve one additional true positive is 2500. It also emphasises that where
the prevalence of hearing impairment is low, the effect of changes in specificity is amplified. The specificity
obtained for the screening tests suggests that considerable numbers of false-positive tests [referrals for a
diagnostic evaluation with an audiologist (DEA) who turn out not to have hearing impairment] will be
generated – 1612 in the case of the HC screener and 2010 in the case of the PTS. This might argue that
specificity should be the metric that decides whether the PTS or the HC screener is preferable. However,
as is discussed further in Chapter 8, the actual number of referrals observed in a health-care system with
SES in place is considerably less than would be predicted considering just the specificity of the screening
test in isolation (see Table 21).
Analyses directly comparing the results of the PTS and HC screener revealed some discordance in the
pass/refer classification, that is, some children who passed the PTS were referred by the HC screener, and
vice versa. This suggests that the tests may be making different types of errors and that the best aspects of
both tests could be combined into a new or hybrid test that is more accurate than either of the individual
existing methods. As well as using different methods, they also have a basic difference in that PTS tests
four frequencies at one level and the operator has the option to repeat tones if he/she feels that the child,
for instance, has lost concentration whereas the HC tests two frequencies at three levels and is automated.
Each frequency is presented only once to the child and there is some regularity to the presentation of
tones such that the next tone could be anticipated. The only tested frequency that the two tests have in
common is 1 kHz. The PTS is applied under headphones, which means that the ear not being tested
has some barrier to any sound being presented to the test ear. The HC screener is applied through a
close-fitting cardboard cup to one ear but the other ear has no sound protection and might hear the
sound applied to the test ear.
Strengths and limitations
The study has a number of strengths. It was carefully designed and conducted, and data analysis was
rigorous and included a number of secondary (sensitivity) analyses across different definitions of
impairment. A sample size calculation was conducted a priori and the recruited sample yielded narrower
CIs (and thus less uncertainty) for the accuracy estimates than the estimates from the economic model in
the 2007 report.12
TABLE 17 Two-by-two table of the PTS and HC test results for hypothetical screening population of 10,000 children
where the prevalence of impairment is 0.5% and given the child-level accuracy estimates
Test result
PTS analysis HC analysis
Reference standard result Reference standard result
Refer Pass Total Refer Pass Total
Refer 48 2010 2058 44 1612 1656
Pass 2 7940 7942 6 8338 8344
Total 50 9950 10,000 50 9950 10,000
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A weakness of the study is that it estimated and compared the diagnostic accuracy between the PTS and
HC screener methods using a two-gate (‘case–control’) design.32 Under this approach those with the target
condition (HI) and those without (NHI) are sampled from separate sources. The impaired children were
largely identified via audiology services and the hearing children were largely recruited through schools.
The two-gate design contrasts with the single-gate (or cohort) design where both those with and without
the target condition are sampled from a single source without any knowledge of their target condition
status. The more traditional single-gate design would have been preferable, but the challenge with this
approach is that, because the prevalence of hearing impairment is so low, a large number of children
would need to be recruited to the study in order to ensure that there is a sufficient number with the target
condition. Fewer than 1 in 2000 children screened at school entry will have sensorineural hearing
impairment8 and 160,000 school children would need to be approached and tested in order to identify the
target of 80 cases originally proposed in this study. The anticipated size of the single-gate design test
accuracy study challenges both its feasibility and value for money in this context. This is not an issue for
the two-gate case–control design used here. The two-gate design, however, is known to be more prone
to biased estimates of accuracy largely resulting from the fact that those with and without the target
condition are sampled from separate sources rather than drawn from a single defined population. This is
problematic when estimating the accuracy of each test but is a less salient issue when comparing accuracy
between hearing screening tests since any biases operating will be experienced equally for each test
assessed. With respect to differential accuracy, conclusions on whether one hearing screen is better than
the other should remain robust.
The criteria used to recruit children in each gate of the design were not used as the reference standard to
categorise the children according to impairment status. A consequence of this is that some of the
participants who were nominally recruited as controls were categorised as having a hearing impairment on
the PTA reference standard. Cases were recruited as having a bilateral or unilateral hearing impairment
and hence some ears were categorised as hearing on the PTA reference standard. In this event, this was a
strength of the study as the HI group included children with established hearing impairment as well as
children with no previously identified hearing impairment. The latter group may have levels of impairment
severity that are more representative of the type of children who one might seek to identify with hearing
impairment using a school entry hearing screen. The recruitment of such children enabled us to carry out
sensitivity analyses based on whether impaired children were known cases (and therefore had a permanent
hearing impairment) or were not previously identified with a problem (and therefore probably included
children with transient hearing impairment).
A higher-than-anticipated number of children nominally recruited as controls were shown to have a
hearing impairment on PTA measurement. We suggest this may be caused by a bias towards participation
in those families who had some concerns about their child’s hearing and therefore saw the study as a
means by which their child could be tested, even though Nottingham operates an open referral system
offering an appointment without a referral from a GP.
For the children nominally recruited as controls (which made up most of the hearing group) the screening
tests and the reference standard were administered on the same day. The children nominally recruited as
cases (mostly children in the HI group), however, generally had the reference standard administered at a
different time to the test; up to 62 weeks before the test and up to 24 weeks after the test. The HL of
children with permanent hearing impairment, however, is likely to be stable or worsening and it is not
possible for children who have permanent sensorineural hearing impairment at one point to not have that
hearing impairment later on.
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Results in comparison with other studies
Several studies assessing the accuracy of the PTS were identified in the 2007 HTA report12 (see Table 6)
and no accuracy studies of the PTS were identified in the update review. The sensitivity from these earlier
studies ranged from 82% to 100% and specificity from 65% to 99%. Thus, the accuracy obtained in
this study, sensitivity 94.2% (95% CI 89.0% to 97.0%) and specificity 82.2% (95% CI 77.7% to 86.0%)
is consistent with the previous findings, and shows no evidence of the overestimation of accuracy, which is
theoretically predicted by using a case–control methodology. This provides reassurance that the accuracy
estimate obtained for the HC screener, particularly the relative accuracy of the HC screener against the
PTS, is also robust, as relative accuracy is less likely to be vulnerable to biases associated with study design.
This is helpful as an additional accuracy study was identified for a HC device relative to reference standard
of PTA in the update review. Gloria-Cruz et al.17 estimated sensitivity as 23% (95% CI 11% to 39%) and
specificity as 97% (95% CI 96% to 98%). The study was conducted in the Philippines in a convenience
sample of Grade 1 elementary school children from three metropolitan schools with a mean age of
7.6 years. The prevalence of hearing loss was approximately 5% (39/821). The circumstances are thus very
different from our consideration of SES in the context of the UK, which is likely to explain the marked
difference in accuracy between the estimates. Additionally, the devices were not identical in each study.
The device used by Gloria-Cruz et al.17 (HC navigator) used three frequencies rather than two and a higher
threshold to define hearing impairment, which would decrease sensitivity and increase specificity.
As well as impacting on the validity of our accuracy estimates, comparison with other studies also
impacted on our decision-making about the choice of accuracy estimates to be used in the base case for
the health economic evaluation. In the current protocol the 2007 HTA study estimates were identified
as the source of estimates for our base-case analysis. This decision seems to be justified both in terms of
the internal validity of the estimates and their applicability relative to alternative sources of accuracy
data identified.
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Chapter 4 False-negative results from
screening tests
Introduction
An important issue to be addressed in any research on population identification is how many people with
the target condition are not identified, that is, the false negatives from any test, screen or awareness
programme. Such data are expensive to collect, involving whole population follow-up and only realistic in
longitudinal whole-cohort studies.
In this particular screening scenario, true and false positives are relatively easy to confirm. A child who is
referred by the screen and is subsequently found to have a hearing impairment is a true positive and a
child who is referred by the screen but is subsequently found to have no hearing impairment is a
false positive.
It is also possible for a child to pass the screen and be therefore a true or false negative. A true negative is
a child who passes the screen and is found to have no hearing impairment. A false negative would be a
child who passes the screen when they in fact did have a hearing impairment.
Delayed identification in children who pass the hearing screen but who do have a hearing impairment
(false negatives) is a concern. The challenge is how to identify false negatives. As children who pass the
screen are not routinely followed up, only by evaluating every child in the SES programme at a diagnostic
centre could one assess the numbers who are true negatives and those who are false negatives.
With the numbers involved this is clearly not feasible. Instead noting children who are referred for
audiological assessment at any time after they have undergone and passed the screen could derive an
estimate of the false negatives. However, even if such children passed the screen and are subsequently
found to have a hearing impairment there can never be any certainty that the hearing impairment was
present on the day the child was screened. If it is a sensorineural impairment, it could have been acquired
or have progressed beyond a level identifiable by the screen. If it is a transient conductive impairment,
by its very nature, it is very likely not to have been present at the time of screening. Only a permanent
conductive impairment caused by anatomical pathology could be presumed to have been present on
both occasions.
One way to address these issues is through a review of the literature, looking specifically for robust
reports of data that explore the impact on the family and the child’s development and education, of an
unidentified or late-identified hearing impairment. However, such studies are likely to be rare for the
reasons outlined above.
In addition, from the data collected in the diagnostic accuracy study (see Chapter 3) we can report the
number of false negatives, that is, children who passed either of the screening tests and were found to be
HI by the reference standard (see Chapter 5). This was a departure from our original protocol, added at the
suggestion of our study steering group.
The key issue to be addressed by the review and the data is the size of any reduction or increase in the
number of children identified late in a system with and without SES, and how much benefit is likely to
accrue through their earlier identification and management.
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Objectives
l To review literature on the impact of false-negative results from screening tests.
l To describe children with false-negative screening results in the diagnostic accuracy study.
Methods
The following electronic databases were searched from inception to May 2014: The Cochrane Library
(via Wiley), MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations (via Ovid), EMBASE
(via Ovid), PsycINFO (via Ovid) and Science Citation Index (via Web of Science). Using the search terms
‘false negative’ and ‘hearing’ identified a total of 173 titles. Using broad inclusion criteria of reference to
hearing screening, sensitivity, specificity and/or false negatives, two of the authors (HF and CH) reviewed
the titles and selected 26 papers for further consideration of abstracts. Applying the same criteria to the
abstracts, 13 papers were identified for full review.
From an additional search using the terms ‘negligence’ and ‘hearing’ we identified 88 titles of which three
abstracts were identified for full review, one of which had previously been included. We therefore sought
15 papers3,7,8,26,43–53 for full review. All but one45 (published in 1981) were published between 1996
and 2014.
Data collected for children participating in the diagnostic accuracy study (see Chapter 3) who passed the
screening tests but had a refer result on the reference standard were extracted and tabulated.
Results
Literature review
No studies were identified that reported false-negative data for the school entry hearing screen. Four of
the studies reported comparisons of two different screening tests without reference standards,44–47 two
of the studies (identified from the search on negligence) reported no cases owing to missed diagnosis of
hearing impairment,48,49 and three included general discussion of the value of hearing screens beyond the
neonatal period.8,50,51 These nine studies were not reviewed further.
Geal-Dor et al.52 reviewed the results of neonatal screening at birth and behavioural screening at
7–9 months for 1545 children in Israel. They identified 58 children who had passed both screening tests or
had passed the only screening test they underwent who were later referred for audiological assessment
between the ages of 1 month and 4 years. Thirty-four had age-appropriate thresholds. Of these, 18 were
discharged and 16 belonged to high-risk groups and were followed up. All of the remaining 24 children
had a conductive impairment. No cases of permanent hearing impairment were identified.
In a further sample of 49 children identified with permanent hearing impairment, the results of the two
screening tests were reviewed. Although eight children passed one screen and were referred by the other,
only one child passed both screening tests, a conservative false-negative rate of 2% (1/49).
In an 8-year follow-up of the cohort of 21,279 babies enrolled in the Wessex (UK) trial of neonatal
screening,3 two of the 31 children identified by the age of 8–10 years with a permanent bilateral hearing
impairment ≥ 40 dB had passed the neonatal screen (false-negative rate 6%). Of the 28,172 children who
did not undergo neonatal screening, 35 children were identified with a permanent bilateral hearing
impairment ≥ 40 dB and six of these had passed the distraction screening test at 7–9 months (false-negative
rate 17%). The authors note that seven children (who had failed early screens) had evidence of progression
of hearing impairment and speculate that the eight children who passed the screens might also have a
progressive impairment, implying that the negative results may not have been false negatives.
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Lo et al.53 compared a parental questionnaire with PTA results in 6- to 7-year-old Chinese children in
Hong Kong. They report that parents were able to identify only 20% of the cases of OME (no permanent
hearing impairments were identified).
A birth cohort of 49,335 children in Australia with no risk factors for hearing impairment at birth
underwent the distraction test at 7–9 months and were followed up at age 6 years.7 Of 45,078 children
who passed the distraction test eight were later identified to have a bilateral hearing impairment
> 40 dB HL and fitted with hearing aids. The authors report a false-negative rate of 0.02% (8/45,078).
If we assume those who failed the distraction test had a hearing impairment, the true false-negative rate
would be 0.19% (8/4257+ 8); however, this assumption cannot be validated.
A study of college students (> 18 years) in the USA43 noted that the false-negative rate was higher when
the reference standard included all frequencies rather than the frequencies at which the screening was
performed. However, they also note that the major reason for this was the presence of hearing
impairment at high frequency (6 kHz) in these young adults, possibly caused by leisure noise. This is an
important issue and is particularly relevant for this project when evaluating the HC screener (1 and 3 kHz)
against gold standard PTA at 0.5, 1, 2 and 4 kHz.
Soares et al.26 compared the results of a new AABR screener against PTA in children and young adults
aged from 3 to 22 years in Japan. For the pre-school children aged 3–5 years the false-negative rate was
zero but increased to 3% (3/108) for ages 6–17 years and 12% (2/17) for 18- to 22-year-olds.
Diagnostic accuracy study (see Chapter 3)
For control children in the diagnostic accuracy study, if a screening test (either PTS or HC) was passed but
the PTA result indicated a hearing impairment, the result of the screening test is defined as a false-negative
result. Sixteen ears of 16 children met this definition. Each ear underwent two screening tests, so the
16 ears underwent 32 screening tests. Of these, 22 tests were passed (false negatives) and 10 tests gave
a refer results (true positives).
Of the 22 false-negative test results, eight passed only the HC, two passed only the PTS and six passed
both screening tests (Figure 14).
Of the six ears that passed both screening tests, all had a PTA score of ≥ 30 dB on at least one of the
four frequencies, 0.5, 1, 2, or 4 kHz, and three of those had a PTA score of ≥ 30 dB averaged across
the four frequencies.
Of the eight ears that passed the HC but referred on the PTS, all had a PTA score of ≥ 30 dB on at least
one of the four frequencies, 0.5, 1, 2, or 4 kHz, and two of those had a PTA score of ≥ 30 dB averaged
across the four frequencies.
Of the two ears that passed the PTS but referred on the HC, both had a PTA score of ≥ 30 dB on at least
one of the four frequencies, 0.5, 1, 2, or 4 kHz, and one of those had a PTA score of ≥ 30 dB averaged
across the four frequencies.
All children for whom there was a refer result on the PTA (regardless of screening test results) were offered
referral for further assessment. Of the 16 children with false-negative screening test results on one ear,
one child was not referred because the result was considered to be because of a lack of concentration and
one did not attend the appointment. Of the remaining 14, 10 were found to have no hearing impairment
and discharged, presumably because a transient hearing impairment had resolved. Three children who
passed the HC test but referred on the PTS test were found to have mild impairments and the one child
who passed both screening tests was found to have a mild impairment.
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Discussion
We were unable to identify studies that reported false-negative data from the school entry hearing screen.
Across five different screening settings (neonatal at birth, distraction test at 8 months, parent questionnaire
at 6–7 years, AABR at age 3–22 years, and the PTS at age 18–49 years), false-negative rates varied from
0.2% to 20%. All of the studies included in this review note the difficulty in assessing false negatives
across evaluations separated in time for a condition that can fluctuate (transient conductive impairments)
or progress or is of later onset (sensorineural impairments). The presence of a hearing impairment at a later
time in an individual who passed a screening test at an earlier time can never be determined with certainty
to be a false-negative result of the screen.
For the children nominally recruited as controls in the diagnostic accuracy study, the screening tests and
the reference standard were conducted on the same day and the false-negative results could be
considered to be more certain. The results of the further assessment which was conducted some weeks
later indicate that most of the impairments identified by the reference standard on the day of the
screening tests were transient and improved before the child attended the later appointment.
Owing to the lack of robust published data on false-negative results from SES, we did not take the results
of this review further in terms of the economic modelling (see Chapter 8).
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Chapter 5 Comparison of a site with a school
hearing screening programme (Nottingham) with
a site without a school hearing screening
programme (Cambridge)
Introduction
One alternative to the standard SES programme would be to not have a programme at all. The systematic
review in the 2007 HTA report12 described one poor quality study that compared screening with no
screening, but the results were inconclusive.16 The updated systematic review reported here in Chapter 2
failed to identify any further studies.
In 2005, one in eight of all services in the UK responsible for implementing a universal school entry hearing
screen were no longer doing so.12 Approximately half of those services ran no screen and the remaining
half offered a targeted screen for children identified as most at risk. The reasons given for not running a
universal screen were based mainly on practical issues, including lack of resources, rather than any
research-based evidence. There is no evidence whether implementing a screen at school entry leads to a
heightened awareness and hence no failure to identify hearing impairment in children, or whether it
results in children, who would otherwise be identified by the screen, slipping through the net and
ultimately either never being identified or being identified much later in their school career.
In this chapter we compare two areas of the UK, one with a standard SES programme (Nottingham) and
one without such a programme (Cambridge).
Objectives
l To compare children referred for investigation of suspected hearing impairment in a geographical area
that applies routine SES (Nottingham) with a service with no routine SES (Cambridge) with respect to
the number of referrals, the age at referral, the source of referral, the route through assessment to
intervention, the number of children ultimately identified to have a hearing impairment (yield) and the
nature of hearing impairment identified.
Methods
Routine data were analysed to compare data on referrals between a site with SES (Nottingham) and a site
without SES (Cambridge).
Background to study sites
Site with a school screen (Nottingham)
The CHAC is a third-tier service and is part of Nottingham Audiology Services within Nottingham University
Hospitals NHS Trust. There is no separate second-tier audiology service for children within Nottingham,
therefore, all children referred are seen within the same service. CHAC provides services for all children up
to the age of 16 years (19 years if in special education) within the catchment area of Nottingham City,
Rushcliffe, Erewash, Ashfield, Broxtowe and Gedling. It also accepts referrals from surrounding areas for
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specialised services. The service is led by a band 8a Clinical Scientist (CB) and has six whole-time equivalent
(WTE) audiological staff ranging from band 6 to 8a. CHAC has an open referral policy and therefore
accepts referrals from parents as well as from all professionals. It works closely alongside the ENT
Department at Nottingham University Hospitals and children move between the two services depending
on their needs. The service has around 3400 new referrals a year with a total number of 5900 patient
appointments on average.
The service assesses children’s hearing according to national and local protocols and provides counselling
and advice to parents with any concerns regarding their child’s hearing. If a child is identified as having a
transient conductive impairment, they are referred onto ENT as appropriate after monitoring. For those
children identified as having a permanent impairment and those children with a transient conductive
impairment whose parent(s) choose not to have surgical management, the service provides hearing aids
and ongoing habilitation (Figure 15).
All schools within the Nottingham City and County authorities carry out the school entry hearing screen as
part of the school entry health screen.
Site with no school screen (Cambridge)
The Cambridge service is a second-tier service provided by Cambridge Community Paediatric Audiology
Service, which is part of the Cambridgeshire Community Services (CCS) NHS Trust. It receives approximately
1800 new referrals per year with a total of approximately 2400 appointments annually. The service provides
second-tier hearing assessment for children aged 7 months to 16 years (19 years if in special education)
and information and education to carers and professionals. The catchment area covers children living in,
attending school in or with a GP in Cambridge City, or South and East Cambridgeshire. The service is
provided by two community paediatricians (total 1.3 WTE, one of which is clinical lead for the service),
one WTE band 7 lead clinical scientist (Audiology) (JM), members from the Addenbrooke’s Paediatric
Audiological Team who provide sessional coverage, and administrative support provided by members of the
Clinical Support Team attached to Children’s Services within CCS.
The service is provided within family-friendly environments located in the community. A community
paediatrician and an audiologist usually run each clinic by working together, using their own areas of
expertise, to look at the whole child.
Referrals are made to the service from GPs, child and family nurse team/health visitors, speech and
language therapists, paediatricians, education, social services, and the Newborn Hearing Screening
Programme (NHSP). When a chronic or permanent hearing impairment is identified the service aim is
to facilitate further assessment and management within third-tier services, that is, the tertiary audiology
service at Addenbrooke’s Hospital, the ENT department at Addenbrooke’s Hospital, and speech and
language therapy.
The role of the service is to assess children’s hearing, according to national and local protocols, for children
referred due to carer or professional concern. It also includes assessment of children who have been
identified to be ‘at risk’ by the NHSP despite clear responses on the screen. The main condition seen in the
second tier is transient conductive hearing impairment associated with middle ear effusion or ‘glue ear’.
The second tier provides carers and professionals with information and education regarding this type of
hearing impairment and good strategies for supporting the child. If the middle ear effusion or conductive
hearing impairment is persistent there are agreed written protocols for referring these children to the ENT
Department at Addenbrooke’s Hospital. If a child is identified as having a sensorineural (unilateral or
bilateral) hearing impairment, the child will be referred to the Tertiary Paediatric Audiology Service at
Addenbrooke’s Hospital for diagnostic assessment and management; this includes any child where it has not
been possible to exclude a sensorineural hearing impairment. Referrals to the second tier are often made in
order to exclude a hearing impairment as a contributing factor to educational, behavioural and/or speech
and language concerns. This includes children who may go on to be identified as being on the autistic
spectrum. A diagrammatic representation of the pathway of care for Cambridge is shown in Figure 16.
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There has been no SES in Cambridge City, South and East Cambridgeshire since 1997, when the health
visitor distraction testing was abolished in this area. Reasons for stopping included cost, variability of practice
and lack of strong guidance from the Department of Health on what should be provided for SES and
how it should be implemented. Community Paediatric Audiology in CCS was set up in 1997 with a strong
campaign to first-tier services (GP, speech and language therapists, etc.) informing them that there would be
no routine hearing tests in Cambridgeshire and emphasising the importance of referring to second-tier
services if there are parental and professional concerns. This involved letters to all GP practices and health
visiting teams, and speech therapy services outlining the changes in provision of routine hearing tests, and
posters in GP practices and speech therapy clinics, highlighting the presenting symptoms of glue ear.
Data collection
Data were collected for children aged between 3 years and 6 years 364 days who were referred to
Nottingham paediatric audiology or Cambridge audiology services by any source other than the UNHS. All
referrals between 1 September 2012 and 30 June 2014 were included. Data on follow-up appointments
that took place up to 30 September 2014 were included.
We originally proposed to explore retrospective data collected in Cambridge from 2007 to 2012. However,
as those data were not collected with the objectives of the research in mind, much information was
missing and it was decided that analyses would not add constructively to the project.
The collaborating audiologists for the areas of Nottingham (site with SES) and Cambridge City, and South
and East Cambridgeshire (site without SES) collected data on referrals. Further data were collected via
questionnaire from parents of children referred from the SES programme to the Nottingham service
(see Chapter 6). Prospective data were processed using a database built by PenCTU.
Audiologists entered data from patient notes. In Nottingham, the waiting list co-ordinator identified eligible
children, and audiologists within the service with permission to access patient records entered the data.
In Cambridge assistance was also provided by one of the Nottingham researchers. Data were entered for
the complete care pathway, from referral through to discharge (or 30 September 2014, whichever occurred
first) including: date of birth; postcode; date of referral; location of clinic; referral source (GP, health visitor,
school screen, etc.) date of appointment(s); type of assessment (e.g. visual reinforcement audiometry, play
audiometry in the soundfield, PTA); result of assessment [normal bilateral, normal soundfield (better ear)
thresholds, unilateral sensorineural, bilateral sensorineural, unilateral conductive, bilateral conductive, mixed
bilateral, incomplete]; tympanometry results; hearing thresholds/minimal response levels; probable cause of
impairment (if known); end of care (yes/no); and outcome [discharge, referral to ENT, referred for diagnostic
confirmation (Cambridge only), hearing aids fitted (Nottingham only)].
Each child’s records were accessed by audiologists authorised to look at them, hence consent was not
required from individual patients. Anonymised data were entered onto the database. These procedures
received ethical approval. Referral data were checked and corrected for implausible values. Staff time to
undertake a planned second data extraction check of 10% was severely restricted by the pressure of
service delivery. Undertaking this data check was not possible with the staff resources available without
causing a significant delay to the study reporting. Copies of the questionnaires were sent to PenCTU for
second data entry and double entry data checking.
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Statistical analysis
The yield, rate of referral and age at referral were compared between the site with a SES programme
(Nottingham) and the site without a SES programme (Cambridge).
Yield was defined as the number of children between their third and seventh birthdays identified as having
hearing impairment whose date of referral was between 1 September 2012 and 30 June 2014 (the study
period) per 1000 person-years at risk. Hearing impairment included transient conductive and permanent
sensorineural or conductive hearing impairments. The rate of referral was defined as number of referrals for
suspected hearing impairment in the same period per 1000 person-years at risk. Some referrals resulted
in more than one appointment. Children for whom the outcome of the last appointment was further
referral or hearing aid were considered to have hearing impairment and included in the numerator in the
calculations for yield; children discharged at the last appointment were considered to have no hearing
impairment. In order to calculate the denominator for yield and the referral rate, the population size in each
site was obtained from the Office for National Statistics mid-2013 estimates54 of the population who were
aged 3, 4, 5 or 6 years in the study sites. The Nottingham site included referrals from the local authorities of
Nottingham, Erewash, Ashfield, Broxtowe, Gedling and Rushcliffe; the Cambridge site included Cambridge,
East Cambridgeshire and South Cambridgeshire. The number of person-years observed was calculated by
multiplying the population size by the number of days during the study period (668 days) and dividing by
the mean number of days in a year (365.25 days). The two sites were compared with respect to yield and
referral rate using the rate ratio, reported with 95% CI and p-value.
The t-test was used to compare the mean age at referral between the Nottingham and Cambridge sites
(1) for all initial referrals; and (2) for confirmed HI cases only.
We report the percentage of referrals that resulted in the identification of HI cases for: (1) Nottingham
referrals that were via a school screen; (2) Nottingham referrals that were via any other source (e.g. GP,
speech therapist); and (3) Cambridge referrals.
Finally, we report the median (IQR) level of hearing impairment in dB at each of four frequencies (0.5, 1, 2
and 4 kHz) in each ear and the source of referral (using numbers and percentages) for both Nottingham
and Cambridge. These variables were summarised for all referrals and then for the subset of referrals that
resulted in the identification of children with impaired hearing.
Analyses were carried out using Stata statistical software.
Results
Referral rate and yield
There were 1702 referrals in Nottingham (21.9 referrals per 1000 person-years) and 1108 in Cambridge
(34.4 referrals per 1000 person-years); the referral rate in Nottingham was two-thirds that of Cambridge
(rate ratio 0.64, 95% CI 0.59 to 0.69; p< 0.001) (Table 18). Hearing impairment was confirmed in
195 children in Nottingham (yield of 2.51 cases per 1000 person-years) and 98 children in Cambridge
(3.04 cases per 1000 person-years). There was little evidence that the yield is different between
Nottingham and Cambridge (rate ratio 0.82, 95% CI 0.64 to 1.06; p= 0.12). Confirmed hearing loss cases
made up 17.0% of referred children in Nottingham (25.2% of children who were referred via SES and
14.9% of children referred via other sources) and 10.6% of referred children in Cambridge (Table 19).
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The mean age of referral was 4.7 years for both the Nottingham and Cambridge sites, but the mean age
at referral for children who were subsequently confirmed as HI was higher in Nottingham than Cambridge
(5.0 years vs. 4.5 years; mean difference 0.47 years, 95% CI 0.24 to 0.70 years; p< 0.001) (Table 20).
The characteristics are summarised in Table 21 for all referred children and in Table 22 for children
confirmed as HI cases, separately for each of the Nottingham and Cambridge sites. In Nottingham 21.5%
of all referrals and 30.8% of the confirmed HI cases were originally referred via SES. Other key sources of
referral in Nottingham were ENT consultants (23.6% of confirmed cases), parents (11.8% of confirmed
cases), GPs (10.8% of confirmed cases) and health visitors (10.8% of confirmed cases). In the Cambridge
site the key sources of referral for confirmed HI cases were GPs (64.3%), health visitors (21.4%) and
speech therapist (12.2%).
TABLE 18 Comparison of referral and yield rates (as at last appointment) between Nottingham and Cambridge
expressed per 1000 children per year
Outcome
Nottingham
estimate
Cambridge
estimate
Nottingham relative to Cambridge
Rate ratio 95% CI p-value
Number of referred children per
1000 children per year
21.9 34.4 0.64 0.59 to 0.69 < 0.001
Number of confirmed cases
(yield) per 1000 children per year
2.51 3.04 0.82 0.64 to 1.06 0.12
TABLE 19 Percentage of referred children who were subsequently confirmed as cases (at last appointment),
stratified by site and, for Nottingham, whether or not referral was via SES
Site/referral source % (n/N) 95% CI
Nottingham – referred via school screen 25.2% (60/238) 19.8% to 31.2%
Nottingham – referred via other source 14.9% (135/907) 12.6% to 17.4%
Cambridge 10.6% (98/923) 8.7% to 12.8%
TABLE 20 Comparison of the mean age of referral (in years) between Nottingham and Cambridge
Participants
Nottingham Cambridge Difference (Nottingham –Cambridge)
n
Mean,
years (SD) n
Mean,
years (SD)
Mean,
years 95% CI, years p-value
All referred children 1702 4.70 (1.01) 1108 4.66 (1.08) 0.04 –0.04 to 0.11 0.37
Confirmed cases only 195 4.97 (0.96) 98 4.51 (0.94) 0.47 0.24 to 0.70 < 0.001
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TABLE 21 Characteristics of children referred
Characteristic/summary Nottingham Cambridge
Number of children referred 1702 1108
Number of confirmed cases (yield) 195 98
Base population 42,553 17624
Person-years at risk for base population 77,825 32,232
Children referred per 1000 person-years at risk 21.9 34.4
Yield per 1000 person-years at risk 2.51 3.04
Age at referral in years, mean (SD) 4.7 (1.0) 4.7 (1.1)
Age at referral at last birthday
3 years, n (%) 508 (29.8) 381 (34.4)
4 years, n (%) 496 (29.1) 316 (28.5)
5 years, n (%) 492 (28.9) 259 (23.4)
6 years, n (%) 206 (12.1) 152 (13.7)
Level of hearing impairment in dB HLa
Left ear (0.5 kHz), median (IQR) 15 (15–25) 15 (10–20)
Left ear (1 kHz), median (IQR) 15 (10–20) 15 (10–20)
Left ear (2 kHz), median (IQR) 15 (10–20) 10 (10–20)
Left ear (4 kHz), median (IQR) 15 (10–20) 10 (10–20)
Left ear (average), median (IQR) 15 (11.3–20) 13.1 (10–20)
Right ear (0.5 kHz), median (IQR) 15 (15–25) 20 (10–20)
Right ear (1 kHz), median (IQR) 15 (10–20) 15 (10–20)
Right ear (2 kHz), median (IQR) 10 (10–20) 10 (10–20)
Right ear (4 kHz), median (IQR) 15 (10–20) 10 (10–20)
Right ear (average), median (IQR) 15 (10–20) 12.5 (10–20)
Source of referral
GP, n (%) 186 (10.9) 458 (41.3)
Health visitor, n (%) 387 (22.7) 269 (24.3)
School screen, n (%) 366 (21.5) N/A
Speech therapist, n (%) 147 (8.6) 278 (25.1)
Paediatrician, n (%) 137 (8.0) 35 (3.2)
Parent, n (%) 211 (12.4) 46 (4.2)
Education, n (%) 0 (0) 21 (1.9)
School nurse, n (%) 53 (3.1) 0 (0)
Community nursery nurse, n (%) 14 (0.8) 0 (0)
ENT consultant, n (%) 139 (8.2) 0 (0)
Other consultant, n (%) 28 (1.6) 0 (0)
NHSP, n (%) 0 (0) 1 (0.1)
Referrals from diagnostic accuracy study, n (%) 34 (2.0) 0 (0)
continued
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TABLE 21 Characteristics of children referred (continued )
Characteristic/summary Nottingham Cambridge
Outcome of referral
Discharge, n (%) 950 (83.0) 825 (89.4)
Further referral, n (%) 149 (13.0) 97 (10.5)
Hearing aid, n (%) 46 (4.0) 1 (0.1)
Missing, n (not reached end of care) 557b 185
N/A, not applicable.
a Sample size for these variables range from 915 to 941 in Cambridge and from 893 to 1050 in Nottingham.
b May be because of non-attendance at ‘opt-in’ review appointments.
Percentages may not add to 100% due to rounding.
TABLE 22 Characteristics of confirmed cases of hearing loss
Characteristic/summary Nottingham Cambridge
Confirmed cases
Age at referral in years, mean (SD) 5.0 (1.0) 4.5 (0.9)
Age at referral at last birthday
3 years, n (%) 35 (17.9) 32 (32.7)
4 years, n (%) 59 (30.3) 38 (38.8)
5 years, n (%) 70 (35.9) 22 (22.4)
6 years, n (%) 31 (15.9) 6 (6.1)
Level of hearing impairment in dB HLa
Left ear (0.5 kHz), median (IQR) 40 (30–45) 30 (25–45)
Left ear (1 kHz), median (IQR) 35 (25–40) 30 (25–40)
Left ear (2 kHz), median (IQR) 30 (20–35) 25 (15–35)
Left ear (4 kHz), median (IQR) 35 (25–45) 35 (22.5–40)
Left ear (average), median (IQR) 35 (26.3–41.3) 31.3 (22.5–38.8)
Right ear (0.5 kHz), median (IQR) 35 (25–45) 35 (25–40)
Right ear (1 kHz), median (IQR) 35 (25–40) 35 (25–40)
Right ear (2 kHz), median (IQR) 30 (20–35) 25 (15–40)
Right ear (4 kHz), median (IQR) 35 (25–45) 32.5 (20–40)
Right ear (average), median (IQR) 32.5 (22.5–40) 31.3 (23.8–37.5)
continued
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Discussion
It might be expected that adding a screen to a system would result in a greater number of referrals.
However, the observational comparison of two sites, one with SES (Nottingham) and one without SES
(Cambridge), showed evidence that the rate of referral for hearing problems is lower when SES is present.
The referral rate was 36% lower in Nottingham relative to Cambridge (rate ratio 0.64; p< 0.001) and the
CI for the rate ratio indicates the true rate is at least 31% lower when there is SES.
In the SES site, one-third of children subsequently confirmed as cases were initially referred via SES.
There was little evidence (p= 0.12) that the yield of confirmed cases is altered by SES; the estimated rate
of confirmed cases was 18% lower in Nottingham relative to Cambridge but it is plausible within the
bounds of the 95% CI that the true yield rate is the same in areas with and without SES. The CI, however,
does indicate that it is unlikely that SES areas truly have a markedly higher yield rate. A higher proportion
of referred children were subsequently confirmed to be HI in the area with SES (17.0% vs. 10.6%).
TABLE 22 Characteristics of confirmed cases of hearing loss (continued )
Characteristic/summary Nottingham Cambridge
Source of referral
GP, n (%) 21 (10.8) 63 (64.3)
Health visitor, n (%) 21 (10.8) 21 (21.4)
School screen, n (%) 60 (30.8) N/A
Speech therapist, n (%) 7 (3.6) 12 (12.2)
Paediatrician 4 (2.1) 0 (0)
Parent, n (%) 23 (11.8) 2 (2.0)
Education, n (%) 0 (0) 0 (0.0)
School nurse, n (%) 9 (4.6) 0 (0)
Community nursery nurse, n (%) 0 (0) 0 (0)
ENT consultant, n (%) 46 (23.6) 0 (0)
Other consultant, n (%) 2 (1.0) 0 (0)
Referrals from diagnostic accuracy study, n (%) 2 (1.0) 0 (0)
Type of hearing impairment
‘Normal’ binaural, n (%)b 7 (3.6) 2 (2.0)
Conductive impairment (bilateral), n (%) 138 (70.8) 70 (71.4)
Conductive impairment (unilateral), n (%) 40 (20.5) 20 (20.4)
Sensorineural impairment (bilateral), n (%) 1 (0.5) 2 (2.0)
Sensorineural impairment (unilateral), n (%) 5 (2.6) 1 (1.0)
Mixed impairment (unilateral), n (%) 0 (0) 2 (2.0)
Incomplete, n (%) 4 (2.1) 1 (1.0)
N/A, not applicable.
a Sample size for these variables range from 79 to 93 in Cambridge and from 146 to 179 in Nottingham.
b Absolute values of HL may be > 30 dB but soundfield testing would indicate that to be ‘normal’.
Percentages may not add to 100% due to rounding.
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The mean age of referral was nearly identical (4.7 years) between the two sites when looking at all referrals.
When focusing solely on children who were subsequently confirmed to have a hearing impairment,
however, there was strong evidence that the children in the site with a screen were older at referral
(5.0 years vs. 4.5 years; p< 0.001). One possibility is that, for children in this age range, parents/professionals
in Cambridge seek referral when concerns are raised whereas in the area with SES, if concerns are raised
around age 4 years, parents and professionals are aware that SES is coming up later that year and wait.
The CIs for the mean age difference indicates that the true mean age at referral in areas with a screen
could plausibly be anywhere between 3 and 8 months greater than areas without one. Delay in
identification of a hearing impairment has the potential to adversely affect development1 but further
research would be needed to evaluate the extent of the impact for children at school age.
There are also differences in the audiology services operated in the two areas. In Nottingham there is no
second-tier audiology service and all referred children are seen within the same service. It has an open referral
policy, which includes referrals from parents. It works closely with the ENT department and children move
between the two services dependent on their needs. A health professional concerned that a child might
have OME and hearing loss has the option to refer for a DEA or to ENT; ENT might then refer for a DEA
if appropriate.
The second-tier service in Cambridge accepts referrals from health and education professionals. It provides
assessment for children and onward referral for those children who may require hearing aids or surgical
management. A health professional with a child with possible OME and hearing loss knows that there is a
well-staffed intermediate (DEA) service which can effectively sieve referrals and send those needing ENT
examination to ENT departments and those requiring hearing aids to third-tier audiology. Thus GPs will be
likely to refer to second-tier audiology and referrals from ENT departments to second-tier audiology
will be highly unlikely.
The very different numbers of children referred from different routes are likely to be a function of these
different systems in the two areas. Parents can directly refer to the CHAC in Nottingham but in Cambridge
they would have to go via a GP (or other professional). GPs in Cambridge would know that they have a
second-tier community service which acts as a filter, so would have a tendency to refer there rather than
to ENT or third-tier audiology. Hence referrals from ENT to second-tier audiology would be rare in
Cambridge, but from ENT to the CHAC would be expected to be higher, as they are. Provision of hearing
aids as an outcome is clear in the CHAC, but second-tier audiology services in Cambridge do not provide
hearing aids.
Strengths and limitations
Our study had a number of strengths. Data collection in both sites was comprehensive and actively
monitored by a senior member of the clinical staff with responsibility for audiological services in each of
the two areas. Both were members of the research team. An electronic database used in both sites was
developed by staff of PenCTU to standardise data collection.
However, our study design of an observational comparison of two areas [one that operates a SES
programme (Nottingham) and the other that does not operate a SES programme (Cambridge)] is subject to
major methodological limitations, in spite of our best attempts to choose two sites that were similar to
each other. We acknowledge that there may be epidemiological and social differences between the two
geographical areas that are likely to confound our findings. Reassuringly, population estimates indicate the
proportion of children aged < 16 years to be similar in Nottinghamshire (18.7%) and in Cambridgeshire
(18.5%).54 However, the index of socioeconomic deprivation indicates the city of Nottingham (rank 17)
to be more deprived on a range of measures than the Cambridge district (rank 188).55 Given the lack of
availability of child-level data, we were unable to adjust our analyses to take account of these and other
potential confounders. Furthermore, given that we consider only two geographical areas, our results may
not be considered as generalisable.
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Both sites mainly receive referrals from a defined geographical region but also accept referrals outwith
that area. Equally, some children within the defined area may be referred elsewhere; the numbers are
estimated to be few by the responsible audiologists. The referral catchment areas also do not exactly
match the areas defined by the Office for National Statistics for the population estimates used and there
may, therefore, be some minor imprecision in the population denominators used in the analyses.
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Chapter 6 Exploring the impact on the child and
family of a child being referred by the school hearing
screen: findings from a questionnaire survey
Introduction
Any analysis of the cost-effectiveness of the screening process needs to consider the costs not only to the
health and education services, but also to the families of children referred by the screen. Some of these
children will be true positives (i.e. they have a confirmed hearing impairment) and many more will be false
positives (identified by the screen but found to have no hearing impairment). Information to contribute to
the cost-effectiveness model might include details of the amount of time and travel spent by families in
attending the screen follow-up process but also an estimate of any anxiety caused. Our literature searches
identified no prior information on the impact and costs of SES referral.
Objectives
l To determine the impact, both psychological and economic, for the child and the family of the child
being referred for further assessment following the SES (both true and false positives).
l To collect cost data to inform the economic model.
Methods
Study population
Questionnaires (see Appendix 5) were distributed to parents of children referred to Nottingham CHAC from
the school entry hearing screen between 1 September 2012 and 30 June 2014 (age range 4–6 years).
Questionnaire
The questionnaire captured data on aspects of the family’s experience of the child being referred for a
hearing assessment. Questions included how they found out about the screen and further testing, parent
opinion about having a school hearing screen, the time taken to attend appointments, the cost of travel to
appointments, and impact on work, school and social activities of attending clinic appointments. Data on
gender, ethnicity and school attended were also requested. The level of anxiety experienced by the parent on
finding out that their child needed further testing and again when they attended the appointment was rated
by the parent on a scale from 0 (not at all anxious) to 10 (extremely anxious). There was also the possibility
of an option to follow-up responses by telephone, with those who gave their contact details. No follow-up
was carried out as it was not considered that it would add anything to the data already collected on the
questionnaire, especially taking into account the bias of recall over a long time period and the small data set.
Data collection
Questionnaires plus pre-paid return envelopes were sent by the audiologist to the parents of all children
referred to the CHAC by the school screen, once the end of care (discharge, hearing aid provision or
referral to ENT) had been reached, whether or not they had a hearing impairment. The audiologist kept a
list of questionnaires sent and which participant ID these related to. Parents who chose to take part
returned the completed questionnaire to the researchers at NHBRU. These returns could be anonymous
but questionnaire responders could also choose to be entered into a prize draw to win vouchers of their
choice to a value of £50, or to agree to a possible follow-up interview and hence supply contact details.
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Nottingham researchers entered the data into the study database and copies of questionnaires (excluding
the contact details page) were sent to PenCTU for second data entry and validation. A tracking log of the
ID numbers of questionnaires returned was kept locally by researchers at NHBRU. A reminder and repeat
questionnaire was sent after 3 months to non-responders identified from the list held by the audiologist.
Consent for the data collected in this study was implied by return of a completed questionnaire. It was
explained to the parents completing the questionnaire that entry into the project was entirely voluntary
and that the management and care of their child would not be affected by their decision on whether or
not to take part.
Data analysis
The quantitative data were summarised using means with SDs or medians with IQRs.
To give structure to the qualitative data obtained from the questionnaires, a thematic analysis was carried
out. Open comments from parents were assessed using a template analysis in which identified themes
from each of the questionnaires were selected and ordered. Responses to the following questions were
analysed using the template: (1) What are the good things about your child having their hearing checked
at school?; (2) What are the not so good things about your child having their hearing checked at school?;
and (3) Any further comments?
A five-step framework for analysing the questionnaire responses was used: familiarisation; identification of
themes; indexing; charting; and interpretation.56
1. Familiarisation: each questionnaire was read through six times to get a feel for the data.
2. Identification of themes: the broad research question was to explore what parents thought about the
SES tests. Using an inductive approach, parents’ opinions were categorised into main themes that
emerged across all the questionnaires. The researchers made notes on relevant points raised under each
category. This process was repeated for all questionnaires and common themes were included in the
final template. Ambiguous statements were not included as they were open to interpretation.
3. Indexing: subthemes based on similarities between all responses within the main identified categories
were explored. Indexing involved generating more precise descriptions of the themes to make the
analysis reader-friendly.
4. Charting: a template was drawn up for each category, theme and descriptor.
5. Interpretation: illustrative quotes were identified to provide the reader with examples of the
parents’ experiences.
Results
Questionnaires were sent to all 246 parents whose child was referred to the CHAC from the school entry
hearing screen in the relevant period, and who reached end of care. Completed questionnaires were
received from 60 parents by the end of the data collection period. No data were collected on the reasons
for non-return.
Quantitative data
Of the 60 children for whom questionnaires were returned, 32 (53%) were female, 44 (73%) were white,
3 (5%) were mixed ethnicity, 10 (17%) were Asian, 1 (2%) was black/African/Caribbean and 2 (3%) were
of other ethnic group.
Forty-five (75%) parents knew that their child was having their hearing checked at school. Parents found
out that their child needed further testing by means of a letter either taken home (n= 25) or sent in the
post (n= 9); by telephone (n= 13) or by other means (n= 13) [already noticed at home (n= 5), told by
school (n= 4), told by school nurse (n= 2), told by doctor (n= 1), do not know (n= 1)].
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Parental anxiety was scored on a 0–10 scale where 0 indicated ‘not anxious at all’ and 10 indicated
‘extremely anxious’. The mean level of anxiety reported by the parent(s) on finding out that their child
needed further testing was 5.3 (SD 2.1), and the median was 5 (IQR 4–7). At the clinic appointment the
mean parental anxiety had reduced to 4.7 (SD 2.4); the median was 5 (IQR 3–6). Frequencies of anxiety are
given in Table 23.
The same anxiety level on both occasions was reported by 36 out of 60 respondents (60%); 18 out of
60 (30%) reported feeling less anxious at the appointment and 6 out of 60 (10%) reported more anxiety
at the appointment.
Most parents [51 out of 60 (85%)], strongly agreed that ‘children should have their hearing checked at
school’, six (10%) agreed, one (2%) had no opinion, no one (0%) disagreed and one (2%) strongly
disagreed (one missing).
Of the 60 questionnaires returned, parents reported that 25 children had only one appointment,
16 children had two appointments in total, nine had three appointments, five had four appointments, and
five had five appointments. Altogether the 60 children had 129 appointments.
Time taken to get to an appointment was < 15 minutes for 24.8% (32/129) of appointments, about half
an hour for 59.7% (n= 77) of appointments, about 1 hour for 14.0% (n= 18) of appointments and
1–2 hours for 1.6% (n= 2) of appointments. The length of appointment was < 30 minutes for 33.3%
(43/129) of appointments, 30–60 minutes for 44.2% (n= 57) of appointments, about an hour for
13.2% (n= 17) of appointments, and 1–2 hours for 7.0% (n= 9) of appointments. Data on length of
appointment were missing for three appointments.
For the journey to an appointment, 20.9% (27/129) included a bus or tram ride, 72.9% (n= 94) of
journeys used a car, 5.4% (n= 7) included a taxi ride and one walked (0.8%). The median (IQR) total cost
per appointment was £4.88 (£3.40–£8.80).
Parents were required to take either all or part of a day off work for 45.0% (58/129) of appointments;
29.5% (n= 38) of appointments were with parents who did not work and 25.6% (n= 33) of
appointments did not require the parent to take time off work. The child was required to miss school for
all or part of the day for 72.9% (n= 94) of appointments.
TABLE 23 Parental anxiety about school hearing screen referral
Anxiety level Anxiety on finding out, n (%) Anxiety at clinic appointment, n (%)
0 (not at all anxious) 1 (2%) 2 (3%)
1 3 (5%) 5 (8%)
2 2 (3%) 5 (8%)
3 5 (8%) 8 (13%)
4 5 (8%) 6 (10%)
5 16 (27%) 14 (23%)
6 10 (17%) 7 (12%)
7 10 (17%) 5 (8%)
8 6 (10%) 5 (8%)
9 0 (0%) 1 (2%)
10 (extremely anxious) 2 (3%) 2 (3%)
Percentages may not add to 100% due to rounding.
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Twelve out of the 60 (20%) children missed other activities, including ballet and music lessons but eight of
these referred to missing school. Thirteen (21.7%) of the 60 parents missed other activities, although
eight referred to work – probably a misunderstanding of the questions. Eight of 60 (13%) families said
appointments caused problems for other family members by requiring additional childcare for
other children.
Qualitative data
Table 24 lists the themes that emerged from the data and provides illustrative quotes.
TABLE 24 What parents think about the school entry hearing screen: thematic analysis
Main themes Subthemes Description Example quotes
Respondent
ID number
What are the good things about your child having their hearing checked at school?
A1. Ease of testing i. Convenience Refers to the benefits to
parents of the hearing test
being carried out at school
during school hours
. . . in normal school hours 1
. . . without parents having to
be proactive
1
Don’t need to take time from
school to attend appointment
16
Easier than trying to attend
appointments
19
It is local . . . 37
. . . don’t need to worry about
. . . taking your child out of
school to have their hearing
tested
39
ii. Familiarisation Refers to how comfortable
the child is having the
hearing test in a location
and with classmates that
are familiar to them
. . . feels normal to child as
everyone has it done
1
Child not . . . upset as they are in
a familiar environment
9
Secure, familiar environment 14
No anxiety for the child 34
Child sees their peers having the
same test
38
All children tested together takes
away. . . fear/anxiety
42
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TABLE 24 What parents think about the school entry hearing screen: thematic analysis (continued )
Main themes Subthemes Description Example quotes
Respondent
ID number
A2. Identification
of hearing
impairment
i. Importance Refers to how important it
is to parents to have any
hearing impairments in
their children identified
. . . they need to hear well in
order to follow lessons
4
. . . the child may become
disengaged with school/learning
if their hearing is impaired
18
. . . notifies the school so they
become aware of [the] hearing
issues . . . sooner
24
It can rule out many other things 33
[A] lack of hearing can have
huge effects on child’s ability
and confidence . . .
40
ii. Early detection Refers to how the hearing
test can enable potential
hearing impairments to be
picked up and treated
quickly
Any problems will be dealt with
much quicker
2
. . . any problems . . . can be
investigated at an early stage
3
. . . parents can be alerted
immediately
37
. . . know early on that there is a
problem and it can be sorted out
51
They can be referred straight
away for further tests
53
iii. Acknowledgement Refers to how a referral
from the hearing screen
at school supported
suspicions that parent may
already have had
[My] concern was acknowledged 10
Confirmation from another
source that there was a concern
11
For us, having our school nurse
check our daughter’s hearing
got her an appointment to get a
proper check
23
. . . backed up suspicions I
already had regarding my
daughter’s hearing . . . and made
me feel it was worthwhile going
back to the GP . . .
50
continued
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TABLE 24 What parents think about the school entry hearing screen: thematic analysis (continued )
Main themes Subthemes Description Example quotes
Respondent
ID number
iv. Otherwise missed Refers to recognition from
parents that any potential
hearing problems may
have been missed without
the school hearing test
. . . children of a young age are
easily distracted and hearing
problems won’t be picked up
readily as this [not hearing]
would be considered the norm
(as in my son’s case)
6
. . . not noticed by home 8
Could identify problems which
are otherwise missed
15
Often parents . . . dismiss things
and . . . wouldn’t follow up on
possible concerns
41
What are the not so good things about your child having their hearing checked at school?
B1. Communication
with parents
i. Lack of
information
Refers to parents being
unaware of the screening
test
Parents not informed about how
the test is done or how accurate
the test is
1
I didn’t know he was having
this done
54
I didn’t know my child was
having a test on that day until
she came home and told me she
had one
47
ii. Poor
correspondence
Refers to the
dissatisfaction parents had
with the correspondence
after their child had been
referred by the school
hearing test
The letter was very vague – it
said she required further testing
and it wasn’t until I spoke to the
school nurse that I established
what the test had clinically
shown. It was probably designed
not to panic parents but I would
have preferred to have been told
50
. . . unreliable test results,
parents get informed there may
be a problem when there isn’t
15
Got letter from school to say he
would be retested but no date.
The retest happened a long time
after first test . . .
15
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TABLE 24 What parents think about the school entry hearing screen: thematic analysis (continued )
Main themes Subthemes Description Example quotes
Respondent
ID number
B2. Parental
absence
– Refers to parents opinions
about not being present
while the school hearing
test was undertaken
Can’t talk to the person carrying
out the test about the results
38
Not being present to ask
questions if test failed
12
A parent is not around for when
something (problem) arises
36
I would have preferred to be
present for checks
16
Parents don’t have the
opportunity to be there
30
Could provoke anxiety in child
(no parent accompanying)
28
Possibly the child may feel more
comfortable with their parent
being present
35
B3. Problems with
the test
B3i. Distractions Refers to testing children
whilst they are at school
may result in them being
distracted from the test
. . . may be distracted 3
Could be distracted if friends
nearby or . . . at end of day and
child not concentrating
9
B3ii. Noise Refers to testing children
within noisy school
environments rather than
in sound proofed
conditions
The school is not the place to
have a proper hearing test as
they don’t have a quiet room or
the equipment to do so
23
Very noisy environment 26
Not in a sound proof[ed] room 44
continued
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TABLE 24 What parents think about the school entry hearing screen: thematic analysis (continued )
Main themes Subthemes Description Example quotes
Respondent
ID number
Any further comments?
C1. Age of the
child
– Refers to hearing tests
being conducted at
pre-school age (earlier
than the current SES
programme)
My child had her pre-school
check missed. This is why it was
done at school
13
I agree children need a hearing
test early and school is the only
option currently. Would be
better to be done before
entering school at a proper
hearing unit
22
As a parent I think a child’s
hearing should also be checked
as part of a pre-school check at
the doctor’s
23
C2. Satisfaction i. With the
follow-up service
Refers to positive
comments on the service
received after the school
hearing test
The staff of . . . was really good
and made my daughter feel
comfortable and less worried
about the tests
56
I found the . . . centre brilliant
and they put my mind at ease
straight away
54
Overall I’m very happy with the
service we received. Everyone
was really nice to my daughter
and she wasn’t worried about
the appointments
47
We have been happy with the
whole process. The initial
communication from the school
test was informative and
prompt. The tests were
thoroughly explained to our
child & to us, as were the results
both immediately after the tests
& via post a week later . . .
48
ii. Overall Refers to summaries about
the school hearing
screening test
I think the pros outweigh
the cons
26
School test cannot replace a
proper hearing test as they
cannot recreate that acoustic
free environment but it can act
as a good indicator of any
problem area
55
Note
For simplification, when quoting: ‘. . .’ is used when the authors excluded text from the original response and [ ] is used
where text has been added in for clarification.
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Discussion
Main findings
The consequences for costs and the views of parents concerning referral for diagnostic evaluation were
assessed by means of a questionnaire sent to parents of children referred to the Nottingham audiological
service by the SES programme. The response rate was 24.4% (60/246). It is possible that those who
did not respond are neutral, that is, they had no strong opinion with respect to the subjects in the
questionnaire, but this cannot be assumed. If an adverse experience engendered non-response, then
the low response rate could conceal an unsuspected level of ‘harm’ associated with SES.
Of the respondents, the majority had more than one appointment. Some of those with multiple
appointments may be individuals in whom hearing impairment was confirmed (true positives), but others
will be those in whom no hearing impairment was identified (false positives).
The mean parental anxiety score on finding out about the referral appointment was 5.3 on a 0–10 scale,
with 0 indicating ‘not at all anxious’ and 10 ‘extremely anxious’. The mean score was 4.7 at the clinic
appointment. Severe anxiety, indicated by scores of 10, was registered by only two (3%) parents. Thus,
although there was some anxiety associated with referral in those who responded, it appeared moderate,
albeit sustained during the waiting period.
Costs were associated with attending the referral appointment in the respondents in terms of time, travel
and activities foregone. The median travel cost per appointment was £4.88, travel times to get to the
appointment was about half an hour in 60% of appointments, and appointment times were 30–60 minutes
in 44% of appointments. Activities foregone were generally work in the case of parents (45% of
appointments involved missing work) and school in the case of children (73% of appointments involved
missing school).
Despite the inconvenience, virtually all respondents were supportive of SES; 85% of parents strongly
agreeing that ‘children should have their hearing checked at school’. Supportive statements and overall
satisfaction were also evident in the open comments. These identified areas where care needs to be
maintained in delivering SES, particularly attention to communication, thereby minimising concerns about
the absence of parents at the initial test but also the potential for noise and other distractions in schools to
reduce the value of hearing tests.
Strengths and weaknesses
The study was prospectively designed and carried out in accordance with a protocol without deviation.
The most important challenge to the validity of the findings was the low response rate, with only 24% of
parents to whom questionnaires were sent out providing responses. This was despite a small incentive for
taking part and a reminder being offered. This may have been in part because of the length of time
between the child being referred and receiving the questionnaire which was sent out after the child
reached the end of care. However, for the specific purpose that this component of the clinical studies was
designed, we do not believe this is a major shortcoming, but the conclusions drawn should be viewed in
the light of a low and potentially biased response rate.
Children referred from SES may truly have a hearing impairment (true positives), may not have a hearing
impairment, or have a hearing impairment at the time of screening which later resolves (false positives).
We failed to identify information in the literature on what the consequences of false positives might be in
a SES programme (see Chapter 4). As far as the original 2007 HTA report12 was concerned, the potential
for disutility associated with false positives was not considered, almost certainly because there was no
evidence to inform any assumptions. In this respect it would be useful to gauge whether there were likely
to be substantial consequences associated with false positives, indicating that they might have a major
impact on overall effectiveness and cost-effectiveness. However, as parents were given the option to return
the questionnaires anonymously we were not able to collect data on outcomes for all those who
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responded. In Chapter 5 we report that there were 366 referrals from the SES to the Nottingham service,
60 (16.4%) of whom were confirmed cases. Nearly 90% of confirmed cases had a conductive impairment.
We can assume, therefore, that the majority of the questionnaires were returned by the parents of children
who did not have a permanent impairment (false positives).
There are clearly some adverse consequences of referral, but these appear to be small, judged externally
or by the effect on parental satisfaction. Furthermore, it is reasonable to assume that the effects in
non-respondents are unlikely to be greater than those observed in the respondents, so we evaluate that
the adverse consequences of referral, particularly for those found not to have hearing impairment, are
likely to be no greater on average than those observed in the respondents.
Results in the context of other studies
We emphasise that this is the first attempt to quantify the effect of the referral process in SES on parents
and children. Inevitably, there is still much uncertainty, but we would argue that the uncertainty has been
reduced. How the results of this study were considered in the economic model of this report is discussed in
more detail in Chapter 8.
We explored the option to formally quantify the impact on health-related quality of life, particularly for
children, through the Health Utilities Index (HUI) instrument but this was not pursued, both because the
instrument is not responsive to specific issues related to hearing and on the grounds of cost of using the
instrument under licence, a factor amplified by the need to repeat the assessment. Given that the response
rate emerged as being problematic in the actual study, it is likely that an attempt to use a more formal
instrument like the HUI may have further compromised the response rate.
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Chapter 7 Observations of the practical
implementation of screening tests for hearing
in schools
Introduction
Aside from the minimal and very weak evidence for the effectiveness of different implementations of SES
reported in the 2007 HTA report,12 we were unable to identify any literature on the practical implications
of different implementations or different screen technologies. One paper17 evaluated the accuracy of the
HC navigator device in children with a mean age of 6.8 years in schools in the Philippines and reported
low sensitivity when used in the school setting where there is significant ambient noise. The use of the PTS
has not been formally evaluated in terms of practicality.
Objectives
l To determine the time resource in implementing either of the two alternative screening methods
(PTS and HC screener) in primary schools.
l To elicit the views of the school nurses implementing the screening tests.
Methods
This was a prospective observational cohort study. A researcher from the project team observed school
nurses while they conducted hearing screening using two methods: the standard PTS and the HC screener.
The primary end point was the mean cost per child of implementing each of the two test technologies
based on time taken to do each test. Secondary end points included a pass or refer for each test, total
time of session, school demographics, nurse opinion on ease of use, how much the nurses would want to
use that screener in the future, plus other comments.
The school nurse team was approached by a member of the research team and asked for support with the
study. School nurses who delivered hearing screening and were happy to be involved drew up a list of
schools in which they routinely screened children for hearing impairment. The research team made contact
directly with the head teachers of these identified schools, initially by letter, to gain approval for the
researcher to access the school to observe the school nurse. Visits were conducted in all three terms of the
school year, in order to cover a range of school conditions and the effects of seasonal infections.
Information sheets were distributed to the school via the school nurses (see Appendix 6). They were given
to parents of children together with information about the school health screen, following the usual
process of securing informed consent for the hearing screen. It was explained that, in addition to the
routinely used PTS, an extra test (HC) would be carried out by the school nurse and why. Anyone not
consenting to either the standard school screen or our extra screen replied to the school nurse,
withdrawing their consent via an ‘opt-out’ system. Only those giving consent to both tests were included
in the study, implied by no reply to the contrary.
Tests during SES were observed in primary schools in the Nottingham area. The number of schools was
chosen to ensure resources were measured for at least 180 child screens, representing a range of
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catchment populations. Children in the Foundation year or Year 1 (age 4–6 years) were included if they
had the usual parental consent for the school screen (following protocols and guidelines for parental
consent normally administered by the service) and had not opted out of the SES study.
Data collection took place in the school year from October 2013 to June 2014.
Before the first school session, the researcher met with the nurse to explain and demonstrate how to use
the HC screener.
In each school all children > 5 years old in Foundation and Year 1 classes were screened by the school
nurse. This meant it was necessary for the school nurse and the observing researcher to attend each school
more than once. All children in the appropriate classes who did not opt out were screened using both
technologies (routine PTS and HC screener), unless the school nurse chose not to perform both tests (for
instance because of a lack of attention or nervousness of the child). The order of the tests was randomised
according to computer-generated lists provided by members of the research team in Exeter, but if the
school nurse felt that the child might have found it difficult to complete two tests, the PTS was performed
first to increase the likelihood of completing the routine screening data.
The HC screening method was used as explained in Chapter 3. The nurse indicated ‘pass’ or ‘refer’ to the
researcher. The researcher recorded this, and the time taken for the screen, on the CRF (see Appendix 6)
(note: on the CRF a refer outcome is entered as a fail). Nurses did not use HC data to inform their decision
on whether a child should be referred for further assessment by audiology services.
The nurse performed the PTS method according to usual practice. The nurse indicated to the researcher
whether or not the child had passed the screen. The researcher recorded the time taken for the screen
(not including explanation). Data were recorded on the CRF. If the result of the PTS was to refer the child
or it was unclear, the child was rescreened on another day and, if necessary, referred onward as
appropriate according to usual practice.
The start and end time of the session were recorded on the CRF, along with date, school name and
postcode, number of pupils on roll, number of pupils eligible for free school meals (a marker of
deprivation), and the name of the nurse and the researcher. Comments were also made about the
conditions for the screen (e.g. room, noise levels, disturbances, number of children seen and any
difficulties during testing). The researcher informed the nurse which screen was to be conducted first for
each child according to the randomisation scheme. The total time of the session included time to take
children to and from classrooms, break time, screen explanation time, other screens (e.g. vision tests) and
interruptions. The CRF included details of what ‘other’ times were included in the session.
If, during an assessment session, a particular child became upset, uncomfortable, or uncooperative it was
up to the school nurse to decide whether or not they continued the session.
Finally, the school nurses were asked on a scale of 0–10 (0 being low) how they would rate each screening
test on ease of use, accuracy and how much they would want to use it in the future.
Each participant was allocated a participant number, but to maintain anonymity and to work with the
school nurse’s system, no record was kept of which child the number applied to. The original CRFs were
kept securely at NHBRU. Photocopies of all CRFs were sent to PenCTU for second data entry and checks.
The schools involved received a short summary of the findings at the end of the study.
Sample size
It was anticipated that a sample size of four schools would provide a convenience sample of about
180 children. The study size was not formally calculated.
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Analysis
The mean and median time taken to complete the screening tests are presented for: (1) all children,
(2) children for whom the PTS was administered first and (3) children for whom the HC screen was
administered first. The mean time was compared between the PTS and the HC screener using linear
regression models. As the distribution of time to complete the test was skewed, bias-corrected accelerated
bootstrap CIs were constructed for the mean difference between the PTS and HC tests.
Results
The three school nurses covering Nottingham East (Carlton, Hucknall, Arnold and Calverton) agreed to do
the extra screening. In the catchment areas of the three nurses, seven of the 34 schools covered were
willing to take part.
Twenty-two observational sessions were conducted in the seven schools in the Nottingham East area
through the school year 2013–14. The parents of four children at the sessions attended did not give
consent for the study. Of the children for whom consent was given, 191 were observed, 184 of whom
completed both tests; three did not complete either test, the other four did not complete the HC screen.
Data were analysed only where the test produced a pass or refer classification. For the remaining
participants either the test was not done at all or was incomplete.
Children were seen in groups of between two and five, depending on distance to the classroom and
occasionally how disruptive the children were. Sometimes, if the classroom was close by, children were
allowed to return to class once they had finished. The total session time was recorded, and included
time spent collecting children, administration of other tests (vision) and activities (brushing teeth) and
occasionally measurement of height and weight, or retests of previous screens.
Of the 188 PTS tests, 40 (21.3%) were referred. Of the 184 HC tests 71 (38.6%) were referred.
Time taken
The mean/median times taken for each screening test were similar for the two tests, at around 1.4 minutes
per test, but the range of test times was wider for the PTS (to be expected as the test was not automated).
The test time did not appear to vary with the order of the tests. The CI for the mean difference across all
screens indicates that the PTS is unlikely to be more than 5 seconds quicker and unlikely to be more than
9 seconds longer on average to administer than the HC screen. That the CI includes zero indicates that it is
plausible that there is no difference between the PTS and HC screener in mean time taken (Table 25).
TABLE 25 Time taken (minutes) to do screening tests and comparison between the PTS and HC screener
Test n Mean (SD) Median (IQR) Range Mean difference (PTS –HC)
Across all occasions
PTS 188 1.39 (0.67) 1.24 (1.05–1.55) 0.63–7.5 0.002 95% CI –0.08 to 0.14a
HC 184 1.39 (0.24) 1.33 (1.27–1.58) 1.03–3.47
When the PTS is administered first
PTS 105 1.37 (0.42) 1.28 (1.08–1.57) 0.73–3.22 –0.007 95% CI –0.08 to 0.09a
HC 102 1.38 (0.18) 1.33 (1.28–1.45) 1.12–2.45
When the HC is administered first
PTS 83 1.42 (0.89) 1.2 (1.03–1.50) 0.63–7.5 0.013 95% CI –0.13 to 0.33a
HC 82 1.41 (0.30) 1.33 (1.25–1.45) 1.03–3.47
a Calculated using the bias-corrected accelerated bootstrap method.
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Observations of researchers and nurses
The researchers observed that schools were often unsuitable for testing hearing because they were too
noisy and a suitable alternative room was often not available. On some occasions the nurse had to give up
with the hearing tests and return on a different day.
The nurses suggested advantages and disadvantages of each test (Table 26)
The three nurses scored each of the tests on a total of 20 occasions for 185 children (no tests at one
session because no suitable room available; hearing testing abandoned at another session, after three
children tested, owing to noise). All nurses scored all tests as 5 or above for ease of use, accuracy and
future use. The mean, median and range of scores are shown in Table 27. The PTS test scores higher than
the HC test on all measures but in terms of ease of use that might have been because the nurses were
TABLE 26 Advantages and disadvantages of the PTS and the HC screener as observed when used by school nurses
PTS HC
Advantages
Provides a full audiogram if needed Lightweight
Can turn it up in noisy situations Portable
Can turn it up to check a child’s
understanding
Hygienic
The headphones help block background
noise
No need for mains electrical socket
No need for headphones
Disadvantages
Headphones can be tight Cannot pause to check understanding
Headphones disliked by some children Cannot pause to wait for background noise to stop
Needs to be plugged into a socket Cannot vary timing of presentation so some children anticipate when to put up
their hand (particularly if they see their peers doing the test before them)
Cannot repeat a particular tone
Only plays six tones – and only two frequencies are tested
The tone at 20 dB is very quiet in a school situation and a lot of children miss it
Younger children found this more difficult to understand
No time between tones to give praise or encouragement
The cups can fall off
The equipment can get in the way of the child’s hand going up
TABLE 27 Ratings of three nurses on the practical implementation of the PTS and HC screener in schools on
20 occasions – scoring from 0 (low) to 10 (maximum)
Attribute
PTS HC
Mean Median Range Mean Median Range
Ease of use 8.75 9 7–10 8.40 8 6–10
Accuracy 8.70 9 7–10 6.45 6 6–9
Future use 9.10 10 7–10 6.30 8 5–8
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more familiar with using the PTS. They also rated accuracy more highly for the PTS than the HC screener.
When asked how much they would want to use a test in the future they again rated the PTS higher, but
commented that they could see the HC screener as being useful as a back-up in some situations.
For two of the nurses the scores all either decreased or stayed the same over time. For the third nurse the
HC screener scores stayed the same and the PTS scores increased for ease of use and future use and
decreased for accuracy over time.
Discussion
In order to assess the practical issues associated with using the PTS or HC screener as the screening tests in
a SES programme, careful observation of screening 184 children in seven schools in the Nottingham SES
programme was undertaken. Three nurses covered 22 sessions. Each child had both tests applied, with the
test given first being randomly determined.
The average time taken to implement each screening test was nearly identical at about 1.4 minutes, noting
that the variability in time was greater for the PTS than for the HC screener. The difference in average time
taken to conduct the test was not statistically significant and this was not affected by which test was the first to
be used.
Nurses slightly preferred the PTS, but acknowledged that the HC screener could still prove a useful backup
for children who refused to wear headphones or when there was no electrical socket available to run the
PTS test. The observations about potentially noisy school environments raise the possibility that the
accuracy of screening tests may be overestimated in the quieter research environment experienced in
diagnostic accuracy studies, including our own.
Strengths and weaknesses
The study was prospective and undertaken in accordance with a protocol without deviation.
The target number of participants was achieved. The observations were carried out in familiar
environments for the children allowing assessment of the operation of the screening tests without being
compromised by the children feeling anxious – an issue that may have hindered the testing of control
children at NHBRU in the diagnostic accuracy study.
Testing took place in a number of different schools throughout the school year, enabling the capture of
seasonal changes that might affect hearing through colds, illness or hay fever.
The observations captured data on a range of children from different backgrounds. Several city schools
were observed, enabling examination of how the hearing screens by school nurses might be affected
by school size, behavioural challenges, support from teaching staff and school facilities, such as test
room conditions.
We note the limitation that feedback on the two screening tests and the observations of testing involved
only three nurses. However, all nurses undergo the same training and follow a set protocol while screening
and therefore procedural differences should not affect test performance. With regard to verbal feedback
provided by the nurses on the two tests, all three demonstrated inter-rater reliability, finding similar
strengths and weaknesses for both the PTS and HC tests. Gaining opinion from a wider nursing
community is unlikely to affect the conclusions drawn.
Results in the context of other studies
As far as we are aware this is the first study to systematically examine the practical issues associated with
applying tests that might be used in SES with children in real-life circumstances.
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Chapter 8 Modelling cost-effectiveness of school
entry hearing screening
Introduction
Ultimately, the value of a new approach to health care must be judged on the degree to which additional
benefits that might arise match the amount of additional resource that would be required to bring about
the new approach. This is equally required of SES and in the forerunner to this HTA report,12 health
economic modelling was employed to this end. The health economists on that research team conducted
a decision-analytic model after finding that there was little relevant health economic literature and reported
it in 2007. The report concluded that SES was potentially cost-effective but subject to considerable
uncertainty. The main source of this uncertainty was test accuracy estimates (Professor Linda Davies,
University of Manchester, 2011, personal communication). One purpose of this project was thus to improve
the estimates of cost-effectiveness by incorporating more precise parameter estimates (particularly test
accuracy) into the existing health economic model, accepting that re-examination and redevelopment
might be required too, which turned out to be the case as indicated in the methods that follow. The
inter-relationship between the studies reported in Chapters 3–7 and the economic modelling as originally
envisaged is shown diagrammatically in Figure 17. The other major change from the original health economic
model was to be more specific about the methods of screening in the current report. The PTS and HC tests
were the two methods evaluated.
Objectives
The overall aim of this chapter is to compare the cost-effectiveness of the PTS and HC tests as methods of
SES for hearing impairment and to compare the cost-effectiveness of SES for hearing impairment relative
to no screening.
Specific objectives were to:
l update the existing hearing screening model from the 2007 HTA report12
l incorporate data from the studies on referrals, costs and diagnostic accuracy (see Chapters 3–7)
l estimate the health-related quality of life, costs and utilities of SES compared with no screening and
of the PTS versus HC screen, with comparisons based on cost per quality-adjusted life-year (QALY) gained.
Methods
Overall approach
Our approach was designed to estimate the cost-effectiveness of SES primarily from a health-care perspective
but to consider other costs where data were available. In this report this was limited to consideration of
transport costs associated with families attending diagnostic evaluation; thus the perspective adopted in this
report was that of the NHS and the family. The study was designed to capture the costs and benefits of the
two different methods of SES in order to inform the policy decision regarding the appropriate use of SES.
Since SES is likely to have an impact on the costs and outcomes of all types of hearing impairment, the
analysis is concerned with the identification of children with sensorineural or permanent conductive (SNPC)
hearing impairment or transitory hearing impairment not diagnosed during the newborn hearing screen or
the first 3 years of life (the final pre-school year which is the starting point for the economic model).
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There are three key considerations that inform whether or not screening is cost-effective relative to no
screening. First, there is the issue of whether or not screening at school entry improves the timeliness with
which children are referred to diagnostic evaluation and, if indicated, to management, thus generating a
more prolonged improvement in quality of life than would otherwise occur. Second, cost-effectiveness will
depend on whether or not the diagnostic accuracy of the test makes a difference in the time at which
children are identified, referred and managed. If a test has a high level of false negatives, children who
should have been picked up by the screening test will experience a delay in their diagnosis and
management. Third, to the extent that there are false positives (either from screening or other modes of
identification), there is a potential associated negative impact on the child and family of stress and lost
time in school or work, as well as additional unnecessary costs to the health system.
The following sections outline the key components of our modelling approach. This includes the rationale
and important assumptions required to estimate the cost-effectiveness of the PTS and HC tests and
provides some background to the evolution of the modelling approach since the 2007 HTA report.12
Decision-analytic structure
The screening question was addressed using a decision-analytical approach to evaluate the
cost-effectiveness of school entry hearing screening programmes. The model estimates the costs and
consequences of a hypothetical cohort of 10,000 children with a given prevalence of hearing impairment
receiving the PTS, HC testing or no screening. The basic structure is presented in Figure 18. Figure 19
shows the route followed from screening to diagnosis of hearing impairment while Figures 20 and 21
illustrate the management follow-up for transitory and SNPC hearing impairment, respectively. As the
decision tree representation does not explicitly capture the time element in the model, this aspect is
detailed in the following sections.
SES
No SES
GP or other health
professional
PTS
HC screener
Referred for 
diagnostic
evaluation
Not referred for
diagnostic
evaluation
Referred for 
diagnostic
evaluation
Not referred for
diagnostic
evaluation
Referred for 
diagnostic
evaluation
Not referred for
diagnostic
evaluation
Child
FIGURE 18 Basic decision tree structure.
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Screening
Refer DEA
Do not refer
True
False
No hearing
impairment
Hearing
impairment
Transitory
SNPC
FIGURE 19 Decision tree: screening arm.
Transitory
Unilateral Non-surgical
Active observation
Surgical
Bilateral Non-surgical
Active observation
Surgical
FIGURE 20 Transitory hearing impairment.
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Initial model development
Although a version of the original model from the 2007 HTA report12 [built in TreeAge Pro 2005 (TreeAge
Software Inc., Williamstown, MA, USA)] was provided for the current research, the updated model was
developed in Microsoft Excel to provide flexibility in the modelling approach. Part of the initial work
on this project was to simplify the decision tree model developed for the 2007 HTA report.12 Based on
consultations with the Project Steering Group, a flexible modelling approach was adopted which would
retain the logic of the original model and could be represented by a decision tree format, but also capture
the way in which hearing impairment is identified over a period of time. This is relevant not only when SES
is unavailable and hearing impairment is identified exclusively by other means, but also in the presence of
screening, when these other routes of identification may also be important. This chapter describes the
SNPC
Mild or moderateUnilateral
Minimal
Severe or profound
No intervention
Non-surgical
No intervention
Non-surgical
Non-surgical
Surgical
Moderate
Mild
Severe
No intervention
Non-surgical
Minimal
No intervention
Non-surgical
Non-surgical
Surgical
Non-surgical
Surgical
Profound
Non-surgical
Surgical
Bilateral
FIGURE 21 Sensorineural or permanent conductive hearing impairment.
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initial development of the model in anticipation of the results of the clinical studies described elsewhere in
this report (see Chapters 3, 5–7) and subsequent to the data becoming available, at which point we were
able to generate final estimates of cost-effectiveness for the new technology (HC screener) and the existing
technology (PTS) compared with no screening. For the two screening tests, the structure of the evaluation
is identical.
Based on information in the 2007 HTA report12 and correspondence with the lead modeller (Professor
Linda Davies), we reconstructed the model used to generate the cost-effectiveness results presented in that
report. Before updating the model, as specified in the original protocol, the modelling approach was
reviewed to ensure that it was still fit for purpose. The alternative of a more detailed simulation model
was considered but it was felt that it would add minimal benefit in terms of answering the research
question. It was concluded that a Markov model or discrete-event simulation would not greatly improve
the representation of screening while adding to the complexity of the modelling by increasing its data
requirements (e.g. the use of transition probabilities). At the same time, this would have presented a
considerable challenge in terms of data availability and would have introduced additional parameter
uncertainty. As part of the validation of the initial model we developed, we were able to reproduce, within
reasonable limits, the original base-case results from the 2007 HTA report.
This initial model was populated with the parameter values used in the original modelling exercise
conducted for the 2007 HTA report12 and was driven by the diagnostic accuracy of the screening tests.
For the screening arm of the model, this generated a number of referrals for suspected hearing impairment
in the first year (true positives and false positives). As Figure 19 indicates, children who are referred by the
screening test (positive result) are sent for a DEA for a definitive assessment (DEA being assumed to be
100% accurate). It was then assumed that all remaining cases of hearing impairment (false-negative results
of the screen) would be identified over the following 2 years (i.e. up to age 7) by referral for a DEA as a
result of concern by parents, teachers or other professionals. An assumption was required about the timing
of these additional cases. In the absence of other evidence, they were evenly spread over the subsequent
2 years of the model. Similarly, an assumption was required about the rate of identification in the no
screening arm. Under no screening, it is assumed that those with a suspected hearing impairment (on the
basis of concern by parents, teachers or other professionals) are referred for a DEA. The background rate
of identification was set so as to generate an even flow of diagnosed cases over a 3-year period.
Those referred by the screen or referred for a DEA on the basis of the concerns of parents, health
professionals, teachers and others (in the presence or absence of screening) will either be found not to
have a hearing impairment (false positives) or will be confirmed as having transitory or SNPC hearing
impairment in either one or both ears (true positives). Management strategies received by children with
hearing impairment include active observation, non-surgical and surgical interventions, with the type of
intervention offered varying depending on the severity of hearing impairment.
Model development incorporating new clinical data
Although the basic model structure illustrated in Figure 18 has remained essentially unchanged in the
current version of the model, there have been substantial revisions compared with the model described
above to take account of the clinical observations reported in previous chapters. The present model has
been informed by the two-gate (‘case–control’) study investigating the diagnostic accuracy of the two
screening methods (see Chapter 3), a comparison of a site with a SES programme (Nottingham) and a site
without a SES programme (Cambridge) (see Chapter 5), a study exploring the impact of referral for
diagnostic evaluation on parents and children (see Chapter 6) and data on practical implementation in
schools (see Chapter 7).
For both transitory and SNPC hearing impairment, the model takes account of the benefits of management
for those found to have mild, moderate or severe hearing impairment. The analysis runs for a 4-year time
period, starting in the year before school entry. By the end of the 4-year time period, evidence on referrals
from the studies undertaken in Nottingham and Cambridge indicates that all cases of hearing impairment
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are likely to have been diagnosed regardless of whether children at age 4 years are screened or not
screened. In the absence of screening, identification of hearing problems occurs as a result of the concerns
of parents, teachers or other professionals, sources which can also generate referrals when a screening
programme is in place. As discussed in the following sections, the results of the model are primarily driven
by the total numbers of referrals with and without screening, and the numbers referred for a DEA in
each year.
Given the key influence of referrals on the results of the analysis, the analysis has explored the effect of
varying the number and pattern of referrals over time. This analysis has been reported as a threshold
analysis following the presentation of the base-case results. A probabilistic sensitivity analysis (PSA) was not
carried out, as it was not considered that probability distributions could usefully be attributed to the
numbers of referrals or their timing based on referrals data drawn from two areas. It is argued here that
PSA may not always be the most informative technique for exploring parameter uncertainty, as it can result
in attention being focused on those variables for which probability distributions are most easily attributed
rather than those that have the greatest influence on the results. In this case, while it is recognised that
there will be variability in the numbers and rate of referrals with and without hearing screening, this
uncertainty is particularly difficult to quantify. Threshold analysis was therefore performed on
these variables.
Total referrals and cases of hearing impairment
Table 28 presents the key items of data obtained from the clinical studies that were used in obtaining
estimates of the prevalence of hearing impairment, numbers of referrals and results of the screening tests.
The total number of cases of hearing impairment to be identified (with or without screening) is based on
the prevalence of hearing impairment using the number of confirmed cases of hearing impairment in
Nottingham (n= 195) as a proportion of the base population (N= 42,553). This gives a prevalence of
approximately 46 cases in a population of 10,000. These cases were divided into SNPC and transitory cases
of hearing impairment in accordance with the assumption used in the 2007 HTA report.12 In the base case,
the number of referrals has been assumed to be the same in both screening and non-screening arms of
the model and is given by the number of children referred in Cambridge (n= 1108) as a proportion of the
base population (N= 17,624), or around 6.3%. This is equivalent to 629 referrals in a population of
10,000. Using the rate of referrals observed in Nottingham does not have a material impact on the
cost-effectiveness results. The estimates of test sensitivity are the child-level estimates reported in
the diagnostic accuracy study. The implications of these data in terms of screening results (true positive,
false positives, true negatives and false negatives) are presented in Table 29.
The three groups of most interest are the true positives, false positives and false negatives since no further
intervention is required in the true-negative group. True positives and false negatives are generated by the
observed diagnostic sensitivity of the two tests, given the prevalence of hearing impairment. Total referrals
are made up of true positives, false positives and false negatives, the last of these groups being referred by
means other than the screening test so that all cases of hearing impairment are ultimately identified.
TABLE 28 Key data points derived from clinical studies
Parameter Parameter value Source
Prevalence of hearing impairment 45.8 per 10,000 children Confirmed cases in Nottingham as a proportion
of base population (see Chapter 5)
Referrals for a DEA 628.7 per 10,000 children Referrals in Cambridge as a proportion of base
population (see Chapter 5)
Diagnostic sensitivity PTS: 95.9%; HC: 88.7% Diagnostic case–control study (see Table 16)
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Owing to the constraints imposed by the numbers of referrals and prevalence of hearing impairment, the
resulting number of false positives implies a substantially higher test specificity (the probability of a child
without hearing impairment testing negative) than that found in the new diagnostic accuracy data from
Nottingham (Table 30). Moreover, these constraints mean that the implied specificity is the same under
either screening method in the base case and cannot be varied between the PTS and HC screener.
However, it was possible to explore the impact of varying the numbers of false-positive referrals between
the screening and no screening options by varying the total number of referrals. This is a particularly
relevant area of uncertainty to consider as, in the base case, total referrals are assumed to be the same
with and without screening, whereas evidence from the service comparison study suggests that the rate
of referrals may be higher in the absence of screening than when a screening programme is in place.
Although the significantly higher referral rate in Cambridge than Nottingham (34.4 vs. 21.9 per 1000
children per year) does not lead to a significantly higher yield of confirmed cases in Cambridge (3.04 vs.
2.51 per 1000 children per year), the possibility that a screening programme will reduce the number of
referrals needs to be considered. Given the differences between the characteristics of the populations in
the two areas, it is unclear what the difference in referral rates might be in any given area in the presence
or absence of screening. Nevertheless, a higher rate of referrals in the no screening arm could result in a
substantial increase in costs relative to the screening option (given the unit cost of diagnostic evaluation
relative to screening) and thus have an important influence on the cost-effectiveness of screening.
We therefore vary the referral rate between screening and no screening arms of the model in
sensitivity analysis.
Distribution of referrals over time
In the current model, the previous assumptions about the identification of hearing impairment over time
have been superseded by data on referrals obtained from the screening area (Nottingham) and the no
screening area (Cambridge). Table 31 gives the distribution of referrals by age at last birthday in Cambridge
and Nottingham. Referrals at age 3 years are taken to apply to the pre-school entry year (year 1 of the
model) while referrals at ages 4–6 years are taken to apply to the first 3 years of school (years 2–4 of
the model). In addition to the distribution over time, the model also takes account of the different sources
of referral in the presence and absence of screening, based on the available data (Table 32). It is worth
noting the importance in the screening area of sources of referral other than screening.
TABLE 29 Screening results: persons per hypothetical cohort of 10,000 children screened
Category PTS HC
True positives 43.9 40.6
False positives 582.9 582.9
True negatives 9371.3 9371.3
False negatives 1.9 5.2
TABLE 30 Diagnostic accuracy
Variable Sensitivity – observed and modelleda Specificity – observedb Specificity – modelledc
PTS 95.9% 79.8% 94.1%
HC 88.7% 83.8% 94.1%
a As measured in accuracy study and value used in model.
b As measured in accuracy study.
c Value used in model, implied by the referral rates for a DEA in Cambridge.
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Management of hearing impairment
Once cases of hearing impairment are confirmed by a DEA, their management will depend on the type of
hearing impairment and its severity. The available management options are essentially unchanged from the
2007 HTA report.12 We simply note here that management of hearing impairment results in an
improvement in quality of life, which translates into QALYs. While the total QALY difference between
screening and no screening will include the QALYs experienced by those with no hearing impairment, we
exclude these from our results, as we assume that the characteristics of the modelled populations are the
same in respects other than their exposure to type of screening (or no screening). The reported QALYs in
screening and no screening groups represent the QALYs accruing only to those with managed hearing
impairment who thereby experience an improvement in quality of life. The assumptions underlying the
QALY calculations and the other parameters in the model are reported in the following sections.
Sources of parameter inputs
Values of input parameters for the model are based on the original HTA model, the literature, the
observational studies described in greater detail elsewhere in this report (see Chapters 3, 5–7) and standard
reference sources. A limited literature review was carried out to update health state utilities and costs. For
probabilities of different severities of hearing impairment and utilisation of management options, the model
used the data on which the original HTA report12 was based as the steering group felt that these were
still relevant.
An overview of sources for the main broad categories of data input is given in Table 33.
TABLE 31 Percentage of children being referred to diagnostic evaluation by year: base case
Age at last birthday
(years)
Model
year
Total referrals
(non-screening area) (%) Cumulative
Total referrals
(screening area) (%) Cumulative
3 1 34.4% 34.4% 29.9% 29.9%
4 (school entry year) 2 28.5% 62.9% 29.1% 59.0%
5 3 23.4% 86.3% 28.9% 87.9%
6 4 13.7% 100% 12.1% 100%
TABLE 32 Distribution of referrals by type of referral
Type of referral No screening (%) Screening (%)
GP 41.3 10.9
Health visitor 24.3 22.7
School screen 0 21.5
Speech therapist 25.1 8.6
Paediatrician 3.2 8.1
Parent 4.2 12.4
Education 1.9 0.0
School nurse 0 3.1
Community nursery nurse 0 0.8
ENT consultant 0 8.2
Other consultant 0 1.7
Referrals from diagnostic accuracy study 0 2.0
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Reviews of the literature
A short literature review was undertaken to search for any updates to the data required by the model that
were not expected to be included in the results of the clinical studies. These were utility values of hearing
impairment, the prevalence of hearing impairment (using data from the NHSP) and costs of management.
The scope for searches was publications since 2007, to capture new research published since the 2007
HTA report.12 Search ranges were from January 2007 to July 2014 and were carried out on 10 July 2014.
The following databases were searched:
l MEDLINE
l EconLit
l SocINDEX
l PsycINFO.
Searches were also run through Google Scholar.
The following charity and support group websites were checked for useful publications (grey literature)
that may not show up in searches of conventional databases:
l Action on Hearing Loss
l National Children’s Bureau
l National Deaf Children’s Society.
Referrals
The clinical studies have, to date, reported on samples of 1108 children referred to audiology services in
the no screening area (Cambridge) and 1702 children referred in the screening area (Nottingham).
TABLE 33 Data sources used for the current model in comparison with the 2007 HTA report12
Type of parameter
HTA 2007 parameter
source
This HTA parameter
source Updated Note
Discount rate (costs
and QALYs)
UK Treasury green book UK Treasury green book57 No Deemed to be still valid
and follows the NICE
Reference Case58
Prevalence of deafness Literature and calculation New clinical studies Yes
Probabilities of types of
hearing impairment
Study, literature and
calculation
HTA 2007 report and
calculation
Yes
Probabilities of
management types
Study, literature and
calculation
HTA 2007 report and
calculation
Yes
Utility values Literature Literature, HTA 2007
report and new clinical
studies
Yes Updated where new
data were available
from systematic search
Costs of screening NHS Reference Costs Clinical studies and NHS
reference costs59,60
Yes
Costs of management NHS Reference Costs New clinical studies and
NHS reference costs
Yes
Diagnostic accuracy
estimates
Literature New clinical studies
(sensitivity and specificity)
Yes
NICE, National Institute for Health and Care Excellence.
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Number of children with hearing impairment
Determining the number of children who need to be identified is a critical assumption within the model
and the majority of the analysis relies on this calculation. The original HTA report12 on which this analysis
draws assumed that the prevalence of hearing impairment was 78 of 1000 children. This was split into
approximately 3.5 of 1000 children with SNPC hearing impairment and 74.5 of 1000 children with
transitory hearing impairment through the probabilities that populate the model. The SNPC number is
supported by research used, and subsequently published, for the 2007 HTA report,12 which gives a figure
of 3.65 of 1000 children with SNPC hearing impairment.8,12
However, although this figure is likely to be an accurate representation of the total prevalence of SNPC
hearing impairment in the child population, it is also likely to be a sizeable overestimate of the numbers of
children who have SNPC hearing impairment yet to be diagnosed at the age of 3 years (prior to the start
of the model). This is because cases of hearing impairment in children are generally identified either
through the NHSP or by parents before school age. Moreover, while our main interest is in children with
SNPC hearing impairment, the vast majority of the children who are detected as a result of screening will
have transitory hearing impairment.
The prevalence of both transitory and SNPC hearing impairment in the modelled population has been
estimated on the basis of the numbers with a confirmed diagnosis of hearing impairment as a proportion of
the base population in the two areas studied. Based on last appointment, we obtain estimates of 46 per
10,000 children in Nottingham (195/42,553) or 56 per 10,000 children in Cambridge (98/17,624). The former
has been used for the purposes of the model and divided between transitory and SNPC hearing impairment
in the ratio 96% : 4% as applied in the 2007 HTA report.12 This gives approximately 2 children per 10,000
with undiagnosed SNPC hearing impairment and 44 with undiagnosed transitory hearing impairment.
Diagnostic accuracy
The sensitivity of the two screening tests used in the model was based on the child-level analysis of the
case–control study using all children whether nominally recruited as cases (HI) or controls (NHI), where
hearing impairment was defined as a PTA score of ≥ 30 dB on at least one of the four frequencies.
Estimates of diagnostic accuracy have been reported (see Table 30).
Both screening methods generate a small number of false-negative cases, and, in these instances, the
children should be picked up via other referral methods such as through GPs or speech therapists.
Differences in sensitivity between the two screening methods will give rise to different numbers of false
negatives which have been distributed over time in the model in the manner illustrated in Table 34. The
distribution draws on the distribution of total referrals but adjusts for false negatives of the screening tests
occurring only in year 2 onwards (rather than all 4 years of the model).
TABLE 34 False negatives under the PTS and HC tests
Parameter PTS value HC value
Total false
negatives (%)
Incorrectly have negative test, will be identified in
subsequent years
1.89 5.20 –
Incorrectly pass screening test but are identified
in first year
N/A, as screening test
run in second year
N/A, as screening test
run in second year
–
Incorrectly pass and are identified in second year 0.78 2.16 42%
Incorrectly pass and are identified in third year 0.78 2.14 41%
Incorrectly pass and are identified in fourth year 0.33 0.90 17%
N/A, not applicable.
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Probabilities of hearing impairment by severity
Table 35 reports the proportions of cases of transitory and SNPC hearing impairment that are unilateral or
bilateral and the distributions of unilateral and bilateral SNPC hearing impairment by severity. The source
of these probabilities is the 2007 HTA report.12
Management probabilities
Probabilities of each management type for unilateral and bilateral transitory hearing impairment and the
different severities of unilateral and bilateral SNPC hearing impairment were sourced from the 2007 HTA
report12 and are listed in Table 36.
Resource use and costs
The following sections report the sources underlying the calculation of costs over the 4-year modelling
period. The cost base year is 2012–13. Costs in the first year are undiscounted and, in subsequent years,
are discounted at an annual rate of 3.5%. This is the rate recommended by the UK Treasury Green Book,57
based on the rate at which individuals discount future consumption over present consumption.
Screening costs
All children in the screening arm incur the costs of screening. Children who are referred by the test also
incur the cost of a DEA and the subsequent cost of management is incurred by children who are referred
by the screening test and are diagnosed with hearing impairment by a DEA.
TABLE 35 Distribution of hearing impairment states
Type of hearing impairment Probability
Transitory hearing impairment
Unilateral 0.56
Bilateral 0.44
SNPC hearing impairment is unilateral
Unilateral 0.60
Bilateral 0.40
Unilateral SNPC
Minimal severity 0.58
Mild or moderate 0.20
Severe or profound 0.22
Bilateral SNPC
Minimal severity 0.20
Mild 0.36
Moderate 0.23
Severe 0.10
Profound 0.11
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The length of time to perform the test was collected (see Chapter 7). A mean duration of 1.4 minutes
(measured to be the same for both methods) and an hourly rate of £73 per hour from the relevant
2012–13 Reference Costs60 (N05OGS – School-Based Children’s Health Other Services – Group Single
Professional) give a staff cost associated with the screening tests of £1.69. This is reported in Table 37
while unit costs for other sources by which hearing impairment can be identified are presented in
Table 38. The cost per child of screening was calculated by dividing the total costs (total costs of screening
tests and total capital costs) by the total cohort of children screened over 5 years (10,000). The cost of
each diagnostic evaluation was £150 (NHS Reference Costs 2012–1360).
Cost of travelling to appointments
Sixty respondents to a questionnaire asking about travel costs to attend screening appointments in
Nottingham reported a total of 129 appointments and expenditure of £788.64, or £13.14 per child.
Unit costs of the pure-tone screen and HearCheck screener
Unit costs of each method of screening are presented in Table 37. Where costs extend beyond 1 year, these
have been discounted accordingly in the model. Equipment suppliers have provided the costs of devices and
consumables. Although the device costs for the PTS are higher than those for the HC screener (£898.80 vs.
£139.20), the total costs for the HC screener are higher, primarily owing to the costs of ear cups. Table 38
reports the unit costs associated with other means by which hearing impairment is identified.
TABLE 36 Distributions of management types
Type of hearing impairment Type of management Probability
Unilateral transitory Active observation 0.935
Non-surgical 0.001
Surgical 0.064
Bilateral transitory Active observation 0.74
Non-surgical 0.05
Surgical 0.21
Unilateral SNPC minimal No intervention 0.99
Non-surgical 0.01
Unilateral SNPC mild or moderate No intervention 0.49
Non-surgical 0.51
Unilateral SNPC severe or profound Non-surgical 0.05
Surgical 0.95
Bilateral SNPC minimal No intervention 0.96
Non-surgical 0.04
Bilateral SNPC mild No intervention 0.7
Non-surgical 0.3
Bilateral SNPC moderate Non-surgical 0.7
Surgical 0.3
Bilateral SNPC severe Non-surgical 0.9
Surgical 0.1
Bilateral SNPC profound Non-surgical 0.5
Surgical 0.5
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TABLE 37 Unit costs of the PTS and HC tests
Parameter Value Source Comment
PTS
School-Based Children’s
Health Other Services – Group
Single Professional (1 hour)
£73.00 NHS Reference Costs 2012–1360
Average duration of screening
test
1.39 minutes Clinical study
Screening cost per child £1.69 Calculation
Cost of device £898.80 Clinical study Equipment suppliers
Printer £228.00 Clinical study Equipment suppliers
Battery £102.00 Clinical study Equipment suppliers
Calibration (per year) £170.88 Clinical study Calibration needed every
12 months
Medicated alcohol-free wipes £0.032 www.firstaid4less.co.uk/12888_-
Infection-Control/Wipes/Multi-
Purpose-Wipes/Bioguard-Wipes.html
200 wipes per pack
HC
School-Based Children’s
Health Other Services – Group
Single Professional (1 hour)
£73.00 NHS Reference Costs 2012–1360
Cost of device £139.20 Clinical study Cost calculated with
20% VAT
Cost of ear cup £0.72 Calculation based on information
from clinical study
One to two ear cups used per
child. Average of 1.5 used to
calculate cost
Calibration cost £70.01 Calculation based on information
from clinical study
Between £50–100
(mid-point used)
Calibration needed after
3 years (cost discounted)
Cost of AAA battery £0.81 www.amazon.co.uk RRP for pack of eight is £6.49
Outcome pad £5.60 Clinical study
RRP, recommended retail price; VAT, value added tax.
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Management costs
Management costs were compiled from NHS Reference Costs for 2012–13,60 representing national unit
costs, and are reported in Table 39. Where cost estimates were available for unilateral impairment only,
these were multiplied by two to give the corresponding costs associated with bilateral impairment. This is a
conservative assumption to account for the costs of providing and maintaining hearing aids for two ears. In
the case of surgery, expert opinion suggests that this approach may overestimate costs. No follow-up costs
or postoperation observation (active observation) were taken into account with surgical interventions. As
with NHS reference costs generally, figures relating to paediatric services or the under 18 years age group
were used where available. However, for hearing aids, the reference costs are not broken down for
children and adults separately.
Utilities
A search to update the utilities from the 2007 HTA model12 was undertaken and the results were used
to inform the updated parameter sheet (Table 40). Where possible, a distinction was made between
unilateral and bilateral hearing impairment; otherwise, the utility associated with hearing impairment was
determined primarily by its severity. In the first year (the pre-screening year), we assume that children
entering the model do so evenly over the course of the year. Total utilities in the first year are therefore
reduced by 50% (in undiscounted terms) compared with subsequent years. QALYs have been calculated
only for children with a managed hearing impairment who consequently achieve a quality-of-life
improvement. As QALYs accruing to children without hearing impairment do not affect the incremental
cost-effectiveness ratio (ICER), they have been excluded from the calculations. Limited updating of the
parameter values used in the 2007 HTA report was possible. For example, utilities for cochlear implants came
from Summerfield et al.,62 and utilities for grommet surgery came from Bisonni et al.63 These studies provided
intervention-specific utility data to supplement the evidence on utility by severity of hearing impairment.
Modelling the potential costs and consequences of false-positive results
Chapter 6 presents the outcomes of a questionnaire given to parents whose children were referred from SES
for a DEA appointment. Survey responses were obtained in respect of 60 children over 129 appointments.
The questionnaire asked a range of questions concerning parents’ views of the screening programme and
the impact on themselves and their children. The travel costs associated with screening and diagnostic
visits were based on this survey. One impact that is commonly discussed in the context of screening
programmes, although not straightforward to value in monetary terms, is the anxiety associated with
false-positive results. This was an issue addressed by the questionnaire.
TABLE 38 Unit costs of all non-screening forms of identification
Method of identification Unit cost Source
GP £45.00 Curtis 201459
Health visitor £20.33 Curtis 201459
Speech therapist £90.00 Curtis 201459
Paediatrician £289.00 Curtis 201459
Parent £13.14 Survey data: 60 children incurred costs of £788.64
Education £14.10 Calculation (based on average teacher salary of
£22,000, working 40 hours a week 39 weeks per year)
School nurse £27.00 Curtis 201459
Community nursery nurse £95.00 Curtis 201459
ENT consultant £289.00 Curtis 201459
Other consultant £289.00 Curtis 201459
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TABLE 40 Utilities used in the model
Health state Utility Source
Utility of 1 year with minimal hearing impairment 1.000 Modelling assumption
Utility of 1 year with mild hearing impairment 1.000 Modelling assumption
Utility of 1 year with conductive hearing
impairment (unilateral and bilateral)
0.677 Modelling assumption
Utility of 1 year with moderate hearing
impairment
0.677 Barton et al., 200461
Utility of 1 year with severe hearing impairment 0.616 Barton et al., 200461
Utility of 1 year with profound hearing
impairment
0.353 Barton et al., 200461
Utility of 1 year with mild or moderate hearing
impairment
0.8385 Average (mild and moderate)
Utility of 1 year with severe or profound hearing
impairment
0.485 Average (severe and profound)
Utility of 1 year with active observation 1.000 Modelling assumption
Utility of 1 year with hearing aid (non-surgical) 1.000 Modelling assumption
Utility of bilateral cochlear implant 0.965 Summerfield et al., 200262
Utility of unilateral cochlear implant 0.934
Utility of 1 year with grommet surgery 0.995 Bisonni et al., 199163
TABLE 39 NHS management-related reference costs used in the model
Item Unit cost Source
Costs of conductive hearing impairment
Cost of ENT consultant appointment £95 NHS Reference Costs 2012–1360
Cost of grommet operation (surgical intervention) £2325.61 NHS Reference Costs 2012–1360
Cost of SNPC hearing impairment
Cost of ENT consultant appointment £95 NHS Reference Costs 2012–1360
Cost of hearing aid assessment £65 NHS Reference Costs 2012–1360
Cost of hearing aid fit: first visit £65 NHS Reference Costs 2012–1360
Cost of hearing aid fit: follow-up visit £54 NHS Reference Costs 2012–1360
Cost of hearing aid repair £26 NHS Reference Costs 2012–1360
Cost of cochlear implant: unilateral £20,148.16 NHS Reference Costs 2012–1360
Cost of cochlear implant: bilateral £35,653.73 NHS Reference Costs 2012–1360
Cost of standard hearing aid £77 NHS Reference Costs 2012–1360
Cost of digital hearing aid £85 NHS Reference Costs 2012–1360
Cost of bone anchored hearing aid: fixture £3077.35 NHS Reference Costs 2012–1360
Cost of bone anchored hearing aid: fit £7997.51 NHS Reference Costs 2012–1360
Note
NHS Reference Costs do not identify hearing aid-related costs for children separately.
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Anxiety
Parents were asked to rate their anxiety level on a scale from 0 to 10 as a result of finding out that their
child needed further testing. Approximately 60% of respondents listed their anxiety as ≤ 5 out of 10, with
only one parent rating their anxiety > 8 out of 10. Between finding out that their child needed further
testing and attending the clinic visit, mean parental anxiety score fell slightly, from a score of 5.3 to a score
of 4.7. The survey was felt to provide insufficiently compelling evidence to make an adjustment to the
model, either by incorporating anxiety into the QALY or as a monetary disbenefit. On the basis of current
evidence, it is unknown whether or not there is a health impact on parents of further hearing tests that
would outweigh the benefits gained by children receiving a correct diagnosis; this is an issue on which
further research may shed some light.
Results
Number of referrals to diagnostic evaluation and numbers diagnosed with
hearing impairment
Tables 41 and 42 show the number of children referred for a DEA and the numbers diagnosed with
hearing impairment in each model arm over the 4 years of the model. Under the base case, a hypothetical
population of 10,000 children has been used, of which the number referred for diagnostic evaluation in
the counterfactual and the two intervention arms is 629, and the number with hearing impairment is
approximately 46. The numbers referred in each year are determined by the data on referrals at different
ages in the screening and no screening sites and have an important bearing on the cost-effectiveness of
screening compared with no screening.
TABLE 41 Rate at which children are referred to diagnostic evaluation with audiologist in each model arm:
base case
Year
No screening PTS HC
Referred
each year Cumulative
Referred
each year Cumulative
Referred
each year Cumulative
1 216.3 216.3 188.0 188.0 188.0 188.0
2 179.2 395.5 181.8 369.8 179.9 367.9
3 147.1 542.6 182.5 552.3 183.8 551.7
4 86.1 628.7 76.4 628.7 77.0 628.7
TABLE 42 Rate at which children are diagnosed in each model arm (based on a hypothetical 10,000 population)
Year
No screening PTS HC
Diagnosed
each year Cumulative
Diagnosed
each year Cumulative
Diagnosed
each year Cumulative
1 15.3 15.3 14.3 14.3 14.3 14.3
2 13.2 28.5 12.5 26.8 10.6 24.9
3 10.6 39.1 12.8 39.6 14.1 39.0
4 6.8 45.9 6.2 45.8 6.8 45.8
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School entry hearing screening versus no screening: costs and
quality-adjusted life-years
Tables 43 and 44 present the undiscounted and discounted costs broken down into the costs of
identification (whether by screening or other means), diagnostic evaluation and management over 4 years
for each arm of the model.
Diagnosis and management of hearing impairment has a positive impact on children’s quality of life as
measured using the QALY. The figure for QALYs gained outlined in Table 45 is an estimate of the QALYs
gained from children being diagnosed and managed (children moving from hearing impairment to no
hearing impairment/managed hearing impairment) over the 4 years of the model. The QALYs accruing to
children with no hearing impairment are not included here. The results show that, in the base case, not
having a screening programme results in more QALYs than either the PTS or HC screen, which is
associated with the lowest QALY gain of the three options.
In order to determine the cost-effectiveness of each method of screening compared with no screening,
the ICER needs to be calculated. The ICER presents the ratio of the marginal gain of the intervention
over the counterfactual in terms of both costs and benefits. It is calculated as:
incremental costs=incremental QALYs. (1)
Table 46 presents incremental costs and QALYs for the two screening approaches relative to no screening
and for the PTS compared with the HC. In the base case, it is not appropriate to report an ICER, as no
screening dominates (is more effective and less costly than) either screening approach. In the context of
our research question, the results indicate that SES is not cost-effective compared with no screening.
TABLE 45 Quality-adjusted life-years for children with hearing impairment
QALYs No screening PTS HC
Undiscounted 40.93 39.91 39.86
Discounted 35.90 35.21 35.16
TABLE 44 Discounted costs
Category No screening PTS HC
Screening and identification £33,553 £61,224 £66,929
Diagnostic evaluation £98,602 £98,360 £98,346
Management £50,177 £50,054 £50,047
Total £182,332 £209,638 £215,322
TABLE 43 Undiscounted costs
Category No screening PTS HC
Screening and identification £34,902 £63,786 £69,699
Diagnostic evaluation £102,564 £102,564 £102,564
Management £52,194 £52,194 £52,194
Total £189,660 £218,544 £224,457
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Sensitivity analysis
The key data from the clinical studies that influence the magnitude and direction of the cost-effectiveness
results primarily relate to the number and timing of referrals with and without a SES programme.
While there is uncertainty about the applicability of the findings from Nottingham and Cambridge to
a more general assessment of the costs and benefits of a screening programme as opposed to no
screening programme, it is difficult to put boundaries on this uncertainty. This is in part because of the
sociodemographic differences between the populations in Cambridge (the counterfactual) and Nottingham
(screening site), and to the differences in service configuration between the two sites. A factor of particular
significance is the difference in the rates of referrals between the two areas (the question of whether a
screening site has more or fewer referrals than a non-screening site was an explicit objective of the study).
In the light of clinical data suggesting that the referral rate in Cambridge is higher than that in Nottingham,
the impact of a higher referral rate in the absence of screening was felt worthy of exploration. Increasing
the referral rate when no screening programme exists increases the costs of this option while leaving QALY
benefits unchanged, as these depend on the timing rather than the number of referrals. Increasing referrals
sufficiently will render no screening more costly than screening and enable the trade-off between costs and
benefits to be investigated.
In order to determine whether an intervention is cost-effective, the National Institutes of Health and Care
Excellence (NICE) recommends comparing the ICER with a benchmark value of between £20,000 and
£30,000 per QALY gained.58 Technologies with an ICER of < £20,000 are generally considered to be
cost-effective while, for those with an ICER > £20,000, reference needs to be made to other factors when
considering value for money (and the case needs to be made increasingly strongly in relation to these
factors when the ICER is > £30,000). Using £30,000 per QALY as the cut-off point for cost-effectiveness,
the referral rate in the absence of screening would need to increase by ≥ 36% for no screening to cease
being cost-effective relative to the PTS. This gives an upper limit on the extent to which referrals can be
increased in the absence of screening without this option becoming excessively costly relative to its
QALY benefits.
We are also interested in the circumstances under which screening becomes more effective than no
screening. Leaving the baseline level of referrals unchanged, we investigated the extent to which referrals
would need to be brought forward with screening compared with no screening. As we lacked clear
bounds to place around the proportions of children referred at different ages, we again conducted a
threshold analysis. It was found that the benefits of the PTS test would be increased sufficiently for the
ICER to fall below £30,000 per QALY gained compared with no screening if the proportion of children
referred in the first year of school (the screening year) increased by 5.9 percentage points or more.
Compared with the distribution and total numbers of referrals, other variables had relatively little impact
on the conclusions of the analysis. For example, raising the sensitivity of the screening tests to 100%
increased the QALY benefits under the PTS and HC but not sufficiently to make screening more effective
than no screening. Altering the prevalence of hearing impairment had no impact on the results.
TABLE 46 Incremental costs and QALYs (discounted)
Cost-effectiveness values PTS vs. no screening HC vs. no screening HC vs. PTS
Total costs £23,171 £28,840 £5,669
QALYs –0.68 –0.74 –0.06
Incremental cost per QALY ratio No screening dominates No screening dominates PTS dominates
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Discussion
Based on a hypothetical population of 10,000 children, it has been calculated that 629 children will be
identified and referred for diagnostic evaluation, of which 46 children will be identified as having hearing
impairment in the screening and no screening scenarios. The summary of results for this population is
as follows:
l The cost of screening ranges between £1.93 (PTS) and £2.49 (HC screener) per child. The total
discounted costs associated with the no screening arm are estimated to be £182,333, which consists of
the costs of identification, referral, diagnostic evaluation (including travel costs) and management. The
screening arm is more costly, with total discounted incremental costs ranging between £27,304 (PTS)
and £32,990 (HC screener).
l The discounted QALY gain associated with children being treated for hearing impairment in the no
screening arm is 35.9 over 4 years. In the base case, QALYs generated in the absence of screening are
greater than those generated in the presence of the PTS (35.21) or HC screen (35.16).
l No screening dominates both screening methods in the base case.
When considering the relative cost-effectiveness of each screening method, the PTS test is less costly
(£5686) and is more effective (incremental QALY gain of 0.06) than the HC screen, rendering it dominant
over the HC screener.
These conclusions appear to be robust in various sensitivity analyses. The notable exception is where SES
is associated with fewer referrals for a DEA, implying a reduction in false-positive cases relative to no
screening, which suggest SES could be the cost-effective (if less effective) option. To be more effective
than no screening, referrals need to be expedited relative to the base case.
Discussion of key assumptions
Several key modelling assumptions require further discussion. Good use of assumptions is crucial to
economic modelling. Done correctly, assumptions simplify the modelling approach, allowing for targeted
models to be built using the best quality of data. A model with large parameter demands often has to
make compromises and assumptions that can end up weakening the model.
One of the main assumptions in the model concerns the rate of referral to diagnostic evaluation. For the
base-case scenario, it has been assumed that the number of referrals in the screening and non-screening
areas is the same. From the comparative data presented in Chapter 5, the rate of referral in Cambridge
(area without SES) was higher than that of Nottingham (area with SES). However, after careful
consideration of the issue, these comparative data were not used for the base case, as Cambridge may
not be reflective of all non-screening areas. Assuming that the rates of referral would be higher when no
screening programme is in place makes an implicit assumption that other methods of referral, such
as referral via GP, health visitors and speech therapists have low specificity. That is, it assumes that these
other methods require a higher number of referrals than are required with a screening programme to
identify the same number of cases of hearing impairment when, in practice, it is not known what the true
increase in rate of referrals for non-SES areas relative to SES areas would be.
In the base case, screening is more costly than no screening. However, if referrals are increased in the no
screening option, there is a point when no screening becomes more costly than screening. If referrals
are increased further, the no screening option will eventually become too costly to justify its additional
QALY benefits over screening relative to conventional cost-effectiveness benchmarks such as the £30,000
figure used by NICE. Sensitivity analysis considered the ‘tipping point’ in terms of referral numbers under
the no screening option at which no screening would no longer be cost-effective. It was found that
the cost per QALY ratio of no screening relative to the PTS test increased to £30,000 if the rate of referrals
was 36% higher in the absence of screening compared with the PTS. In this case, screening is the
cost-effective (if less effective) option.
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An alternative way in which screening could become cost-effective is if, despite being more costly than
no screening (as in the base case), it was also more effective. This could come about if screening was
associated with more rapid detection of cases of hearing impairment than no screening. A threshold
analysis on the pattern of referrals suggested that, under screening, referrals would need to increase by
around 5.9 percentage points in the screening year (increasing the proportion of referrals taking place
either in the pre-screening year or the screening year from 59% to 64.9%) in order to reduce the cost per
QALY of the PTS relative to no screening to £30,000. While there are grounds for believing that the
number of referrals is likely to be higher without screening, the potential for screening to achieve timelier
referral and management of HI children is less clear.
Strengths and weaknesses
The model developed has a number of features that support the validity of its results.
It builds on an existing model (2007 HTA report12), which allowed a systematic consideration of areas
where the original model could be improved and incorporates these into the updated model. This was
greatly assisted through the involvement of the architect of the original model who contributed to the
project as a consultant (Professor Linda Davies).
The model was conducted by an experienced multidisciplinary team of researchers who had been involved
in the development of economic models, and models concerning hearing impairment in particular, prior to
this project.
The model also drew on the experience of the project steering group, both in terms of content knowledge
to advise on the design of the model and the input of a health economics specialist who fed back on the
model design and early results.
The model was underpinned by a protocol outlining the key features and limiting the opportunity for
results to be data driven. In the event, changes were made to the structure of the model so that it could
capture aspects of the impact of SES that were not originally anticipated. These changes have been fully
documented relative to the original model plan, so reducing the opportunity for bias.
The model was conducted in parallel with a series of clinical studies that were designed to improve
information on key parameters where high levels of uncertainty had been identified in the 2007 HTA
report model (see Chapters 3, 5–7).12
There were also some limitations. The greatest limitation was that, despite attempts to reduce uncertainty,
the data collection in the accompanying clinical studies was unable to overcome this uncertainty
completely. For instance, the study designs for accuracy were chosen on the basis of feasibility and used a
diagnostic case–control study, which is known to exaggerate accuracy, particularly where the controls are
healthy subjects. Similarly, a randomised comparison between SES and non-SES areas would have been
desirable to assess the impact of SES on referrals and yield. Instead we had to employ an observational
two-centre comparative study design subject to major potential limitations, including confounding and lack
of generalisability. In retrospect we could have invested research in quantifying the accuracy of processes
used to refer children for a DEA where SES was not in place, but the importance of this emerged only
when the results of the clinical studies were reported.
The inevitable lack of availability of the results of the clinical studies until late in the research programme
limited the time available to perform sensitivity analyses in the economic model. These were thus
prioritised in consultation with the research and steering group and we remain confident that all key
aspects have been covered and that the cost-effectiveness findings remain robust.
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Findings in comparison with other health economic evaluations
The 2007 HTA report12 identified virtually no health economics literature on SES, and the update search
for this report identified no new health economics literature since the 2007 report. Thus the main point of
comparison for the new economic model is the economic model from the 2007 HTA report.12
The most important difference between the two reports is a change in view about the likely
cost-effectiveness of SES from possibly cost-effective (albeit with considerable uncertainty in 2007) to
probably not cost-effective in this report. This change is primarily because of the use of observations on
the timing of referrals as the basis for the updated model. The 1-year results from the 2007 report,
showing a favourable cost-effectiveness ratio for screening, are consistent with a substantial advantage for
screening in terms of the timeliness of referrals compared with no screening. This is also implied by the
assumptions used in initial attempts to replicate the 2007 results. In comparison, the observational data
incorporated into the model on which the findings presented here are based suggest that screening does
not result in a more rapid rate of referral and that other methods used in the absence of screening may be
more effective in this regard.
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Chapter 9 Conclusions and recommendations
The overarching aims of this project were to evaluate the diagnostic accuracy of hearing screening testsand the cost-effectiveness of screening for hearing impairment at school entry in the UK.
Summary of findings
Systematic review of diagnostic accuracy (see Chapter 2)
The updated review of diagnostic accuracy studies confirms the conclusion from the 2007 HTA report12
that research to date demonstrates significant variability in the design, methodological quality, and results.
Robust conclusions about the performance of individual test types for use in SES cannot be drawn.
Summarising the review reported in the 2007 HTA report and this update we conclude that:
l Parental questionnaires had the poorest diagnostic accuracy compared with all other tests.
l The findings from the new audiometry-based studies evaluating computer-based devices and the
HC screener reported higher and more consistent specificity but lower and widely varying sensitivity
estimates compared with the sweep PTA studies included in the original report.
l Studies evaluating TEOAE reported variable sensitivity with wide CIs, while specificity estimates were
relatively high and more consistent.
l The study evaluating AABR reported high sensitivity and specificity.
The review included studies from countries with and without an established UNHS system and with very
different systems of health-care delivery. The generalisability of the findings to other situations, including
the UK NHS system, is likely to be limited.
Diagnostic accuracy study (see Chapter 3)
The findings of our diagnostic accuracy study indicate that the PTS and HC devices have a high level of
sensitivity (PTS ≥ 89%, HC ≥ 83%) and an acceptably high level of specificity (PTS ≥ 78%, HC ≥ 83%) for
identifying hearing impairment at the level of the ear. The PTS test has greater sensitivity than the HC
screener and the HC screener has greater specificity than the PTS.
These conclusions appear robust, with the child-level analyses indicating similar levels of sensitivity and
specificity for the screening tests to those seen for the ear-level analyses and for all different definitions
of impairment.
Assessment of false negatives (see Chapter 4)
Assessment of false-negative rates is challenging for screening evaluations of a condition that may
fluctuate, progress or be of later onset. From our review of the existing literature and data from the
diagnostic accuracy study, we are unable to quantify the effect of false-negative results from the PTS or
HC screening, but were able to confirm that the rate was extremely low. Of the 16 ears of children in our
diagnostic study (total N= 630) which passed one or both of the screening tests but were referred by the
PTA measure, only four were confirmed to have a hearing impairment at diagnostic evaluation and all
were mild (4/630, 0.63%).
Comparison of school entry hearing screening and non-school entry hearing
screening services (see Chapter 5)
There was strong evidence that the rate of referral for hearing problems is lower when a SES programme
is present. The referral rate was 36% lower in Nottingham (SES) relative to Cambridge (no SES) (rate ratio
0.64, 95% CI 0.59 to 0.69; p< 0.001).
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There was little evidence that the yield of confirmed cases differs between areas with and without a SES
programme but a higher proportion of referred children were subsequently confirmed to be HI in the area
with a SES programme (17.0% in Nottingham vs. 10.6% in Cambridge).
The mean age of referral was nearly identical between the two sites when looking at all referrals but for
children who were subsequently confirmed as having a hearing impairment there was strong evidence
that children in sites with a screen are older at referral (mean age difference 0.47 years, 95% CI 0.24 to
0.70 years; p< 0.001).
It appears that the site with a SES programme is referring fewer children for suspected hearing problems
than the site with no SES programme, but there was little evidence that the yield of children with
confirmed hearing impairment was different. Children with confirmed hearing impairment are older at
referral in the SES site.
Survey of parents (see Chapter 6)
We found from our survey of parents of children referred by the SES programme in Nottingham that the
consequences of the referral process for parents and children, including false positives, are minor. They
certainly do not appear to be sufficient to undermine parental views about the value of SES. However,
it should be noted that the referral process, including the possibility of false positives, occurs both in a
system with SES and one relying on ad-hoc referral based on concern alone and hence the data on anxiety
and costs could apply to both service implementations. The difference for parents whose child is referred
by the SES programme is that they may have had no concerns prior to the screening test.
Practical implementation (see Chapter 7)
We demonstrated minimal differences between the PTS and HC tests in terms of time taken to conduct
each examination and practical issues. Testing covered a range of schools throughout the school year and
thus we suggest the findings might be generalisable beyond the Nottingham schools.
Cost-effectiveness of school entry hearing screening (see Chapter 8)
Our economic modelling showed that SES is unlikely to be cost-effective and, using base-case assumptions,
including the assumption that the number of referrals is the same in the presence or absence of screening,
is dominated by a no screening strategy. This is consistent with the observed results of the clinical studies
(see Chapter 5), which suggest that cases of hearing impairment are identified in similar numbers but at a
younger average age in the absence of SES.
Two situations where SES might be cost-effective were identified. In the first situation, SES may be
considered cost-effective if there are fewer referrals associated with SES or, conversely, if there are more
referrals without screening. This assumption might be supported by the observation from our clinical study
(see Chapter 5) that referral rates (and by assumption, potential false positives) were less in the site where
SES had been in place for many years. However, in order for this to be the case the reduction in referrals
would need to be attributable to SES and there is considerable uncertainty about this. The model is also
sensitive to a second set of assumptions in which referrals occur more quickly with screening than is
observed from our study comparing SES and non-SES sites.
Discussion
The underlying rationale of this research project was to revisit an earlier attempt to assess the clinical
effectiveness and cost-effectiveness of SES in the context of the UK NHS, and to seek to improve the
quality of evidence on key pieces of information about which there was great uncertainty in the 2007 HTA
report.12 These key uncertainties included (1) the accuracy of the screening tests which might be used;
(2) the feasibility of using such tests, particularly in terms of the time required to do them; (3) the
consequences to children and parents of being referred for a DEA; and (4) most importantly, the difference
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in number of referrals and yield which might arise where SES is implemented. We have integrated the
findings from our clinical studies designed to address these key uncertainties into an updated version of
the economic model used in the 2007 HTA report.12 The overall conclusions for this report should be
drawn from our updated overarching cost-effectiveness analysis.
A good example of the need to adopt this more integrated approach to the interpretation of the results is
the test accuracy study for the PTS and HC screener (see Chapter 3). Although it is clear that the accuracy
of both tests, particularly their sensitivity, may look acceptable for the purposes of screening in isolation, it
is only when these results are put in the context of our economic model and the screening test considered
in the context of the wider health-care system as part of a programme of care, that the question of
whether or not the tests are accurate enough can be truly answered. Integrating the various clinical studies
of this project, our economic modelling shows that SES is unlikely to be cost-effective and, using base-case
assumptions, is dominated by a no screening strategy.
There are, however, some aspects of the individual clinical studies that deserve highlighting in addition.
We examined the diagnostic accuracy of two devices, but it might be argued that these were not the
optimal devices to assess, and that other devices would perform better, leading to improved effectiveness
and cost-effectiveness of SES. The relatively good accuracy achieved by the chosen devices suggests
otherwise. Even though there may be devices that achieve greater accuracy, sensitivity analysis on the
cost-effectiveness results suggests that even an assumption of 100% sensitivity would not give a
cost-effective result. The differences between the tests could be of value in terms of guiding technology
for developing improved hearing screening devices. Considering some combination of the two tests might
be appropriate, but this was not evaluated here. The updated systematic review does, however, emphasise
that technology is constantly evolving with new devices continually emerging and improved evaluations of
existing devices being produced.
Two further issues arise when considering diagnostic accuracy. The first relates to considerations of
sensitivity and specificity. Sensitivity measures the extent to which the screening test correctly identifies
children with a hearing impairment (true positives). Specificity measures the extent to which the screening
test correctly identifies children who do not have a hearing impairment (true negatives). Evaluation of the
screening tests is influenced by the balance between the two. A high false-negative rate (low sensitivity,
i.e. children with a hearing impairment who pass the screening test) is probably a more important problem
than a high false-positive rate (low specificity, i.e. children with no hearing impairment referred for a DEA
by the screening test). Thus, the desirable balance is for high sensitivity over high specificity.
The second issue concerns the definition of hearing impairment that the screening tests aim to identify and
that definition concerns both degree and type. In terms of degree, the 2007 HTA report12 found that there
was considerable variation around the UK in the frequencies used by different services (not all used 0.5, 1,
2, and 4 kHz) and the referral level (20, 30 or 35 dB). The diagnostic accuracy study reported here used the
20 dB level as a referral criterion for the PTS test (as used in several SES programmes) and ≥ 30 dB (PTA)
to indicate a hearing impairment.
A more important issue of definition concerns the type of hearing impairment the screening test is
designed to identify. Sensorineural hearing impairments are permanent and have implications for the child
at whatever level they occur, although the greater the level of impairment, the greater the consequences
tend to be. Conductive hearing impairments may be permanent, often associated with anatomical causes,
but are usually transient. Such impairments are often caused by OME (glue ear), a very prevalent condition
in children. When considering long-term effects for the child, management of permanent impairments
is critical but transient impairments can be important in the shorter term, particularly if the glue ear is
persistent, and so do warrant management.
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One crucial question is ‘What should a screening test of hearing be aiming to identify and hence how
should the sensitivity and specificity be assessed?’. Hearing screening tests as they are currently used
cannot distinguish between sensorineural and conductive impairments so all children with a hearing
impairment will be referred by the screening test. There is an argument that any assessment of
cost-effectiveness of a hearing screening programme should consider only permanent impairments and
consider the identification of transient losses as an unavoidable by-product. A key point here is that if the
programme is not cost-effective when transient impairments are included (and hence more children are
identified), a situation based on only identification of permanent impairments is unlikely ever to be
cost-effective because identifying and managing transient impairment is no longer counted as a benefit.
For the diagnostic accuracy study we have considered a positive result as any impairment, since that is
what the screening tests are designed to identify. We have analysed this by ear (to assess the screening
tests) and by child (to assess the screening programme).
Ascertaining and capturing the impact of false negatives is a major challenge in any assessment of any
screening programme. False negatives arising from hearing impairment, which would be invisible even
if the best diagnostic test (PTA) was applied to all children, need to be distinguished from hearing
impairment that is overlooked because a screening test is used. Concerning the former, the evidence is
that this is likely to be small in amount and minor in nature. In practice false-negative cases are most likely
to arise where children are not exposed to the general surveillance of the health care and educational
system that might prompt an ad-hoc referral. In contrast, the false negatives arising because a screening
test is used instead of a definitive test are measurable and reflected in the screening test’s sensitivity. It is
again noted that the sensitivity of the PTS and HC screener is good with few false negatives and that
where hearing impairment was missed, the nature of the hearing impairment was minor.
The comparison between a site with a SES programme and a site that has not provided a SES programme
for a number of years is novel and timely given the number of sites that are actively reviewing all their
audiological services. However, any service without a SES programme needs to be very responsive and
backed up with information strategies for parents and professionals.
One issue not raised thus far is the availability of the population to be screened. Children who undergo
hearing screening at school age could be considered to be a captive audience. Their parents usually have
the option to opt out of the screen but the default situation is that children will be screened. In an area
with no SES programme, children are referred only if concern is expressed. For this reason in the SES
system it could be argued that fewer children with true hearing impairment might be missed (fewer false
negatives). For both systems the rate of parents not attending for a DEA with their children is about 15%.
The survey of parents provided measures of anxiety and qualitative data on views of the service as a
whole. We did not quantify the costs of that anxiety which might have informed any disutility associated
with false positives. False positives would be particularly important if it was thought that screening does
lead to a reduction in referrals because, if there was serious disutility, this would amplify the effect of
reducing false positives.
This project is unique in that it observed the screening devices being used by regular personnel under usual
situations. The data collected on time taken for each test have contributed to the economic model.
Perhaps more notable were the anecdotal observations of the researchers and nurses although views from
only three nurses using two devices were sought. Confirming the situation reported in the 2007 report,12
the rooms and facilities offered for screening in many schools are not ideal. Account was not always taken
of the requirement for a relatively quiet environment. The presence of children waiting to be screened
while another child is screened allows them to become bored and impatient as well as enabling them to
see how the system works and what they have to do. This raises the issue of how well accuracy studies
that are carried out in rather more optimal conditions with individual children (including our own
diagnostic accuracy study), can truly reflect performance in the real-world situation. In assessing the
practical implementation of the tests the views of those administering the test are important.
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There are strengths and weaknesses of this programme of research that need to be taken into account in
drawing an overall conclusion. The strengths and limitations of the various individual studies of this project
have been identified in the context of the contributory chapters of this report. The key overarching
strength in this project is that it was planned and conducted in a prospective manner specifically to address
the key uncertainties of the 2007 HTA report12 and thereby provide an improved understanding of the
clinical effectiveness and cost-effectiveness of SES, particularly in the context of the UK NHS. The main
limitation is that, although uncertainty has been reduced, it has not been eliminated and these continuing
areas of uncertainty are highlighted below to inform the suggestions for further research. The most
important uncertainty remains the estimates of the number of referrals and yield attributable to SES. The
evidence collected here to inform this comes from the observational study comparing an established SES
site (Nottingham) with a site where SES has not been employed for many years (Cambridge). While its
prospective design limits some of the biases associated with this comparison, major threats to its validity
remain, in particular selection bias and confounding. In other words, differences between the areas of
Nottingham and Cambridge (other than the provision of SES), such as population characteristics and the
nature of the other parts of the health-care system contributing to identification and management of
hearing impairment in children, may explain the observed differences in referral rate and yield. While a
more experimental design, such as a cluster randomised controlled trial, may overcome these biases and
therefore provide a higher level of evidence, this needs to be weighed against the ethical and logistical
challenges and costs of such a study.
Overall conclusions and recommendations
In the context of the UK NHS, and similar health-care systems, SES using tests such as the PTS test is
unlikely to be effective in increasing the number of cases of hearing impairment identified or lowering the
average age at which these cases are identified. SES is also unlikely to be cost-effective when judged
against the benchmarks normally used by NICE, relative to a system entirely reliant on ad-hoc referral
when a suspicion of hearing impairment is raised.
Implications for practice
Although our finding that the lack of cost-effectiveness of SES may be considered as a reason to withdraw
SES where it is currently being practised, we would highlight aspects of the results that suggest caution.
First, we have not completely excluded the possibility that SES is cost-effective and we have shown that
there are at least two scenarios in which it may be cost-effective. Second, our conclusions are highly
dependent on findings in the two specific areas (Nottingham and Cambridge) that were used here, and
may not be generalisable to other areas. Third, the cost-effectiveness of SES depends on how effective
(or ineffective) the ‘no SES system’ is. This, in turn, is highly dependent on the effectiveness of ad-hoc
identification and referral for a DEA, which is not only largely unknown, but likely to be variable. It seems
plausible that SES might have greater potential to be cost-effective where ad-hoc identification and referral
is less well developed than in a system where it is well established. If withdrawal of the SES service is to
be considered it needs to be carefully managed to ensure that the ad-hoc referral system is working
effectively. Health professionals, school and nursery staff, and parents who would then be responsible for
referral of children about whom there were concerns in the school entry year might need to be reminded
to be more vigilant for signs of hearing impairment.
Implications for research
There are opportunities for further research.
We have highlighted the continuing evolution of evidence on the accuracy of tests for screening for
hearing impairment in children of school entry age, and think that it would be useful to do this in an
ongoing manner, particularly for the general value of the information to health-care workers testing
hearing in childhood. Cochrane now includes reviews of test accuracy, and so would be an ideal vehicle
for such an ongoing systematic review. We thus suggest that even though it might not directly impinge on
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a decision about SES, systematic reviews of the accuracy of devices that might be used to measure
hearing in children at around school entry age should continue to be pursued, as this performance will
undoubtedly influence the performance of any ad-hoc referral system prompted by suspicion of
hearing loss.
Our economic model has highlighted the need for careful consideration of the alternatives to SES. It is
not appropriate to consider a comparison with SES where there is absolutely no screening/identification
activity. Although less well described and potentially subject to variation, the alternative to SES in the UK is
a system in which parents, or those involved in the care of children, raise concerns. Where the concerns
are substantiated this is followed by referral from a health-care professional, such as a GP, for a DEA. This
system will also be taking place where SES is provided, not just in the years before or after school entry,
but also in the year of SES. This is an important general finding from this work. Success in identifying
hearing impairment in children in the UK is heavily dependent on the effectiveness and cost-effectiveness
of the ad-hoc system of referral by a wide range of agents (parents, education, social services and health
care) for formal evaluation on suspicion of hearing impairment. This appears to have been very little
explored. Thus, in the future, characterising and then measuring the cost-effectiveness of different
approaches to the ad-hoc system, with a view to optimising it should receive as much, if not greater
priority, than further evaluation of SES.
A related issue is the process by which concern, or referral from SES, is converted into DEAs. It is clear
from this project that there is considerable additional triage as the actual number of referrals for a DEA in
Nottingham (a service with a SES programme) is much less than the number of referrals that would be
expected from the false-positive rates seen in the accuracy estimates (see Chapter 3). This may, in part,
be because of the fact that, in the real-world implementation of the SES, a child who is referred by a
screening test will be re-tested some weeks later before an onward referral for a DEA is made. In this
respect, more research on what determines programme specificity (as opposed to test specificity) would
be useful.
Understanding why the referral rate in Nottingham was less than in Cambridge (a service without a SES
programme) and whether or not this is related to the presence of SES would be of specific interest.
Whether or not the difference and cause of any differences is generalisable to other areas would be the
wider objective of further research. Further observational studies similar to our comparison between
Nottingham and Cambridge could be undertaken, albeit recognising the difficulty of matching the
geographical areas.
Further research to better quantify the impact of referral, particularly with respect to anxiety, and whether
or not all referrals are affected to the same degree as respondents in our study may be required,
particularly if it appears that overall effectiveness and cost-effectiveness could be critically dependent on
the costs and disutilities experienced by those testing false positive. We note also that our research has not
explored children’s perspectives on testing for hearing impairment and so this could be an important target
for further research.
Expanding the research on implementation to more sites could contribute further information on
differences in provision and further opinion from nurses applying the tests within those different systems.
If withdrawal of SES is contemplated in particular settings, this could be used as an opportunity for further
data collection. Particularly where the pattern of referrals and cases was known over many years in the run
up to withdrawal, any change in pattern of referrals/cases could be very useful evidence confirming the
lack of effectiveness and cost-effectiveness of SES, or challenging it. More formally if SES cessation is being
contemplated in many areas, a randomised trial of withdrawal of SES programmes could be designed
using referrals and hearing impairment cases identified as outcomes.
CONCLUSIONS AND RECOMMENDATIONS
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Appendix 1 Executive summary from
2007 report12
This text is reproduced from Bamford J, Fortnum H, Bristow K, Smith J, Vamvakas G, Davies L, et al.Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen.
Health Technol Assess 2007;11(32) under the Non-Commercial Government Licence for public
sector information.
Background
The ability to hear is important, particularly during children’s formal education. Hearing impairment is
amenable to intervention and hence a screening programme when children begin their school careers has
potential value. School entry hearing screening (SES) has been implemented throughout the UK since the
1950s. There is evidence of mixed practice and uncertainty about the value of the screen. In addition,
recent changes in childhood hearing screening policy (abandonment of a screen at 8 months and
introduction of universal newborn screening) have implications for identification of children with hearing
impairment at school entry.
Objectives
This report aimed to determine answers to the following three questions:
l What is current practice for the SES in the UK?
l What is known about the accuracy of alternative screening tests and the effectiveness of interventions?
l What is known about costs, and what is the likely cost-effectiveness of the SES?
Methods
A national postal questionnaire survey was addressed to all leads for the SES in the UK, considering current
practice in terms of implementation, protocols, target population and performance data. Primary data from
cohort studies in one area of London were examined. A systematic review of alternative SES tests, test
performance and impact on outcomes was carried out. Finally, a review of published studies on costs, plus
economic modelling of current and alternative programmes was prepared.
Results
The evidence from the national survey of current practice is that:
l the SES is in place in most areas of England, Wales and Scotland; just over 10% of respondents have
abandoned the screen; others are awaiting guidance in the light of the national implementation of
newborn hearing screening
l coverage of the SES is variable, but is often over 90% for children in state schools
l referral rates are variable, with a median of about 8%
l the test used for the screen is the pure-tone sweep test but with wide variation in implementation,
with differing frequencies, pass criteria and retest protocols; written examples of protocols were often
poor and ambiguous
l there is no national approach to data collection, audit and quality assurance, and there are variable
approaches at local level
l the screen is performed in less than ideal test conditions
l resources are often limited and this has an impact on the quality of the screen.
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The evidence from the primary cohort studies is that:
l the prevalence of permanent childhood hearing impairment continues to increase through infancy
l of the 3.47 in 1000 children with a permanent hearing impairment at school screen age, 1.89 in 1000
required identification after the newborn screen
l the introduction of newborn hearing screening is likely to reduce significantly the yield of SES for
permanent bilateral and unilateral hearing impairments; yield had fallen from about 1.11 in 1000
before newborn screening to about 0.34 in 1000 for cohorts that had had newborn screening, of
which only 0.07 in 1000 were unilateral impairments
l just under 20% of permanent moderate or greater bilateral, mild bilateral and unilateral impairments,
known to services as 6-year-olds or older, remained to be identified around the time of school entry.
The evidence from the systematic review of the alternative tests and of the effectiveness of interventions
is that:
l no good-quality published comparative trials of alternative screens or tests for school entry hearing
screening were identified
l studies concerned with the relative accuracy of alternative tests are difficult to compare and often
flawed by differing referral criteria and case definitions; with full pure-tone audiometry as the reference
test, the pure-tone sweep test appears to have high sensitivity and high specificity for minimal, mild
and greater hearing impairments, better than alternative tests for which evidence was identified
l there is insufficient evidence to draw any conclusions about possible harm of the screen
l there were no published studies identified that examined the possible effects of SES on
longer-term outcomes.
The evidence from the cost-effectiveness study is that:
l no good-quality published economic evaluations of SES were identified
l a universal SES based on pure-tone sweep tests was associated with higher costs and slightly higher
quality-adjusted life-years (QALYs) compared with no screen and other screen alternatives; the ICER for
such a screen is around £2500 per QALY gained; the range of expected costs, QALYs and net benefits
was broad, indicating a considerable degree of uncertainty
l targeted screening could be more cost-effective than universal SES
l lack of primary data and the wide limits for variables in the modelling mean that any conclusions must
be considered indicative and exploratory only.
A national screening programme for permanent hearing impairment at school entry meets all but three of
the criteria for a screening programme, but at least six criteria are not met for screening for transient
hearing impairment.
Conclusions
The lack of good-quality evidence in this area remains a serious problem. Services should improve quality
and audit screen performance for identification of previously unknown permanent hearing impairment,
pending evidence-based policy decisions based on the research recommendations.
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Recommendations for research
Further research is highlighted in the following areas:
l evaluation of an agreed national protocol for services delivering the SES to make future studies and
audits of screen performance more directly comparable
l development and evaluation of systems for data monitoring so that robust data on screen performance
are available
l determination with greater certainty of the prevalence of congenital unilateral hearing impairment, and
permanent mild and minimal hearing impairment at school entry, that could be identified by a suitable
quality-assured screen protocol
l a comparison of the effectiveness, efficacy and efficiency of alternative approaches (reactive services,
formal surveillance, targeted screening and universal screening at school entry age) to the identification
of permanent hearing impairment post newborn screen
l controlled studies of the effectiveness of hearing screening and subsequent interventions for later
outcomes in children with permanent mild, minimal and unilateral hearing impairment identified at
school entry
l determination of the distribution of detection thresholds for pure tones in the population at
school entry.
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Appendix 2 Systematic review
Search strategies: accuracy of diagnostic tests
Ovid MEDLINE(R)
Date range of search: January 2005 to July 2014.
Date of search: 10 July 2014.
Search strategy
1 audiometry.mp. or audiometry/ or exp
audiometry, pure-tone/
2 exp otoacoustic emissions, spontaneous/ or
otoacoustic emission$.mp.
3 exp acoustic impedance tests/ or acoustic
impedance.mp.
4 exp hearing tests/is, mt [instrumentation,
methods]
5 hearing test$.mp.
6 sweep audio.mp.
7 sweep test$.mp.
8 (hearing adj2 questionnaire$).mp.
9 cmedhq.mp.
10 conventional audiometry.mp.
11 conditioned play audiometry.mp.
12 cpa.mp.
13 exp audiometry, evoked response/
14 audiologic$ assessment$.mp.
15 acoustic intermittance.tw.
16 tympanometry.mp.
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17 otoscopy.mp. or exp otoscopy/ or exp
diagnostic techniques, otological/
18 otological exam$.mp.
19 acoustic reflex test$.mp.
20 teoae.mp.
21 dpoae.mp.
22 (impedance adj screening).mp.
23 (impedance adj method$).mp.
24 fixed frequency audio.mp.
25 (speech adj2 noise).mp.
26 reflectometry.mp.
27 acoustic impedance.mp.
28 or/1-27
29 exp hearing loss, sensorineural/pc, di
30 exp hearing disorders/di, pc
31 exp otitis media/pc, di
32 exp hearing loss, high-frequency/pc, di
33 exp hearing loss/di, pc
34 hearing impairment$.mp.
35 exp hearing loss, conductive/di, pc
36 (hearing adj3 screen$).mp.
37 exp “sensitivity and specificity”/
38 exp predictive value of tests/
39 (diagnos$ adj2 accura$).mp.
40 or/37-39
41 exp child, preschool/ or school entry.mp.
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42 exp child development/
43 early detect$.mp.
44 infant school$.mp.
45 exp schools, nursery/ or exp nurseries/ or exp
child day care centers/ or kindergarten$.mp.
46 nursery school$.mp.
47 or/41-46
48 screen$.mp. or exp mass screening/
49 (school entry adj3 (screen$ or exam$)).mp.
50 (medical exam$ adj2 school$).mp.
51 or/48-50
52 28 and 40
53 47 or 51
54 or/29-36
55 52 and 53
56 40 and 54
57 53 and 56
58 55 or 57
EMBASE
Date range search from: January 2005 to July 2014.
Date of search: 10 July 2014.
Search strategy
1 exp pure tone audiometry/ or exp audiometry/
or audiometry.mp.
2 otoacoustic emission$.mp. or exp spontaneous
otoacoustic emission/ or exp otoacoustic
emission/
3 acoustic impedance.mp. or exp acoustic
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impedance/
4 hearing test$.mp.
5 exp hearing test/
6 sweep audio.mp.
7 sweep test$.mp.
8 (hearing adj2 questionnaire$).mp.
9 cmedhq.mp.
10 ((conventional or conditioned play) adj
audiometry).mp.
11 cpa.mp.
12 exp evoked response audiometry/
13 (audiologic$ adj assessment$).mp.
14 (acoustic adj intermittance).mp.
15 tympanometry.mp. or exp tympanometry/
16 otoscopy.mp. or exp otoscopy/
17 (otological adj2 technique$).mp.
18 (otological adj2 (exam$ or technique$)).mp.
19 teoae.mp.
20 dpoae.mp. or exp distortion product
otoacoustic emission/
21 (impedance adj (screen$ or method$)).mp.
22 fixed frequency audio.mp.
23 (speech adj2 noise).mp.
24 reflectometry.mp. or exp reflectometry/
25 or/1-24
26 hearing loss/pc, di [prevention, diagnosis]
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27 hearing disorder/pc, di [prevention, diagnosis]
28 otitis media/pc, di [prevention, diagnosis]
29 hearing impair$.mp.
30 hearing impairment/pc, di [prevention,
diagnosis]
31 (hearing adj3 screen$).mp.
32 exp “sensitivity and specificity”/
33 (predictive adj2 test$).mp.
34 (diagnos$ adj2 accura$).mp.
35 or/32-34
36 or/26-31
37 25 and 35
38 school entry.mp.
39 pre-school.mp.
40 child/
41 exp child development/
42 early detect$.mp.
43 infant school$.mp.
44 nursery school$.mp. or exp nursery school/
45 exp child care/ or child day care.mp.
46 kindergarten$.mp. or exp kindergarten/
47 or/38-46
48 screen$.mp.
49 exp mass screening/
50 (school entry adj3 (screen$ or exam$)).mp.
51 (medical exam$ adj2 school$).mp.
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52 or/48-49
53 or/50-51
54 25 and 35 and 47
55 35 and 36 and 47
56 54 or 55
57 or/52-53
58 47 or 57
59 35 and 36 and 58
60 56 or 59
Cumulative Index to Nursing and Allied Health Literature
Date range searched from: January 2005 to July 2014.
Date of search: 10 July 2014.
Search strategy
1 audiometry.mp. or exp audiometry, evoked
response/ or exp audiometry/ or exp
audiometry, pure-tone/
2 otoacoustic emission$.mp. or exp otoacoustic
emissions, spontaneous/
3 exp acoustic impedance tests/ or acoustic
impedance.mp.
4 hearing test$.mp. or exp hearing tests/
5 sweep test$.mp.
6 sweep audio.mp.
7 (hearing adj2 questionnaire$).mp.
8 cmedhq.mp.
9 (conventional adj2 audiometry).mp.
10 (conditioned adj2 audiometry).mp.
11 cpa.mp.
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12 evoked response.mp. or exp evoked
potentials/
13 (audiologic$ adj assessment$).mp.
14 (acoustic adj intermittance).mp.
15 tympanometry.mp.
16 otoscopy.mp.
17 (otological adj2 technique$).mp.
18 (otological adj2 exam$).mp.
19 teoae.mp.
20 dpoae.mp. or exp otoacoustic emissions,
evoked/
21 (impedance adj (screen$ or method$)).mp.
22 fixed frequency audio.mp.
23 (speech adj2 noise).mp.
24 reflectometry.mp.
25 or/1-24
26 hearing disorders/di, pc
27 hearing impair$.mp.
28 exp hearing screening/
29 (hear$ adj2 screen$).mp.
30 or/26-29
31 exp “sensitivity and specificity”/
32 exp “predictive value of tests”/
33 (predictive adj2 test$).mp.
34 (diagnos$ adj2 accura$).mp.
35 or/31-34
36 school entry.mp.
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37 exp child, preschool/ or pre-school.mp.
38 exp child development/
39 early detect$.mp.
40 infant school$.mp. or exp infant development/
41 nursery school$.mp. or exp schools, nursery/
42 child day care.mp. or exp child day care/
43 kindergarten$.mp.
44 or/36-43
45 screen$.mp.
46 exp hearing screening/
47 exp school admissions/
48 (school entry adj2 (screen$ or exam$)).mp.
49 (medical exam$ adj2 school$).mp.
50 or/45-46
51 or/47-49
52 25 and 35 and 44
53 30 and 35 and 44
54 52 or 53
55 50 or 51 or 44
56 30 and 35 and 55
57 54 or 56
PsycINFO
Date range searched: January 2005 to July 2014.
Date of search: 10 July 2014.
Search strategy
1 exp bone conduction audiometry/ or exp
audiometry/ or audiometry.mp.
2 otoacoustic emission$.mp.
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3 acoustic impedance.mp.
4 hearing test$.mp.
5 sweep audio.mp.
6 sweep test$.mp.
7 (hearing adj2 questionnaire$).mp.
8 cmedhq.tw.
9 cpa.mp.
10 evoked response audiometry.mp.
11 audiologic$ assessment$.mp.
12 acoustic intermittance.tw.
13 tympanometry.mp.
14 otoscopy.mp.
15 (otological adj2 diagnos$).mp.
16 otological exam$.mp.
17 acoustic reflex test$.mp.
18 teoae.mp.
19 dpoae.mp.
20 (impedance adj screening).mp.
21 (impedance adj method$).mp.
22 fixed frequency audio.mp.
23 (speech adj2 noise).mp.
24 reflectometry.mp.
25 acoustic impedance.mp.
26 or/1-25
27 (sensitivity adj2 specificity).mp.
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28 (predictive value adj2 test$).mp.
29 (diagnos$ adj2 accurac$).mp.
30 or/27-29
31 ((hearing loss$ or hearing disorder$ or
hearing impair$ or otitis media) adj3
(diagnos$ or screen$)).mp.
32 30 or 31
33 26 and 32
34 child$.mp. or exp child day care/
35 exp early childhood development/ or exp
preschool education/ or exp preschool
students/ or pre-school.mp. or exp nursery
schools/
36 kindergarten$.mp. or exp kindergartens/
37 nursery school$.mp.
38 exp elementary school students/ or infant
school$.mp.
39 exp early intervention/ or early detect$.mp.
40 or/34-39
41 33 and 40
Education Resources Information Center (Cambridge Scientific Abstracts)
Date range searched: January 2005 to July 2014.
Search date: 10 July 2014.
Search strategy
(hearing or otitis) and (diagnos* or screen* or
test*) and (school*or nurser* or infant*) and
(accur* or predictive or sensitiv*)
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Science Citation Index (Web of Knowledge)
Date range searched: January 2005 to July 2014.
Search date: 10 July 2014.
Search strategy
(Hearing or otitis or deaf*) and (screen* or test*
or diagnos*) and (accura* or predictive or
sensitive) and (pre-school or infant* or nurser* or school*
Full-text studies excluded from the review and reasons
for exclusion
Anon. The EarCheck Middle Ear Monitor for detection of middle ear effusion in children. Med Lett Drugs
Ther 2008;50:55–6. (Not a diagnostic accuracy study, description of device.)
Ahn JH, Lee HS, Kim YJ, Yoon TH, Chung JW. Comparing pure-tone audiometry and auditory steady state
response for the measurement of hearing loss. Otolaryngol Head Neck Surg 2007;136:966–71. (Mean age
around 20 years.)
Arnold L, Boyle P, Canning D. Development of a paediatric audiovisual speech test in noise. Cochlear
Implants Int 2010;11(Suppl. 1):244–8. (Not a screening study, cochlear implant users.)
Bagatto MP, Brown CL, Moodie ST, Scollie SD. External validation of the LittlEARS(R) Auditory
Questionnaire with English-speaking families of Canadian children with normal hearing. Int J Pediatr
Otorhinolaryngol 2011;75:815–7. (Not a diagnostic accuracy study, children younger than 2 years.)
Bamford J, Fortnum H, Bristow K, Smith J, Vamvakas G, Davies L, et al. Current practice, accuracy,
effectiveness and cost-effectiveness of the school entry hearing screen. Health Technol Assess 2007;11(32).
(Systematic review, 2007 HTA report.)
Bhatia P, Mintz S, Hecht BF, Deavenport A, Kuo AA. Early identification of young children with hearing
loss in federally qualified health centers. J Dev Behav Pediatr 2013;34:15–21. (Not a diagnostic accuracy
study, children 0–3 years old.)
Blomgren K, Haapkyla J, Pitkaranta A. Tympanometry by nurses–can allocation of tasks be optimised?
Int J Pediatr Otorhinolaryngol 2007;71:7–10. (Evaluate performance of nurses, aim is not screening but
testing effectiveness of training.)
Bristow K, Fortnum H, Fonseca S, Bamford J. United Kingdom school-entry hearing screening: current
practice. Arch Dis Child 2008;93:232–5. (Not a diagnostic accuracy study, survey included in the original
HTA report.)
Chen G, Fu S, Luo S, Zhang W, Yang G. Screening of delayed-onset hearing loss in preschool children in
the mid-south of China. Int J Audiol 2013;52:568–71. (Only patients with positive result on the index test
received the reference standard.)
Dale OT, McCann LJ, Thio D, Wells SC, Drysdale AJ. The use of transient evoked otoacoustic emissions as a
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List of criteria used in the methodological quality assessment
1. Was the spectrum of participants representative of the population who will receive the test in practice?
The spectrum was considered representative if the study included children 4–6 (± 1) years old at or around school entry
stage who had been tested and found to have no hearing impairment at birth.
2. Were the selection criteria clearly described?
3. Is the reference standard likely to correctly classify the target condition?
The reference standard was considered able to correctly classify the target condition if it included a combination of PTA
and tympanometry performed in a suitable setting (quite room with ambient noise monitored) by a qualified
professional.
4. Is the time period between reference standard and index test short enough to be reasonable?
The time period between the performance of the index test and the reference standard was considered reasonable if it
was < 4 weeks.
5. Did the whole sample or a random selection of the sample receive verification using a reference standard?
6. Did patients receive the same reference standard regardless of the index test result?
7. Was the reference standard independent of the index test?
(i.e. the index test did not form part of the reference standard)
8. Was the execution of the index test described in sufficient detail to permit replication of the test?
9. Was the execution of the reference standard described in sufficient detail to permit its replication?
10. Were the index test results interpreted without knowledge of the results of the reference standard?
11. Were the reference standard results interpreted without knowledge of the results of the index test?
12. Were the same clinical data available when test results were interpreted as would be available when the test is used in
practice?
Testers usually have no prior information about children’s hearing, so any information that may affect the interpretation
of the index test was considered inappropriate.
13. Were uninterpretable/intermediate test results reported?
14. Were withdrawals explained?
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Appendix 3 Diagnostic accuracy study:
information
Case record form – cases p. 140.
Case record form – controls p. 144.
Participant information sheet – cases p. 147.
Participant summary information sheet – cases p. 150.
Children’s pictorial information sheet – cases p. 152.
Participant information sheet – controls p. 153.
Participant summary information sheet – controls p. 156.
Children’s information sheet – controls p. 157.
DOI: 10.3310/hta20360 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 36
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Fortnum et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
139
The diagnostic accuracy of hearing tests and cost-effectiveness of school entry hearing screening programmes 
Page 1 of 4 
SES Study 1  Case child: ID number  
Research tesng 
 
Date of Screen: / /  (DD/MM/YYYY)      
 
Locaon of test:        Clinic    /   Home   /    NHBRU    /    Other, please state ___________________ 
[circle as required] 
Background noise level:  dB   Notes: __________________________________________ 
_____________________________________________________________________________ 
 
 
Background informaon 
Locaon of hospital: ____________________              Date of Birth: / /  
 
Gender [circle as required]:     Male    /   Female             Post code:    
 
Ethnicity [tick as required]:                 Known medical condions [List below]:  
 
 
 
 
 
 
 
Procedural informaon [pre-randomised] 
 
Order of sweep tests?        
Pure Tone then Hearcheck       Hearcheck then Pure Tone      
  
Order of ears for the 2 tests? [record overleaf too]  
Le, right       Right, le         
 
 
Pure Tone Sweep results      
    
 Frequency detected? [ck if heard, cross if not heard] 
First test (20db) 1kHz 2kHz 4kHz 500Hz 
Le Ear             
 1kHz 2kHz 4kHz 500Hz 
Right Ear             
 
Analysis: (tick pass or fail)    Le Ear   Right Ear 
3/3 or 2/3 responses at every frequency     Pass     Pass   
1/3 or 0/3 responses for at least one frequency   Fail       Fail     
 
 
 
SES study 1 - CRF case children - v 1.3 26.09.13        
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03 
White 
Mixed / Multiple ethnic groups 
Asian / Asian British 
Black / African / Caribbean / Black Brish 
Other ethnic group 
Inials of 
screener: 
--------------
Time taken 
(mins): 
  
(DD/MM/YYYY) 
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ID Number:  DOB: / /  Postcode:    
Page 2 of 4 
 
 
HearCheck Sweep Results    
Which ear to test ﬁrst?  Le    Right   
 
 1KHz 3KHz  
 55dB 35dB 20dB 75dB 55dB 35dB  
Le Ear       Total heard          /6 
Right Ear       Total heard          /6 
 
Analysis: (tick pass or fail)     Le Ear   Right Ear 
Heard all 6 tones in both ears?      Pass     Pass   
Heard 0-5 tones in either ear?       Fail       Fail     
 
 
Which test was actually done ﬁrst?  Hearcheck  Pure Tone    
 
 
Blinding:  Did the second researcher know if the child passed or failed the ﬁrst screen? 
  Yes               No  
 
 If yes, please explain __________________________________________________________ 
 
 
 
Hearing History from Pure Tone Audiogram 
 
Date of PTA(dd/mm/yyyy):  
PTA aached?  Y    /    N 
RESULTS Frequency 250Hz 500Hz 1kHz 2kHz 4kHz 8kHz 
SF/Binaural AC (dBA)       
 Right AC (dBHL)       
Le AC (dBHL)       
Right Unmasked BC (dBHL)       
Le Unmasked BC (dBHL)       
Right Masked BC (dBHL)       
Le Masked BC (dBHL)       
 
Circle as appropriate 
(Required when there is no BC) 
Tymps Right Tymps Le 
A B C A B C 
 
 
 
 
 
 
 
SES study 1 - CRF case children - v 1.3 26.09.13        
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03 
Inials of 
screener: 
 
Time taken 
(mins): 
  
KEY to read PTA: 
 
     Right AC 
  X   Le AC 
 Δ   Unmasked BC 
 [     Right BC 
   ]   Le BC 
 
0-20 dBHL   Normal 
21-40   Mild Loss 
41-70   Moderate Loss 
71-95   Severe Loss 
> 95     Profound Loss 
Inials of 
researcher 
compleng 
the table: 
 
 
__________ 
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ID Number:  DOB: / /  Postcode:    
Page 3 of 4 
 
 
 
 
 
 
 
REPEAT 
AUDIOGRAM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SES study 1 - CRF case children - v 1.3 26.09.13        
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03 
 
Date of Repeat Audiogram(dd/mm/yyyy): 
PTA aached?  Y    /    N 
RESULTS 
Frequency 
250Hz 500Hz 1kHz 2kHz 4kHz 8kHz 
SF/Binaural AC (dBA)       
 Right AC (dBHL)       
Le AC (dBHL)       
Right Unmasked BC (dBHL)       
Le Unmasked BC (dBHL)       
Right Masked BC (dBHL)       
Le Masked BC (dBHL)       
 
Circle as appropriate 
(Required when there is no BC) 
Tymps Right Tymps Le 
A B C A B C 
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ID Number:  DOB: / /  Postcode:    
Page 4 of 4 
 
 
 
 
 
 
Would parent(s) like a summary of the project to be sent to them?          Y   /   N 
[Note down preferred contact details] 
 
 
 
 
 
 
 
 
 
 
 
 
--------------------------------------------------------------------------------------------------------------------------  
Is another PTA required (out of date/incomplete?) 
 
 
 
Details of the request (BY PHONE) for repeat audiogram: 
 
Name of audiologist:  ______________________________ 
 
Name of researcher:    _________________________       [signature]     
 
Date of request:    / /  (DD/MM/YYYY)    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SES study 1 - CRF case children - v 1.3 26.09.13        
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03 
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SES study 1 - CRF control children - v 1.3 27.09.13     Page 1 of 3 
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03 
 
SES Study 1  Control child – ID number  
Research tesng      
Date of screen:  / /  (DD/MM/YYYY)     
 
Locaon of test [circle as required]:       Clinic    /   NHBRU    /    Other, please state _______________ 
Background noise level:  dB   Notes: _______________________________________________ 
__________________________________________________________________________________ 
 
Background informaon 
Name of School: ______________________            Date of Birth:  / /  
Gender [circle as required]:     Male    /   Female             Post code:     
 
Ethnicity [tick as required]:                 Known medical condions [List below]:  
 
 
 
 
 
 
Procedural informaon [pre-randomised] 
 
Order of sweep tests?   
Pure Tone then Hearcheck       Hearcheck then Pure Tone        
 
Order of ears for the 3 tests? [Record overleaf too]  
Le, right, le    Right, le, right       
 
 
Pure Tone Sweep results        
 Frequency detected? [ck if heard, cross if not heard] 
First test (20db) 1kHz 2kHz 4kHz 500Hz 
Le Ear             
 1kHz 2kHz 4kHz 500Hz 
Right Ear             
Analysis: (tick pass or fail)    Le Ear   Right Ear 
3/3 or 2/3 responses at every frequency     Pass  Pass  
1/3 or 0/3 responses for at least one frequency   Fail    Fail    
 
 
HearCheck Sweep Results    
 1KHz 3KHz  
 55dB 35dB 20dB 75dB 55dB 35dB  
Le Ear       Total heard          /6 
Right Ear       Total heard          /6 
Analysis: (tick pass or fail)     Le Ear   Right Ear 
Heard all 6 tones in both ears?      Pass  Pass  
Heard 0-5 tones in either ear?       Fail    Fail    
Which test was actually done ﬁrst?  Hearcheck  Pure Tone   
 
 
 
White  
Mixed / Multiple ethnic groups  
Asian / Asian Brish  
Black / African / Caribbean / Black Brish  
Other ethnic group  
Time taken 
(mins):  
  
Inials 
of 
screener
:
Time taken  
(mins): 
  
(DD/MM/YYYY) 
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The diagnostic accuracy of hearing tests and cost-effectiveness of school entry hearing screening programmes ID 
Number:  DOB: / /  Postcode:    
   
SES study 1 - CRF control children - v 1.3 27.09.13     Page 2 of 3 
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03 
 
 
 
PURE TONE AUDIOGRAM (Gold standard)   
[2nd researcher to conduct and enter results only aer both screening tests have been completed by the 1 
researcher]  
 
Which ear to test ﬁrst?  Le      Right   
 
 
 
 
 
 
PTA results attached (printed out)?     Y    /    N     
PTA Result:       Normal     /   Refer       [circle as required]     
[Refer to Audiology if any frequencies >30dBHL are not heard] 
 
 
Blinding:  Did the second researcher know if the child passed or failed the screening tests? 
  Yes               No  
  
If yes, please explain __________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
RESULTS Frequency 
 1kHz 2kHz 4kHz 8kHz 500Hz 250Hz 
Right AC (dBHL)       
Le AC (dBHL)       
KEY to read PTA: 
 
  0-20 dBHL   Normal 
21-40   Mild Loss 
41-70   Moderate Loss 
71-95   Severe Loss 
> 95     Profound Loss 
Inials of 
tester: 
 
Time taken 
(mins): 
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The diagnostic accuracy of hearing tests and cost-effectiveness of school entry hearing screening programmes ID 
Number:  DOB: / /  Postcode:    
   
SES study 1 - CRF control children - v 1.3 27.09.13     Page 3 of 3 
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03 
 
 
 
Would parent(s) like a summary of the project to be sent to them?          Y   /   N 
[Note down preferred contact details] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
--------------------------------------------------------------------------------------------------------------------------  
Referral to Nongham Audiology Services Required?     Y    /    N       
 
Name of Child: ___________________________   Name of Parent: __________________________ 
Address: _________________________________________________________________________ 
_________________________________________________________________________________ 
Telephone Number: _______________________   Signature of Parent: _______________________ 
 
If referred, explain to parents and give them a leer and leaﬂet to take home 
Copy the CRF and pass to Claire or Shelly 
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The diagnostic accuracy of hearing tests and cost-effectiveness of school entry hearing screening programmes
Information Sheet Study 1 cases Version 1.3 Date: 20.09.13
(Form to be printed on NHBRU headed paper)
INFORMATION SHEET
(S1 Cases v1.3 20.09.13)
The diagnostic accuracy of hearing tests and cost-effectiveness of
school entry hearing screening programmes
Name of Researcher(s): Dr Heather Fortnum, Ms Sam Catterick and Ms Mara Ozolins
Invitation
We would like to invite your child to take part in a research study. Before you decide whether you
want to do that, it is important for you to understand why the research is being done and what it will
involve. If you would like, one of our team will go through the information sheet with you and
answer any questions you have. Talk to others about the study if you wish. Ask us if there is
anything that is not clear or if you would like more information.
Why has my child been chosen?
Your child is being invited to take part because we know they have a hearing loss. We are inviting 80
children like your child to take part. We are also inviting 160 children who do not have a hearing loss
to take part. Because we know whether or not the children taking part in this study have a hearing
loss we can tell if the screening tests we are assessing are able to correctly identify those with and
without a hearing loss.
Who are the researchers?
The research is being led by Dr Heather Fortnum, an Associate Professor and Reader in Hearing
Research at the University of Nottingham. She is working with two research fellows, Sam Catterick
and Mara Ozolins who will see the children in this study. The research also involves audiologists in
Nottingham and Cambridge, and research methods experts in Exeter.
What is the purpose of the study?
Identifying children who have a permanent hearing loss at the earliest possible age is very
important. When a hearing loss is detected early, the child’s speech and language is usually better
and they do better in school. There is now a hearing test at birth for all babies and this means that
the vast majority of children born with a hearing loss are identified at birth. However, not all children
who will eventually have a hearing loss have that hearing loss at birth.
In most parts of the UK at the moment, children have another hearing test when they start school,
using a machine to screen for permanent hearing loss. However, this might not be the best test to
use. A new system using a hand-held device to test hearing might be more accurate, and quicker
and easier for the children and for the school nurses who do the testing. One aim of this project is to
compare two types of hearing tests which can be used in schools to find out which one is better able
to identify hearing loss in children.
Does my child have to take part?
It is up to you to decide whether or not he or she takes part. If you do decide that your child will
take part, you will be asked to sign a consent form. If you later decide that he/she no longer wishes
to take part, please inform us and he/she will be withdrawn from the study. You do not need to give
a reason and it will not affect the standard of care your child receives.
What will happen to my child if they take part?
The research will involve just one session of testing with your child. If your child wears hearing aids,
they will be asked to remove these before we test them. We will test your child’s hearing with the
screening system currently used in schools and with the new handheld device. Each gives out sounds
at levels up to the equivalent of a noisy room and your child will need to tell us when they hear a
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Information Sheet Study 1 cases Version 1.3 Date: 20.09.13
sound by pressing a button. Each ear will be tested separately. The first system plays the sounds via
headphones and the second system plays the sounds from a small machine held next to the child’s
ear.
We also need to compare the two screening hearing tests with a full test of your child’s hearing.
This will be done in one of two ways:
1. If your child has had a recent hearing test at your local audiology service, or has an
appointment for a hearing test in the next 3 months we will just need to access a copy of
these results with your permission.
2. If they have not had a hearing test in the last 12 months and do not have an appointment to
have a hearing test in the next 3 months we would need to do a full hearing test in your local
audiology clinic or in the research facility in Nottingham.
Where will the tests take place?
We will carry out these tests in your own home or at our research facility at Ropewalk House in the
centre of Nottingham. You will be able to choose which is most convenient for you. The research
session should take no longer than 30 minutes in total and you can be with your child at all times.
When will my child take part?
The researchers intend to test children just once between December 2012 and October 2014 and
your child could be included at any point during this time. Therefore although we would like to know
now whether you would like your child to take part, please be aware that you will not be invited for
testing until your child is at least 4yrs old.
Expenses and payments
We will pay for all your travel expenses to attend for the hearing tests and each child will be offered
a book token to the value of £20 to say thank you for taking part.
What are the possible disadvantages or risks of taking part?
There should be no risk or discomfort for your child. The loudest sound that they will listen to is
approximately the equivalent of a noisy room.
What are the advantages of taking part?
We cannot promise the study will help your child but the information we get from this study may
help to decide how best to detect hearing loss in children in the future.
What if I have any concerns?
If you have a concern about any aspect of this study, you should ask to speak to the researchers
who will do their best to answer your questions. The researchers’ contact details are given at the
end of this information sheet. If you are still unhappy and wish to complain formally, you can do
this by contacting NHS Complaints <<PALS number for the appropriate hospital to be inserted>>.
Will my child taking part in this study be kept confidential?
All information about your child will be handled in confidence.
If your child joins the study, some parts of audiology records and the data collected for the study will
be looked at by authorised persons from the University of Nottingham who are organising the
research. The data may also be looked at by authorised people to check that the study is being
carried out correctly. All will have a duty of confidentiality to your child as a research participant and
we will do our best to meet this duty.
All information which is collected about your child during the course of the research will be kept
strictly confidential, stored in a secure and locked office, and on a password protected database.
Any information about your child which leaves the hospital will have your child’s name and address
removed (anonymised) and a unique code will be used so that they cannot be recognised from it.
Your child’s personal data (address, telephone number) will be kept for up to 12 months after the
end of the study. All research data will be kept securely for 7 years following publication. After this
time your child’s data will be disposed of securely. During this time all precautions will be taken by
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all those involved to maintain your child’s confidentiality; only members of the research team will
have access to their personal data.
What will happen if I do not want my child to carry on with the study?
Taking part in the study is voluntary and you are free to withdraw your child at any time, without
giving any reason, and without their legal rights being affected. If you withdraw your child, then the
information collected so far cannot be deleted and this information may still be used in the project
analysis.
What will happen to the results of the study?
The results of the study will be written up into a report for the National Institute for Health Research
who are funding the study. We will also publish the results in academic journals and present the
results at academic and clinical conferences. The results will feed into government decisions about
the best way to screen for hearing loss in children. We will send you a summary of the results if you
would like to receive it.
Who is organising and funding the research?
This research is being organised by the University of Nottingham and is being funded by the National
Institute for Health Research, Health Technology Assessment Programme.
Who has reviewed this study?
All research in the NHS is looked at by independent group of people, called a Research Ethics
Committee, to protect participant’s interests. This study has been reviewed and given favourable
opinion by the West Midlands, Staffordshire Research Ethics Committee.
Further information and contact details
If you have any questions or would like to talk to someone about this research, please contact either
the Chief Investigator, Dr Heather Fortnum or the study researchers, Sam Catterick or Mara Ozolins
on 0115 8232600 or email us at SES@nottingham.ac.uk. Alternatively, please write to: Heather
Fortnum at the Nottingham Hearing Biomedical Research Unit, Ropewalk House, 113 The Ropewalk,
Nottingham, NG1 5DU.
Thank you for reading this
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SUMMARY INFORMATION SHEET
(S1 Cases v1.1 20.09.13)
Are hearing tests at school accurate and cost eﬀecve?
What is the study about?
Most children in the UK have a hearing test when they start school. This study will
compare diﬀerent ways of tesng hearing to see which is best.
Why has my child been chosen?
We are inving 80 children with a hearing loss (like your child) and 160 children who do
not have a hearing loss to take part. We want to see if the hearing tests used can correctly
idenfy those with and without a hearing loss.
What will my child have to do?
We will either come to your home or you can come to us at Ropewalk House in the centre
of Nongham. Your child’s hearing will be tested using the hearing tests. Each test will
play sounds and your child will need to tell us when they hear them by pressing a buon.
Each ear will be tested separately. The ﬁrst test plays the sounds over headphones and
the second test plays the sounds from a small machine (like a telephone) held next to your
child’s ear. The research session should take no longer than 30 minutes in total.
When will my child take part?
We will test children just once between December 2012 and October 2014.
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What are the advantages of taking part?
The study may not help your child, but the informaon could help to decide how hearing
loss should be tested in children in the future.
Are there any risks to taking part?
There should be no risk or discomfor or your child. The loudest sound that they will
listen to is approximately the equivalent of a noisy room.
Will my child’s informaon be kept conﬁdenal?
All informaon about your child will be handled in conﬁdence.
Will we receive any payment?
We will pay for any travel expenses and your child will be given a £20 book token to say
thank you.
For further informaon or contact details of the researchers, please read the detailed
informaon sheet included in this pack.
If you would like to support the research, please return the reply slip to us
in the prepaid envelope provided.
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INFORMATION SHEET
(S1 Controls v1.3: 20.09.13)
The diagnostic accuracy o hearing tests and cost-effectiveness of
school entry hearing screening programmes
Name of Researcher(s): Dr Heather Fortnum, Ms Sam Catterick and Ms Mara
Ozolins
Invitation
We would like to invite your child to take part in a research study. Before you decide whether
you want to do that, it is important for you to understand why the research is being done and
what it will involve. One of our team will go through the information sheet with you and
answer any questions you have. Talk to others about the study if you wish. Ask us if there is
anything that is not clear or if you would like more information.
Why has my child been chosen?
Your child is being invited to take part because to the best of our knowledge they have normal
hearing. We are inviting 160 children like your child to take part. We are also inviting 80
children who do have a hearing loss to take part. Because we know whether or not the
children taking part in this study have a hearing loss we can tell if the screening tests we are
assessing are able to correctly identify those with and without a hearing loss.
Who are the researchers?
The research is being led by Dr Heather Fortnum, an Associate Professor and Reader in
Hearing Research at the University of Nottingham. She is working with two research fellows,
Sam Catterick and Mara Ozolins who will see the children in this study. The research also
involves audiologists in Nottingham and Cambridge, and research methods experts in Exeter.
What is the purpose of the study?
Identifying children who have a permanent hearing loss at the earliest possible age is very
important. When a hearing loss is detected early, the child’s speech and language is usually
better and they do better in school. There is now a hearing test at birth for all babies and this
means that the vast majority of children born with a hearing loss are identified at birth.
However, not all children who will eventually have a hearing loss have that hearing loss at
birth.
In most parts of the UK at the moment, children have another hearing test when they start
school, using a machine to screen for permanent hearing loss. However, this might not be the
best test to use. A new system using a hand-held device to test hearing might be more
accurate, and quicker and easier for the children and for the school nurses who do the testing.
One aim of this project is to compare two types of hearing tests which can be used in schools
to find out which one is better able to identify hearing loss in children.
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Does my child have to take part?
It is up to you to decide whether or not he or she takes part. If you do decide that your child
will take part, you will be asked to sign a consent form. If you later decide that he/she no
longer wishes to take part, please inform us and he/she will be withdrawn from the study. You
do not need to give a reason and it will not affect the standard of care your child receives.
What will happen to my child if they take part?
The research will involve just one session of testing with your child. We will test your child’s
hearing with the screening system currently used in schools and with the new handheld device.
Each gives out sounds at levels up to the equivalent of a noisy room and your child will need
to tell us when they hear a sound by pressing a button. Each ear will be tested separately.
The first system plays the sounds via headphones and the second system plays the sounds
from a small machine held next to the child’s ear.
We also need to compare the two screening hearing tests with a full test of your child’s
hearing. This involves your child listening through headphones to a longer series of tones and
indicating to the researcher when they can hear something by moving an object.
Where will the tests take place?
We will carry out these tests at our research facility at Ropewalk House in the centre of
Nottingham. The research session should take no longer than 45 minutes and you can be with
your child at all times.
When will my child take part?
The researchers intend to test children just once between December 2012 and October 2014
and your child could be included at any point during this time. Therefore although we would
like to know now whether you would like your child to take part, we may not arrange the
research appointment straight away.
What will happen if you find that my child has a hearing loss?
If the hearing tests indicate that your child might have a hearing loss we will give you a letter
explaining that we will refer your child for an appointment at the local audiology clinic to have
a further test of their hearing and where you can talk to a hearing specialist.
Expenses and payments
We will pay for all your travel expenses to attend for the hearing tests and each child will be
offered a book token to the value of £20 to say thank you for taking part.
What are the possible disadvantages or risks of taking part?
There should be no risk or discomfort for your child. The loudest sound that they will listen to
is approximately the equivalent of a noisy room.
What are the advantages of taking part?
We cannot promise the study will help your child but the information we get from this study
may help to decide how best to detect hearing loss in children in the future.
What if I have any concerns?
If you have a concern about any aspect of this study, you should ask to speak to the
researchers who will do their best to answer your questions. The researchers’ contact details
are given at the end of this information sheet. If you are still unhappy and wish to complain
formally, you can do this by contacting NHS Complaints on 0800 0153367.
Will my child taking part in this study be kept confidential?
All information about your child will be handled in confidence.
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If your child joins the study, some parts of the data collected for the study will be looked at by
authorised persons from the University of Nottingham who are organising the research. The
data may also be looked at by authorised people to check that the study is being carried out
correctly. All will have a duty of confidentiality to your child as a research participant and we
will do our best to meet this duty.
All information which is collected about your child during the course of the research will be
kept strictly confidential, stored in a secure and locked office, and on a password protected
database. Any information about your child which leaves the research facility will have your
child’s name and address removed (anonymised) and a unique code will be used so that they
cannot be recognised from it.
Your child’s personal data (address, telephone number) will be kept for up to 12 months after
the end of the study. All research data will be kept securely for 7 years following publication.
After this time your child’s data will be disposed of securely. During this time all precautions
will be taken by all those involved to maintain your child’s confidentiality; only members of
the research team will have access to their personal data.
What will happen if I do not want my child to carry on with the study?
Taking part in the study is voluntary and you are free to withdraw your child at any time,
without giving any reason, and without their legal rights being affected. If you withdraw your
child, then the information collected so far cannot be deleted and this information may still be
used in the project analysis.
What will happen to the results of the study?
The results of the study will be written up into a report for the National Institute for Health
Research who are funding the study. We will also publish the results in academic journals and
present the results at academic and clinical conferences. The results will feed into government
decisions about the best way to screen for hearing loss in children. We will send you a
summary of the results if you would like to receive it.
Who is organising and funding the research?
This research is being organised by the University of Nottingham and is being funded by the
National Institute for Health Research, Health Technology Assessment Programme.
Who has reviewed this study?
All research in the NHS is looked at by independent group of people, called a Research Ethics
Committee, to protect participant’s interests. This study has been reviewed and given
favourable opinion by the West Midlands, Staffordshire Research Ethics Committee.
Further information and contact details
If you have any questions or would like to talk to someone about this research, please contact
either the Chief Investigator, Dr Heather Fortnum or the study researchers, Sam Catterick or
Mara Ozolins on 0115 8232600 or email us at SES@nottingham.ac.uk. Alternatively, please
write to: Heather Fortnum at the Nottingham Hearing Biomedical Research Unit, Ropewalk
House, 113 The Ropewalk, Nottingham, NG1 5DU.
Thank you for reading this
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SUMMARY INFORMATION SHEET (S1 Controls v1.1 20.09.13)
Are hearing tests at school accurate and cost eﬀecve?
What is the study about?
Most children in the UK have a hearing test when they start school. This study will compare different ways
of tesng hearing to see which is best.
Why has my child been chosen?
We are inving 80 children with a hearing loss and 160 children who do not have a hearing loss (like your
child) to take part. We want to see if the hearing tests used can correctly idenfy those with and without a
hearing loss.
What will my child have to do?
Your child’s hearing will be tested using two hearing tests. Each test will play sounds and your child will
need to tell us when they hear them by pressing a buon. Each ear will be tested separately. The ﬁrst test
plays the sounds over headphones and the second test plays the sounds from a small machine (like a
telephone) held next to your child’s ear.
We also need to compare the two hearing tests with a full test of your child’s hearing which involves
listening to a longer series of sounds.
The research session should take no longer than 45 minutes in total.
When will my child take part?
We will test children at our research unit at Ropewalk House in the centre of Nongham just once
between December 2012 and October 2014.
What are the advantages of taking part?
The study may not help your child, but the informaon could help to decide how hearing loss should be
tested in children in the future.
Are there any risks to taking part?
There should be no risk or discomfort for your child. The loudest sound that they will listen to is
approximately the equivalent of a noisy room.
Will my child’s information be kept conﬁdenal?
All informaon about your child will be handled in conﬁdence.
Will we receive any payment?
We will pay for any travel expenses and your child will be given a £20 book token to say thank you.
For further informaon or contact details of the researchers, please read the detailed informaon sheet
included in this pack.
If you would like to support the research, please return the reply slip
to us in the prepaid envelope provided.
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Appendix 4 The relationship between the
pure-tone screen and HearCheck screener results
TABLE 47 Cross-tabulation of the PTS vs. HC results for ear-level analysis: analyses include only impaired ears that
belong to children recruited as cases – impaired ears defined as those with a PTA score of ≥ 30dB on at least one
of the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 104 0 1 105
Pass 2 1 0 3
Missing 0 0 0 0
Total 106 1 1 108
Hearing (by reference standard)
HC test results Refer 34 26 0 60
Pass 45 340 0 385
Missing 0 1 0 1
Total 79 367 0 446
Missing (no reference standard)
HC test results Refer 13 2 1 16
Pass 3 2 1 6
Missing 2 0 4 6
Total 18 4 6 28
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TABLE 48 Cross-tabulation of the PTS vs. HC test results for ear-level analyses: analyses include only impaired ears
that belong to children recruited as controls – impaired ears defined as those with a PTA score of ≥ 30 dB on at
least one of the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 32 2 0 34
Pass 8 6 0 14
Missing 0 0 0 0
Total 40 8 0 48
Hearing (by reference standard)
HC test results Refer 34 26 0 60
Pass 45 340 0 385
Missing 0 1 0 1
Total 79 367 0 446
Missing (no reference standard)
HC test results Refer 13 2 1 16
Pass 3 2 1 6
Missing 2 0 4 6
Total 18 4 6 28
TABLE 49 Cross-tabulation of the PTS vs. HC test results for ear-level analyses: analyses include all impaired ears
regardless of whether belong to children recruited as case or control – impaired ears defined as those with an
average PTA score of ≥ 30 dB across the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 109 1 1 111
Pass 2 4 0 6
Missing 0 0 0 0
Total 111 5 1 117
Hearing (by reference standard)
HC test results Refer 61 27 0 88
Pass 53 343 0 396
Missing 0 1 0 1
Total 114 371 0 485
Missing (no reference standard)
HC test results Refer 13 2 1 16
Pass 3 2 1 6
Missing 2 0 4 6
Total 18 4 6 28
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TABLE 50 Cross-tabulation of the PTS vs. HC test results for ear-level analyses: analyses include only impaired ears
that belong to children recruited as cases – impaired ears defined as those with an average PTA score of ≥ 30dB
across the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 89 0 1 90
Pass 1 1 0 2
Missing 0 0 0 0
Total 90 1 1 92
Hearing (by reference standard)
HC test results Refer 61 27 0 88
Pass 53 343 0 396
Missing 0 1 0 1
Total 114 371 0 485
Missing (no reference standard)
HC test results Refer 13 2 1 16
Pass 3 2 1 6
Missing 2 0 4 6
Total 18 4 6 28
TABLE 51 Cross-tabulation of the PTS vs. HC test results for ear-level analyses: analyses include only impaired ears
that belong to children recruited as controls – impaired ears defined as those with an average PTA score of ≥ 30 dB
across the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 20 1 0 21
Pass 1 3 0 4
Missing 0 0 0 0
Total 21 4 0 25
Hearing (by reference standard)
HC test results Refer 61 27 0 88
Pass 53 343 0 396
Missing 0 1 0 1
Total 114 371 0 485
Missing (no reference standard)
HC test results Refer 13 2 1 16
Pass 3 2 1 6
Missing 2 0 4 6
Total 18 4 6 28
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TABLE 52 Cross-tabulation of the PTS vs. HC test results for child-level analyses: analyses include only impaired
children who were nominally recruited as cases – impaired children defined as those with an PTA score of ≥ 30dB
on at least one of the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 59 0 0 59
Pass 0 1 0 1
Missing 0 0 0 0
Total 59 1 0 60
Hearing (by reference standard)
HC test results Refer 18 14 0 32
Pass 22 144 0 166
Missing 0 0 0 0
Total 40 158 0 198
Missing (no reference standard)
HC test results Refer 14 0 1 15
Pass 1 0 0 1
Missing 1 0 3 4
Total 16 0 4 20
TABLE 53 Cross-tabulation of the PTS vs. HC test results for child-level analyses: analyses include only impaired
children who were nominally recruited as controls – impaired children defined as those with a PTA score of ≥ 30dB
on at least one of the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 26 1 0 27
Pass 8 2 0 10
Missing 0 0 0 0
Total 34 3 0 37
Hearing (by reference standard)
HC test results Refer 18 14 0 32
Pass 22 144 0 166
Missing 0 0 0 0
Total 40 158 0 198
Missing (no reference standard)
HC test results Refer 14 0 1 15
Pass 1 0 0 1
Missing 1 0 3 4
Total 16 0 4 20
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TABLE 54 Cross-tabulation of the PTS vs. HC test results for child-level analyses: analyses include all impaired
children regardless of whether recruited as case or control – impaired children defined as those with an average
PTA score of ≥ 30 dB across the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 70 0 0 70
Pass 3 2 0 5
Missing 0 0 0 0
Total 73 2 0 75
Hearing (by reference standard)
HC test results Refer 33 15 0 48
Pass 27 145 0 172
Missing 0 0 0 0
Total 60 160 0 220
Missing (no reference standard)
HC test results Refer 14 0 1 15
Pass 1 0 0 1
Missing 1 0 3 4
Total 16 0 4 20
TABLE 55 Cross-tabulation of the PTS vs. HC test results for child-level analyses: analyses include only impaired
children who were nominally recruited as cases – impaired ears defined as those with an average PTA score of
≥ 30dB across the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 53 0 0 53
Pass 0 1 0 1
Missing 0 0 0 0
Total 53 1 0 54
Hearing (by reference standard)
HC test results Refer 33 15 0 48
Pass 27 145 0 172
Missing 0 0 0 0
Total 60 160 0 220
Missing (no reference standard)
HC test results Refer 14 0 1 15
Pass 1 0 0 1
Missing 1 0 3 4
Total 16 0 4 20
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TABLE 56 Cross-tabulation of the PTS vs. HC test results for child-level analyses: analyses include only impaired
children who were nominally recruited as controls – impaired ears defined as those with an average PTA score of
≥ 30 dB across the four frequencies
PTS test results
Refer Pass Missing Total
Impaired (by reference standard)
HC test results Refer 17 0 0 17
Pass 3 1 0 4
Missing 0 0 0 0
Total 20 1 0 21
Hearing (by reference standard)
HC test results Refer 33 15 0 48
Pass 27 145 0 172
Missing 0 0 0 0
Total 60 160 0 220
Missing (no reference standard)
HC test results Refer 14 0 1 15
Pass 1 0 0 1
Missing 1 0 3 4
Total 16 0 4 20
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Appendix 5 Parent questionnaire
The diagnostic accuracy of hearing tests and cost-effectiveness of school entry hearing screening programmes
Study 3 questionnaire – NHBRU V1.2: 26.09.13 NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03
School Entry Hearing Screening
Questionnaire for parents and carers (version 1.2: 26.09.13)
We thank you for completing and returning this questionnaire.
If you would like to be entered into a prize draw for a chance to win a £50 voucher of your
choice, please provide us with some contact information on page 5.
Page 1 of 5
Participant identifier:
Date returned:
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Study 3 questionnaire – NHBRU V1.2: 26.09.13 NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03
Page 2 of 5
Page One of Five Continued overleaf
1. Were you aware that your child was having their hearing checked at school?
Y / N (please circle one)
2. How did you find out that your child needed further testing for their hearing? (please circle
one)
Letter taken home by child / Letter in the post / Telephone / Other, please state ___________
3. When you heard that your child needed further testing for their hearing, how anxious did
you feel? Please indicate by circling the appropriate number below:
Not at all anxious Extremely anxious
0 1 2 3 4 5 6 7 8 9 10
4. How many hospital or clinic appointments did your child attend (in total) after being told
they needed further testing for their hearing? _____________________
5. How much do you agree with the following statement; “children should have their hearing
checked at school”. (Please circle one)
Strongly agree / Agree / No opinion / Disagree / Strongly disagree
6. What are the good things about your child having their hearing checked at school?
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
7. What are the not so good things about your child having their hearing checked at school?
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
8. Do you have any further comments?
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
A: School Screen
B: Opinion
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Page Two C ontinued overleaf
9. WHEN COMPLETING THE QUESTIONS BELOW PLEASE CONSIDER THE FIRST FIVE
APPOINTMENTS THAT YOUR CHILD MAY HAVE HAD.
APPOINTMENTS 1st 2nd 3rd 4th 5th
How long was the journey from home to each appointment? (please tick)
Less than 15 minutes
About 30 minutes
About 1 hour
Between 1 – 2 hours
More than 2 hours
How did you travel to each appointment? (please tick all that apply)
Bus or Tram
_______ _______ _______ _______ _______
Car
Taxi
Train
Other, please state:
How much did it cost to travel to each appointment? (please state)
Return no. of miles _______ _______ _______ _______ _______
Parking (£) _______ _______ _______ _______ _______
Tickets/Fares (£) _______ _______ _______ _______ _______
Other (£) _______ _______ _______ _______ _______
How long were you at each appointment? (please tick)
Less than 30 minutes
Between 30 minutes and 1 hour
About 1 hour
Between 1 – 2 hours
More than 2 hours
How much time was taken off work to attend each appointment? (please tick)
Not working
No time taken off
Part of a day
Full day
How much time did your child have off school to attend each appointment? (please tick)
None
Part of a day
C: Impact
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10.Did any of the appointments prevent your child from taking part in activities or events that
he/she would normally attend? Y / N (please circle one)
If yes, please state what. ____________________________
If yes, how many times were these activities or events missed? ____________________
11. Did any of the appointments prevent you from taking part in activities or events that you
would normally attend? Y / N (please circle one).
If yes, please state what. ____________________________
If yes, how many times were these activities or events missed? ____________________
12. Did attending appointments cause problems for other members of your family?
Y / N (please circle one ). If yes, please state how: ____________________________
13.When your child attended hospital or clinic appointments, how anxious did you feel?
Please indicate by circling the appropriate number below:
Not at all anxious Extremely anxious
0 1 2 3 4 5 6 7 8 9 10
14. Your Child's Gender: Male / Female (please circle one)
15. Your Child’s Ethnicity: (please tick one)
16. Please provide the name of your child’s school: _________________________
Thank you for taking the time to complete this questionnaire. Your information will remain confidential.
Please return your completed questionnaire in the prepaid envelope provided.
We may conduct a telephone interview to gain some further information about the school
hearing screening process from a parent’s point of view. While not everyone would be
contacted, if you would like to be considered, please supply your details on the next page:
Full day
White
Mixed / Multiple ethnic groups
Asian / Asian British
Black / African / Caribbean / Black British
Other ethnic group
D: Background Information
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Please tick any boxes that apply to you:
I would like to be considered for a telephone interview; Yes No
I would like to be entered into a prize draw to win a £50 voucher of my choice Yes No
Contact Details:
Name: ___________________________ Telephone Number: _______________________
Your contact details will be used if we decide to call you about your responses on the
questionnaire or if you win the prize draw.
Your details will not be used for any other reason and they will be destroyed once the study
has ended.
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Appendix 6 Practical implementation of screening
tests for hearing in schools: information
Participant information sheet
The diagnostic accuracy of hearing tests and cost-effectiveness of school entry hearing screening programmes 
Parent Information Sheet Study 4 Final Version 1.2     23.05.13  
   Page 1 of 3
 
Information Sheet  
Study title: The accuracy of hearing tests and cost-effectiveness of school entry 
hearing screening programmes 
 
Name of Researcher(s):  Dr Heather Fortnum, Ms Sam Catterick and Ms Mara 
Ozolins 
 
Invitation 
We would like to invite your child to take part in a research study.  Before you decide 
whether you agree to their participation it is important for you to understand why the 
research is being done and what it will involve.  If you would like, one of our team will go 
through the information sheet with you and answer any questions you have. Talk to 
others about the study if you wish. Ask us if there is anything that is not clear or if you 
would like more information.   
 
What is the purpose of the study? 
Identifying children who have a permanent hearing loss at the earliest possible age is 
very important. When a hearing loss is detected early, the child’s speech and language is  
usually better and they do better in school. There is now a hearing test at birth for all 
babies and this means that the vast majority of children born with a hearing loss are 
identified at birth. However, not all children who will eventually have a hearing loss have 
that hearing loss at birth.  
 
In most parts of the UK at the moment children have another hearing test when they 
start school to screen for permanent hearing loss. However, this might not be the best 
test to use. A new system using a hand-held device to test hearing might be more 
accurate, and quicker and easier for the children and the school nurses who do the 
testing.  
 
One aim of this project is to compare the current test with this new way of testing 
hearing in schools and find out which one is better able to identify hearing loss in 
children. 
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What will happen to my child if they take part? 
Your child’s hearing will be tested with the system currently used in schools, regardless 
of whether or not your child takes part in the research. As part of the research we would 
also like to test your child’s hearing with a new handheld device. Each hearing test gives 
out sounds at levels up to the equivalent of a noisy room and your child will need to say 
when they hear a sound. Each ear will be tested separately. The first system plays the 
sounds via headphones and the new system plays the sounds from a small device held 
next to the child’s ear. Your child tells the school nurse when they hear something by 
raising their hand. 
The school nurse will carry out each of the tests in your child’s school during the normal 
school day. A member of the research team will observe the tests and record how long it 
takes and other general observations about the two tests. 
Why has my child been chosen? 
Your child is being invited to take part because they have recently started school and are 
eligible to have a routine hearing test. 
 
Does my child have to take part? 
It is up to you to decide whether or not he or she takes part. If you do decide that your 
child will take part, you don’t need to do anything.  If you decide that he/she should not 
take part, please return the reply slip on the invitation letter and return it to the school 
nurse at your child’s school. 
  
What are the possible disadvantages or risks of taking part? 
There should be no risk or discomfort for your child. The loudest sound that they will 
listen to is approximately the equivalent of a noisy room.  
 
What are the advantages of taking part? 
We cannot promise the study will help your child but the information we get from this 
study may help to decide how best to detect hearing loss in children in the future. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions.  The researchers’ contact 
details are given at the end of this information sheet.   
 
Will information about my child be kept confidential? 
We will not collect any information about your child in this piece of research, as we are 
interested only in the methods used to test hearing and not your child’s personal details. 
What will happen to the results of the study? 
The results of the study will be written up into a report for the National Institute for 
Health Research who are funding the study. We will also publish the results in academic 
journals and present the results at academic and clinical conferences. The results will 
feed into government decisions about the best way to screen for hearing loss in children.   
 
Who are the researchers? 
The research is being led by Dr Heather Fortnum, an Associate Professor and Reader in 
Hearing Research at the University of Nottingham. She is working with two research 
fellows, Sam Catterick and Mara Ozolins who will see the children in this study.  
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Who is organising and funding the research? 
This research is being organised by the University of Nottingham and is being funded by 
the National Institute for Health Research, Health Technology Assessment Programme 
 
Who has reviewed this study? 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect participant’s interests. This study has been reviewed and 
given favourable opinion by West Midlands, Staffordshire Research Ethics Committee. 
 
Further information and contact details 
The chief investigator for this study is Dr Heather Fortnum, telephone 0115 8232600 or 
email heather.fortnum@nottingham.ac.uk. The two researchers working on the study are 
Sam Catterick, telephone 0115 8232607, email samantha.catterick@nottingham.ac.uk 
and Mara Ozolins, telephone 0115 8232827, email mara.ozolins@nottingham.ac.uk.   
 
Thank you for reading this 
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Case record form
The diagnostic accuracy of hearing tests and cost-effectiveness of school entry hearing screening programmes 
SES study 4 - CRF v 2 28.01.14   
NRES ref: 12/WM/0195, Sponsor ref: 12064, Ethics ref: 106333, NIHR HTA10/63/03 
1 of 4 
CRF: SES Study 4  
SCHOOL DETAILS 
Name of school  
Postcode  Researcher: MO or SC?     
No. of pupils on roll  No. of pupils receiving free school meals  
Location Urban  Rural  
SESSION DETAILS 
Date of Observation  
Start time  End time  
No. of Hearcheck disposable cups used during the session  
Name of Nurse  
Is a member of school staff present? Yes  No  
 If yes, state job role  
FEEDBACK FROM NURSE AFTER THE SESSION 
PURE TONE SCREEN (PTS) 
On a scale of 0-10 (with 0 being low), how would you rate the PTS on ease of use?  
On a scale of 0-10 (with 0 being low), how would you rate the PTS on accuracy?  
On a scale of 0-10 (with 0 being low), how much would you want to keep the PTS in the 
future? 
 
Additional comments on the PTS: 
HEARCHECK (HC) 
On a scale of 0-10 (with 0 being low), how would you rate the HC on ease of use?  
On a scale of 0-10 (with 0 being low), how would you rate the HC on accuracy?  
On a scale of 0-10 (with 0 being low), how much would you want to keep the HC in the 
future? 
 
Additional comments on the HC: 
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INFORMATION ABOUT THE CIRCUMSTANCES OF THE SCREEN 
Make comments on items such as; Where did the screening take place? How many children were 
present? How were explanations done? Were there any interruptions? Any other details that affected 
the screening. 
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